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 SUMMARY  
 
 
Summary 
 
This thesis describes crystal structures of complete, 12-subunit yeast RNA polymerase II (Pol II) 
in complex with a synthetic transcription bubble and product RNA, with an NTP substrate 
analogue, and in complex with the transcription elongation factor TFIIS. The structure of the 
Pol II-transcription bubble-RNA complex reveals incoming template and non-template DNA, a 
seven base-pair DNA-RNA hybrid, and three nucleotides each of separating DNA and RNA. 
Based on this structure, those parts of Pol II were identified which are involved in separating 
template DNA from non-template DNA before the active site, and DNA from product RNA at 
the upstream end of the DNA-RNA hybrid. In both instances, strand separation can be 
explained by Pol II-induced duplex distortions. Only parts of the complete transcription bubble 
present in the complexes are ordered in the crystal structure, explaining the way in which high 
processivity of Pol II is reconciled with rapid translocation along the DNA template. The 
presence of an NTP substrate analogue in a conserved putative pre-insertion site was unveiled in 
a Pol II-transcription bubble-RNA complex crystal soaked with the substrate analogue 
GMPCPP.  The structure of the Pol II-TFIIS complex was obtained from Pol II crystals soaked 
with TFIIS. TFIIS extends from the Pol II surface to the active site and complements the active 
site with two essential and invariant acidic residues for hydrolytic RNA cleavage. TFIIS also 
induces extensive structural changes in Pol II that reposition nucleic acids, in particular RNA, 
near the active centre.  These results support the idea that Pol II contains a single tuneable active 
site for RNA polymerisation and cleavage. The technical obstacles imposed by crystal structure 
determination of large, transient protein-DNA-RNA complexes were overcome by two novel, 
fluorescence-based assays to monitor and optimise the composition of the crystals. Both assays 
are not limited to Pol II complexes, but can serve as a general tool for the crystallographic 
community. 
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 INTRODUCTION 1 
1 FLOW OF GENETIC INFORMATION 
Genes specify the kinds of proteins that are made by cells. However, DNA is not the direct 
template for protein synthesis. Rather, the templates for protein synthesis are RNA molecules. A 
special class of RNA, messenger RNA (mRNA), is the information-carrying intermediate in 
protein synthesis (Brenner e t  a l . , 1961). Other classes of RNA include transfer RNA (tRNA) and 
ribosomal RNA (rRNA) which are involved in protein biosynthesis, and small nuclear RNAs 
(snRNAs) which play a key role in directing the alignment of splice sites and in mediating the 
splicing process (see chapter 10.4). The “molecular machines” producing all forms of cellular 
RNA are RNA polymerases, which take instructions from DNA templates (“DNA dependent 
RNA polymerases”). In the case of mRNAs, this process of transcription is followed by 
translation, the synthesis of proteins according to instructions given by mRNA templates. Thus, 
the flow of genetic information in normal cells, enunciated by F. Crick in 1958 as “The central 
dogma of molecular biology” (Crick, 1970), proceeds as illustrated in Figure 1.  
 
 
Figure 1: The central dogma of molecular biology 
 
The concept of mRNA as the information-carrying intermediate in protein synthesis was 
proposed by F. Jacob and J. Monod (Jacob, 1961) and experimentally confirmed by S. Brenner, 
F. Jacob and M. Meselson (Brenner e t  a l . , 1961). By that time it was evident that an intermediate 
is necessary, which transports the information stored by DNA in the nucleus to the protein-
synthesising ribosomes in the cytoplasm of eukaryotic cells. From studies of time-dependent 
expression of the inducible protein β-galactosidase, they hypothesised that the messenger 
molecule must be a very short-lived polynucleotide. Jacob and Monod proposed, based on 
infection studies of E. co l i  with T2 bacteriophages, that the base composition of the messenger 
is analogous to the base composition of the DNA that codes for it (Jacob, 1961).  Variable 
lengths of messenger molecules reflect variable lengths of proteins occurring in a cell. The rapidly 
synthesised and degraded messenger molecules were proposed to be transiently associated with 
ribosomes. Jaques Monod and François Jacob received the 1965 Nobel Prize for medicine 
together with André Lwoff for “their discoveries concerning genetic control of enzyme and virus 
synthesis”. 
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2 DISCOVERY OF RNA POLYMERASES 
The novel concept of mRNA fuelled the search for an enzyme that produces this molecule in a 
DNA-templated manner. Such an enzyme was discovered independently by Jerard Hurwitz 
(Hurwitz e t  a l . , 1961) and Samuel Weiss (Weiss and Nakamoto, 1961). Both termed this enzyme 
“RNA polymerase”. The earliest evidence for the existence of DNA dependent RNA 
polymerases was the finding that the base composition of newly synthesised RNA is 
complementary to that of the DNA template. Hybridisation experiments revealed that also the 
RNA sequence is complementary to its DNA template (Hall and Spiegelman, 1961).  
3 THREE CLASSES OF CELLULAR RNA POLYMERASES 
While in prokaryotes all RNA is synthesised by a single kind of polymerase, the work is shared by 
three types of RNA polymerases in the nucleus of eukaryotes. These three polymerases differ in 
promoter specificity, localisation and susceptibility to inhibitors. The three types of nuclear RNA 
polymerases were identified in crude cell lysate fractionated by chromatography over an anion 
exchange (DEAE) column. At three different salt concentrations, fractions were obtained which 
catalysed RNA synthesis. These fractions were classified according to their sensitivity to α-
amanitin, a toxic cyclic octapeptide from the mushroom Amanita phalloides. (Roeder, 1974a; 
Roeder, 1974b; Schwartz and Roeder, 1974). 
 
RNA polymerase (Pol) I is insensitive against α-amanitin, Pol III needs 10 µg/mL of α-amanitin 
for complete inhibition, while Pol II is inhibited by concentrations as low as 0.5 µg/mL of α-
amanitin (Schwartz e t  a l . , 1974). RNA polymerase I transcribes the tandem array of genes for 
18S, 5.8S and 28S ribosomal RNA and is located in the nucleolus. The other ribosomal RNA 
molecule, 5S rRNA, as well as several small RNAs and all transfer RNA are synthesised by RNA 
polymerase III in the nucleoplasm (reviewed in Lassar e t  a l . , 1983). RNA polymerase II is also 
located in the nucleoplasm, possibly clustered in “transcriptional hotspots” (Cook, 1999; Iborra 
e t  a l . , 1996; Lodish, 1996) and transcribes all mRNA, as well as several snRNAs.  
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Figure 2: DEAE anion exchange chromatography of RNA polymerases from mouse myeloma 
cells (Schwartz and Roeder, 1974). Fractions were collected and the RNA elongation activity was 
measured with calf thymus DNA in the absence ( ) or presence ( ) of 0.5 µg/mL of α-amanitin or 
with poly[(d(AT)] DNA in the presence of 0.5 µg/mL of α-amanitin (▲). ____, ammonium sulphate 
concentration; ....., absorption at 280 nm.  
4 MECHANISM OF DNA-DEPENDENT RNA POLYMERASES 
All DNA-dependent RNA polymerases are able to generate RNA from a DNA template in 
5’→3’ direction independent of a primer. At the site of transcription, the double-stranded DNA 
is locally melted to form a “transcription bubble” (Figure 3). RNA polymerases proceed along the 
DNA, opening the downstream end of the transcription bubble. Upstream of the polymerase, 
template and non-template DNA re-anneal. The RNA transcript is separated from the template 
after a short DNA-RNA hybrid region. RNA synthesis has to be processive, i.e. RNA 
polymerases must not dissociate before synthesis of transcripts of up to several thousand bases in 
length is complete. The fidelity of RNA polymerases is several orders of magnitude lower than 
the fidelity of DNA polymerases (Jeon and Agarwal, 1996; Thomas e t  a l . , 1998), likely because 
an erratic RNA is rapidly turned over and a misincorporation is not further propagated. The basis 
of discrimination between the correct and incorrect base is the slow addition of the next 
nucleotide to the mismatched terminus (Thomas e t  a l . , 1998). The chain elongation reaction 
proceeds in an SN2-type fashion and depends on two metal ions (see chapter 10.3). RNA 
synthesis can be interrupted by pausing and/or arrest, which co-occur with a backward 
movement of the polymerase, termed “backtracking” (Figure 3). 
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Figure 3: Schematic view of a transcribing DNA-dependent RNA polymerase. 
 
 
5 TRANSCRIPTION FACTORS REGULATE RNA POLYMERASES 
With all the information of tens of thousands of genes being transcribed by a single enzyme, the 
necessity for precise regulation is obvious. Therefore, a plethora of transcription regulatory 
factors exists to activate or repress the synthesis, processing and degradation of a particular set of 
mRNAs at a given time. Regulation at the level of transcription is indeed the major regulatory 
principle of protein biosynthesis. A large number of gene-specific transcription factors regulate 
the expression of certain proteins at a certain time. At these factors, a manifold of cellular 
signalling pathways converge and influence each other. Both the temporal and quantitative 
pattern of gene expression is subject to stringent control, which is essential for all cell processes 
such as metabolism, proliferation, differentiation and the response to environmental signals. 
Defective regulation of transcription is responsible for a number of serious diseases including 
cancer (Gnatt, 2002; Hurst, 1996).  
 
6 COMPOSITION OF MULTI-SUBUNIT POLYMERASES 
In contrast to single-subunit RNA polymerases like those found in bacteriophages or in 
mitochondria, prokaryotic and eukaryotic RNA polymerases consist of multiple subunits (Table 
1). The 12 subunits of S. cerevisiae RNA Pol II, as a representative for eukaryotic RNA 
polymerases, sum up to a mass of about 500 kDa. There is evidence that multi-subunit RNA 
polymerases evolved from a single-subunit ancestor, based on the following set of observations: 
The active site of multi-subunit RNA polymerases is formed by elements from the two large 
subunits (Figure 7), (Cramer e t  a l . , 2000; Cramer e t  a l . , 2001).  
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Table 1: Subunit composition of multi-subunit RNA polymerases. 
Adapted from (Cramer, 2002b) 
Eukaryotes Archaea Bacteria Class* 
Pol I  Pol II  Pol III    
A190  Rpb1  C160  A’+A’’ β’ core 
A135  Rpb2  C128 B (B’+B’’) β core 
AC40  Rpb3  AC40  D  α core  
AC19  Rpb11  AC19  L α core  
Rpb6  Rpb6  Rpb6  K  ω core/common 
Rpb5  Rpb5  Rpb5  H  — common 
Rpb8  Rpb8  Rpb8  — — common 
Rpb10  Rpb10  Rpb10  N  — common 
Rpb12  Rpb12  Rpb12  P — common 
A12.2  Rpb9  C11  X  —  
A14** Rpb4 — F   
A43** Rpb7 C25 E   
+ two 
others 
 + four 
others 
+one other —  
*Core, sequence partially homologous in all RNA polymerases; common, shared by all 
eukaryotic RNA polymerases. ** Potential paralogues of Pol II subunits Rpb4 and Rpb7 
(Cramer, 2002b). 
 
 
In archaea and eubacteria, the genes for the two large RNA polymerase subunits are arranged in 
tandem, with the second largest subunit always preceding the largest subunit (Severinov e t  a l . , 
1997). Accordingly, the multi-subunit RNA polymerase structures show that the C-terminus of 
the second largest subunit is in close proximity of the N-terminus of the largest subunit. Indeed, 
the two large subunits are fused in Helicobacter pylori (Zakharova e t  a l . , 1998). Further, a 
functional polypeptide can be engineered by fusing the two large subunits of the E. coli enzyme. 
(Severinov e t  a l . , 1997). Analogously, the two largest subunits are responsible for substrate 
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binding and catalysis, while the smaller subunits adopt mainly structural roles (see below). The 
two largest subunits are split into three polypeptides in most archaea.  
7 STRUCTURE DETERMINATION OF RNA POLYMERASES 
7.1 Single-subunit RNA polymerases 
The smaller size of 99 kDa (883 residues) and the composition of only one polypeptide chain of 
bacteriophage T7 RNA polymerase fostered structure determination seven years before a detailed 
atomic model of multi-subunit polymerases was possible. Although unrelated to multi-subunit 
RNA polymerases in both sequence and structure, catalytic principles are shared between these 
enzymes. T7 RNA polymerase has however modest sequence homology to the single-subunit Pol 
I family of DNA polymerases.  
 
First structures of T7 RNA polymerase as free enzyme and in complex with a natural inhibitor, 
T7 lysozyme, were obtained already in 1993 (Sousa e t  a l . , 1993) and in 1998 (Jeruzalmi and 
Steitz, 1998), respectively. An “early initiation complex” (Cheetham and Steitz, 1999) of T7 RNA 
polymerase bound to a 17 base-pair promoter DNA containing a five nucleotide single-strand 
template extension and a trinucleotide RNA showed an unexpected rearrangement of large 
portions of the enzyme (Figure 4A). Yet another drastic structural rearrangement, namely 
alternative folding of about 300 residues was observed in the structure of a T7 elongation 
complex (Tahirov e t  a l . , 2002; Yin and Steitz, 2002) in 2002. Here, formation of an eight base-
pair DNA-RNA hybrid in the active site induces this rearrangement (Figure 4B). In this 
conformation, the DNA-RNA hybrid is buried in a deep cavity and RNA emerges from a newly 
formed exit pathway.  
 
DNA-RNA strand separation after a 7 bp DNA/RNA hybrid is achieved by a hydrophilic loop, 
the “RNA displacement loop”, that projects towards the axis of the hybrid and has a net negative 
charge (Tahirov e t  a l . , 2002; Jiang e t  a l . , 2004; Yin and Steitz, 2002). The RNA is then 
redirected into a positively charged RNA exit pore, which is only present in the elongation 
complex. An intact non-template strand, which can base-pair with the template strand upstream 
of the transcription bubble was shown to be essential for efficient DNA-RNA strand separation. 
DNA-DNA strand separation at the downstream end of the transcription bubble is achieved by 
rotation of the so-called “O-helix” upon pyrophosphate release. This structure also lead to a 
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concept of the transition from the initiation phase to processive elongation, because the major 
refolding results in a loss of the promoter binding site and goes along with promoter clearance.  
 
Most recent structural data on nucleotide incorporation and translocation have been published by 
two independent groups and lead to complementary results (Temiakov e t  a l . , 2004; Yin and 
Steitz, 2004). These structures include complexes of T7 Pol with template DNA, product RNA 
and substrate NTP, as well as the reaction product pyrophosphate. These two models form the 
structural basis for substrate selection and for the discrimination of ribose versus deoxyribose 
substrates. Dissociation of the product pyrophosphate after nucleotide addition was proposed to 
drive the conformational change resulting in translocation and strand separation. Thus, valuable 
insights into the mechanism of regulated, template-directed RNA synthesis came from studies of 
T7 RNA polymerase.  
 
Taking together structural and biochemical data, each round of nucleotide addition can be 
divided into at least four steps (Steitz, 2004): 
 
1. The NTP binds to the polymerase in a pre-insertion site. 
2. The NTP occupies the NTP-binding site (N-site) and is basepaired to the template base. 
3. Catalysis: pyrophosphate is formed and the RNA transcript is extended by one nucleotide. 
4. The 3’ end of the RNA translocates from the N-site to the priming site (P-site). 
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Figure 4: Transition from initiation to elongation in T7 RNA polymerase.  
Ribbon diagrams of the elongation complex (a) and the early initiation complex (b) are shown 
in the same orientation with respect to the unaltered C-terminal portion (white). Nucleic acids 
are shown as ribbon (phosphate backbone) and ball-and-stick (bases) models. (c) Amino acid 
sequence of the N-terminal domain; secondary structures for the elongation complex and the 
early initiation complex are shown above (cylinders, α-helices; thin lines, coils; dashed lines, 
disordered regions). The colour scheme is the same as in (a) and (b). Adapted from (Tahirov 
e t  a l . , 2002). 
 
 
The set of T7 polymerase structures elucidated structural changes accompanying these four steps. 
The substrate analogue adenosine-5'-[(α,β)-methyleno]-triphosphate (AMPCPP) was found to 
bind to the catalytically inactive “open” conformation, where it is base paired with the acceptor 
template base and bound two conserved basic residues (R627 and K631) in the O helix. 
Specificity for NTPs versus dNTPs is achieved by a conserved tyrosine (Y639) which interacts 
with the 2’-OH of incoming NTPs (Svetlov e t  a l . , 2004). The binding of the correct NTP leads 
to the closing conformational change. During this transition, helices O and O’ move, displacing a 
tyrosine residue, which blocked the nucleotide addition site. Two highly conserved aspartate 
residues (D537 and D812) coordinate two metal ions that are required during the phosphoryl 
transfer reaction. The end of a nucleotide addition cycle is accompanied by an opening 
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conformational change, which is the reversal of the O/O’ helix rotation described above. This 
rotation is coupled to the release of PPi and is responsible for DNA-DNA strand separation, 
DNA/RNA separation and translocation (Temiakov e t  a l . , 2004; Yin and Steitz, 2004).  
 
7.2 Multi-subunit RNA polymerases 
By the time this work was started, atomic-resolution structures of 10-subunit core RNA 
polymerase II (Pol II) from yeast at various resolutions and in the presence or absence of a 
“tailed template”-DNA/RNA complex were available (Table 2). These structures were the result 
of a series of attempts carried out over more than a decade to obtain structural information of 
this complex. 
 
Table 2: Structure determination of yeast Pol II 
Model Resolution 
(Å) 
PDB-ID Reference 
Electron crystallographic model from lipid 
layer crystals 
≈30 — (Edwards e t  a l . , 1990) 
Electron crystallographic model from 2D 
crystals 
≈16 — (Darst e t  a l . , 1991) 
Electron crystallographic model of open 
conformation 
— — (Asturias and Kornberg, 
1995) 
Localisation of the C-terminal domain of 
Rpb1 by electron microscopy 
16 — (Meredith e t  a l . , 1996) 
Electron crystallographic model of closed 
conformation 
— — (Asturias e t  a l . , 1997) 
Electron microscopic reconstitution (2D 
crystals and multi-particle averaging) 
≈12-20 — (Asturias e t  a l . , 1998) 
First x-ray crystallographic characterisation of 
Pol II (self-rotation function, similar folds of 
Rpb1 and 2) 
≈4 
(unphased) 
— (Fu e t  a l . , 1998) 
Electron crystallographic model from lipid 
layer crystals 
16 — (Asturias and Kornberg, 
1999) 
Electron microscopic image of a 
Pol II-Mediator complex  
40 — (Asturias e t  a l . , 1999) 
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Model Resolution 
(Å) 
PDB-ID Reference 
Tantalum heavy-atom cluster-phased Pol II 
electron density map 
≈6.0 — (Fu e t  a l . , 1999) 
Electron microscopic reconstitution of an 
elongation complex 
16-24 — (Poglitsch e t  a l . , 1999) 
Backbone model of core Pol II  (form 1) 3.1 1I3Q (Cramer e t  a l . , 2000) 
Backbone model of core Pol II  (form 2) 2.8 1I50 (Cramer e t  a l . , 2001) 
X-ray crystal structure of core Pol II -
DNA/RNA minimal elongation complex 
3.3 1I6H (Gnatt e t  a l . , 2001) 
X-ray crystal structure of a Pol II-α-amanitin 
complex 
2.8 1K83 (Bushnell e t  a l . , 2002) 
Electron microscopic reconstitution of 
complete Pol II 
18 — (Craighead e t  a l . , 2002) 
Backbone model of  complete Pol II  4.2 1NT9 (Armache e t  a l . , 2003) 
Backbone model of  complete Pol II 4.1 1NIK (Bushnell and Kornberg, 
2003) 
Architecture of the RNA polymerase II-TFIIS 
complex and implications for mRNA cleavage 
3.8 1Y1V (Kettenberger e t  a l . , 
2003), this study 
Backbone model of the complete Pol II-
TFIIB complex 
4.5 1R5U (Bushnell e t  a l . , 2004) 
Electron microscopy model of a complete 
Pol II-TFIIF complex 
≈18 — (Chung e t  a l . , 2003) 
Core Pol II-“Strand Separated Elongation 
Complex” 
3.6 1SFO (Westover e t  a l . , 2004b) 
Structural basis of substrate selection by Pol II 4.3 
3.5 
2.3 
1R9S 
1R9T 
1TWF 
(Westover e t  a l . , 2004a) 
Complete RNA Polymerase II Elongation 
Complex Structure and Its Interactions with 
NTP and TFIIS 
4.0 
4.0 
4.5 
1Y1W 
1Y1Y 
1Y77 
(Kettenberger e t  a l . , 
2004), this study 
Atomic structure of Rpb4/7 and refined 
model of complete Pol II 
3.8 1WCM (Armache e t  a l . , 2004) 
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Two-dimensional crystals for electron crystallography had been available as early as in 1990 
(Edwards e t  a l . , 1990). Electron microscopic studies of Pol II were published in 1990, 91, 95, 97, 
98 and 99 (Table 2). In one of these crystal forms, the conformation of the enzyme appears 
“open”, allowing entry of DNA, as required for the initiation of transcription (Asturias and 
Kornberg, 1995). By contrast, another crystal form contained the enzyme in a “closed” 
conformation, appropriate for retention of DNA during RNA chain elongation (Asturias e t  a l . , 
1997). Interaction with two polymerase subunits, the heterodimer Rpb4/Rpb7, were shown to 
trigger the open-closed transition. Biochemical evidence was available by that time which lead to 
the conclusion that the open-closed transition is a crucial step in the transcription initiation 
process. In 1997, Gnatt e t  a l .  reported the purification and crystallisation of a “minimal 
elongation complex” (Gnatt e t  a l . , 1997). This complex comprised the 10-subunit Pol II core 
and a “tailed template” DNA with the product RNA synthesised in the pre-assembled 
Pol II/DNA complex. However, structure solution of this complex had to await the year 2002 
(see below). In 1998, the first electron microscopic multi-particle reconstruction of Pol II was 
described (Asturias e t  a l . , 1998) to a nominal resolution of 12 Å. Between 12 and 20 Å, data 
quality was rather weak, indicating conformational flexibility of large parts of the enzyme. This 
flexibility was later ascribed to a movement of the “clamp” in the absence of nucleic acids 
(Cramer, 2002b). The first extension of the Pol II core machinery was reported in 1999 (Asturias 
e t  a l . , 1999). In this publication, the multi-particle electron microscopic reconstitution of a Pol II 
“Holoenzyme”, i.e. the complex of Pol II with the Mediator, was reported.  It showed the multi-
subunit Mediator complex wrapped around Pol II at a resolution of about 40 Å. In 1999, two 
other electron crystallographic models were published. One model  showed Pol II in complex 
with nucleic acids corresponding to a transcription bubble and product RNA (Poglitsch e t  a l . , 
1999). The other electron crystallographic model revealed Pol II in complex with TFIIE and 
TFIIF (Asturias and Kornberg, 1999). This model revised the view of DNA entering the 
polymerase at one face and leaving it at the opposite face. In contrast, nucleic acids were shown 
to interact with only one face (i.e. the cleft, Figure 7) of Pol II.  
 
In the same year, a breakthrough in structure determination using x-ray crystallography could be 
achieved: A 6 Å crystallographic map of core Pol II was obtained  with phases derived from a 
Ta6Br
2+
12  heavy atom cluster (Fu e t  a l . , 1999; Figure 6). For the first time, more robust 
information of the cleft and the mobile clamp could be observed. The crystallographic map was 
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reported to be in good accordance with the electron crystallographic map derived earlier (Asturias 
and Kornberg, 1999).  
 
 
Figure 5: Three-dimensional positive differences between streptavidin-labelled, paused 
elongation complexes and RNA polymerase II dimer, superimposed on the 3D 
reconstruction of RNA polymerase II. Differences 2.5 σ above the mean are shown in 
yellow, and the surface of RNA polymerase II is shown in white. Isolated, small difference 
densities less than about 15 Å in largest dimension were omitted for clarity. A portion of this 
density, labelled d, appears in the cleft, directly connected by density a to that corresponding 
to streptavidin, labelled s. Two other protrusions of density, labelled b and c, emanate from 
the cleft. Adapted from (Poglitsch e t  a l . , 1999). 
 
The low-resolution structural data were excelled by a backbone model of core Pol II at 3.1 Å 
resolution (Cramer e t  a l . , 2000). For the first time, the arrangement and secondary structure 
elements of the 10 subunits in the complex could be determined, and functional domains like 
jaws, clamp, wall and the active site could be identified. Additionally, a suggested path for 
substrate NTP entry and for the extrusion of backtracked RNA (see chapter 10.3) was presented. 
Finally, atomic models of core Pol II and a Pol II-DNA/RNA complex could be obtained at 2.8 
and 3.3 Å resolution, respectively (Cramer e t  a l . , 2001; Gnatt e t  a l . , 2001). This breakthrough in 
structure determination was obtained by a special dehydration and shrinkage protocol, which 
improved diffraction substantially. The phase problem was solved by MIRAS, using a set of 12 
datasets to obtain phase information from zinc, tantalum, iridium, mercury and rhenium heavy 
atom derivatives (Cramer e t  a l . , 2000). These structures allowed the detailed analysis of the 
proteins involved, they explained a plethora of biochemical observations, and fuelled structure-
guided analysis of the transcription machinery.  
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Figure 6: Molecular Envelopes of RNA Pol II. (A) Protein envelope obtained by MIRAS at 
6 Å resolution (Fu e t  a l . , 1999). The envelope is displayed as a single isocontour representing 
about 90% of the molecular volume. a, b, and c denote the unit cell axes of the 3D crystal. 
(B) The molecular envelope from electron crystallography (Asturias and Kornberg, 1999) with a 
contour level representing about 70% of the molecular volume. Adapted from (Fu e t  a l . , 1999). 
 
Table 3: Structures of bacterial RNA polymerase 
Structure Resol. 
(Å) 
PDB- 
ID 
Reference 
Crystal structure of a Thermus aquaticus core RNA 
polymerase 
3.3 1HQM (Zhang e t  a l . , 1999) 
Thermus aquaticus core RNA polymerase- 
Rifampicin Complex 
3.3 1I6V (Campbell e t  a l . , 2001) 
Crystal structure of a Thermus aquaticus RNA 
polymerase σ-subunit fragment  
2.9 1KU2 (Campbell e t  a l . , 2002) 
Thermus aquaticus RNA polymerase holoenzyme  4.0 1L9U (Murakami e t  a l . , 2002b) 
Thermus aquaticus RNA polymerase holoenzyme/fork-
junction promoter DNA complex  
6.5 1L9Z (Murakami e t  a l . , 2002a) 
Crystal structure of the RNA polymerase holoenzyme 
from Thermus thermophilus  
2.6 1IW7 (Vassylyev e t  a l . , 2002) 
Regulation of RNA polymerase by the Alarmone ppGpp 2.7 1SMY (Artsimovitch e t  a l . , 
2004) 
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8 STRUCTURE OF POL II AND COMPARISON WITH OTHER MULTI-SUBUNIT 
RNA POLYMERASES 
The multi-subunit cellular RNA polymerases of eukaryotes, bacteria and archaea exhibit a high 
degree of sequence homology (Cramer e t  a l . , 2001). A particular high degree of conservation is 
observed for a core around the active site (Minakhin e t  a l . , 2001; Sweetser e t  a l . , 1987). 
Comparing the structures of bacterial RNA polymerase from Thermus aquaticus (Zhang e t  a l . , 
1999) and yeast Pol II (Cramer e t  a l . , 2000; Cramer e t  a l . , 2001), it is evident that the five core 
subunits (Table 1) share a common overall architecture. The central mass and opposite sides of a 
central cleft is formed by two large subunits (Rpb1 and 2 in Pol II; β and β’ in bacterial Pol; 
Figure 7). Two smaller subunits are involved in assembly and fastening the two large subunits of 
both RNA polymerases (Rpb3-Rpb11 in Pol II; α homodimer in bacterial Pol). Rpb1, but not the 
β subunit, has a C-terminal repeat domain (CTD) of 26-50 heptapeptide repeats (see chapter 9). 
Another core subunit (Rpb6 in Pol II; ω in bacterial Pol) further buttresses and stabilises the 
large subunits (Minakhin e t  a l . , 2001; Mukherjee and Chatterji, 1997; Nouraini e t  a l . , 1996; 
Sweetser e t  a l . , 1987). 
 
A striking feature which was already evident in the early electron density maps (Fu e t  a l . , 1999) is 
a mobile “clamp”. In two crystal forms of free Pol II, the clamp was trapped in two different 
open states. In the first Pol II elongation complex, the clamp was found to be in a closed state, 
apparently induced by nucleic acid binding (Gnatt e t  a l . , 2001). The transition from the open to 
the closed state goes along with a 30° rotation, paralleled by ordering of five mobile “switch” 
regions upon nucleic acid binding (Cramer e t  a l . , 2001; Gnatt e t  a l . , 2001; Figure 7). The high 
stability of elongation complexes, which is required for efficient transcription of very long genes, 
can be rationalised by this clamp closure. The switches apparently couple clamp closure to the 
presence of the DNA-RNA hybrid. The dissociable subcomplex Rpb4/7 (chapter 8.1) further 
restricts the clamp to its closed conformation (Armache e t  a l . , 2003; Bushnell and Kornberg, 
2003). The active site is located at the floor of the cleft above a funnel, which narrows down to a 
pore (Pol II) or secondary channel (bacterial Pol), respectively. The active site is surrounded by a 
wall (Pol II)/flap (bacterial Pol) and a bridge helix/β’ F-helix. In the EM model and in the 
structure of the minimal elongation complex, nucleic acids were observed in a multi-subunit 
RNA polymerase. The DNA-RNA hybrid is situated above the active site and the pore in the 
cleft (Gnatt e t  a l . , 2001; Poglitsch e t  a l . , 1999). Substrate NTPs are likely to enter the active site 
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via the funnel and the pore, although very recent kinetic data suggest the existence of an 
alternative route: Incoming NTPs are hypothesised to base-pair with the +2 base in the template 
strand, entering through the cleft. In the translocation step (see chapters 4 and 10.3), this NTP is 
shuttled to the catalytic site. Thus, two NTP molecules are bound simultaneously at the +1 and 
+2 position and “line up” for incorporation in this model (Gong e t  a l . , 2004; Nedialkov e t  a l . , 
2003; Zhang and Burton, 2004). To date, there is no published structure of a bacterial RNA 
polymerase-DNA/RNA complex.  
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Figure 7: Overview of multi-subunit RNA polymerases. (A) RNA polymerase from T. aquaticus 
(Zhang e t  a l . , 1999) and (B) complete Pol II from S. cerevisiae (Armache e t  a l . , 2004) in similar 
orientations (related to the “top” view in Cramer e t  a l . , 2000). Subunits are coloured according to the 
scheme above the structures. Homologous subunits are coloured identically. In panels (C) and (D), two 
different orientations of S. cerevisiae Pol II shown in (B) are coloured to highlight functional elements 
discussed in the text. This figure and all other structure figures were prepared with PyMol 
(www.pymol.org) unless otherwise indicated.  
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8.1 Core Pol II and the subcomplex Rpb4/Rpb7 
Pol II consists of the ten-subunit catalytic core and the dissociable heterodimer Rpb4/Rpb7 
(Rpb4/7). Assembly of Pol II with general transcription factors to the pre-initiation complex 
(PIC, see chapter 10) requires the presence of Rpb4/7 (Edwards e t  a l . , 1991; Ruet e t  a l . , 1980), 
whereas it is dispensable for transcription elongation. In yeast, a knockout of Rpb4 leads to 
facilitated dissociation of the (essential) Rpb7. Therefore Pol II isolated from a ∆Rpb4 strain 
lacks both Rpb4 and Rpb7. In the course of this project, the structure of the complete Pol II 
including Rpb4/7 was derived independently by two groups (Armache e t  a l . , 2003; Bushnell and 
Kornberg, 2003). Bushnell e t  a l .  isolated endogenous complete Pol II by means of an affinity tag 
on Rpb4 from yeast cells in the stationary phase. Armache e t  a l .  established an alternative 
approach: Endogenous purified core Pol II was supplemented with an excess of recombinant 
Rpb4/7 and purified by gel filtration. The advantage of the latter strategy lies in the fact that 
mutations and heavy atom derivatisation can be performed more easily in the recombinant 
system.  
 
The subcomplex Rpb4/7 was first localised by electron microscopy (Craighead e t  a l . , 2002). The 
Rpb4/7-Pol II interaction via Rpb4 proposed by these authors was disproved in the x-ray models 
(Armache e t  a l . , 2003; Bushnell and Kornberg, 2003). The early x-ray data at ≈4.2 Å resolution 
(Armache e t  a l . , 2003; Bushnell e t  a l . , 2002) allowed to reconstruct the 12-subunit complex 
from atomic models of the 10-subunit Pol II core and the distantly related archaeal orthologues 
of Rpb4/7, subunits RpoE and RpoF from Methanococcus jannaschii (Todone e t  a l . , 2001). A 
backbone model for most parts of Rpb4/7 could be derived this way, since archaeal RpoE and 
RpoF exhibit comparable overall structures (Armache e t  a l . , 2003). Eventually, a refined atomic 
model of complete 12-subunit Pol II could be derived at 3.8 Å by an improved alternative 
strategy (Armache e t  a l . , 2004): First, an atomic model of Rpb4/7 alone was derived and fitted, 
together with an atomic model of core Pol II, into a 3.8 Å electron density map. Full-length 
Rpb4/7 failed to crystallise, but crystals were obtained after 34 residues were removed from the 
proteolytically sensitive N-terminal tail of Rpb4. Additional deletion of a proteolytically sensitive 
loop in Rpb4 resulted in larger crystals, suitable for structure determination at 2.3 Å resolution 
(Figure 8). Starting from two refined structures, refinement was possible even at 3.8 Å resolution 
and converged at a free R-factor of 28.5 %. This structure of complete Pol II was used for 
phasing diffraction data of Pol II complexes presented in this work (see Results and Discussion).  
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Figure 8: High-resolution structure of the Rpb4/Rpb7 heterodimer (Armache 
et  al . , 2004). Disordered in the structure are the Rpb7 tip loop (residues 57-68), 
Rpb4 residues 35-46, 77-81, and 101-118. Rpb4 residues 1-34 and 82-100 were not 
present in the crystallised variant. This high-resolution structure was docked in a 
3.8 Å crystallographic map of complete Pol II to obtain an atomic structure of the 
whole complex.  
 
 
Rpb4/7 protrudes from the polymerase “upstream face” on which initiation factors are thought 
to assemble for promoter DNA loading and preinitiation complex formation (Armache e t  a l . , 
2003; Bushnell e t  a l . , 2002). Since Rpb7 contains a ribonucleoprotein (RNP) fold, and an 
oligonucleotide-binding (OB) fold, a possible involvement of Rpb7 in transcript binding and its 
redirection towards the CTD has been suggested (Armache e t  a l . , 2003; Bushnell e t  a l . , 2002). A 
very small interaction surface is consistent with the dissociable nature of Rpb4/7. The presence 
of Rpb4/7 has pronounced effects on the structure of core Pol II: Rpb7 forms a wedge between 
the clamp and the linker which restricts the clamp to a closed position. Binding of Rpb4/7 
induces a conformation in two switch regions, which is indistinguishable from the conformation 
with bound template strand. A closed clamp prevents the entry of double-stranded promoter 
DNA into the active centre cleft, and switch regions poised for template strand binding might 
facilitate transcription initiation. Rpb4/7 also plays a role in Pol II recycling (see chapter 10.5). 
CTD dephosphorylation is carried out by the phosphatase Fcp1 (Lin e t  a l . , 2002), which is 
apparently recruited to the phosphorylated CTD by Rpb4/7, since Rpb4 binds Fcp1 (Chambers 
e t  a l . , 1995).  
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9 THE C-TERMINAL DOMAIN OF POL II 
The C-terminal domain (CTD) of Pol II is comprised of a number of repeats of the heptapeptide 
YSPTSPS which seems to increases with organismic complexity from 26 in yeast, 32 in 
C. elegans, 45 in Drosophila to 52 in mammals (Hampsey, 1998). Unique to Pol II, the CTD is 
essential for cell viability and plays a central role in the regulation of mRNA synthesis in vivo.  
 
An unstructured, extended yeast CTD would span a distance of about 650 Å (Cramer e t  a l . , 
2001) and serves as a platform for the assembly and recruitment of various factors involved in 
initiation, elongation, mRNA maturation, surveillance, and export (Hirose and Manley, 2000; 
Orphanides and Reinberg, 2002; Proudfoot e t  a l . , 2002). The CTD is extensively phosphorylated 
and dephosphorylated during the transcription cycle. Phosphorylation in the preinitiation 
complex (see chapter 20) is performed by a kinase-module of TFIIH. Generally, CTD 
phosphorylation at serine-5 coincides with transcription initiation and early elongation, whereas 
serine-2 phosphorylation is associated with transcribing Pol II further away from the promoter 
(Sims e t  a l . , 2004).  
 
Dephosphorylation of the CTD, a prerequisite for Pol II recycling, is accomplished by the 
phosphatases Fcp1 (Ser2) and Ssu72 (Ser5) (Kamenski e t  a l . , 2004; Meinhart e t  a l . , 2003b; Yeo 
e t  a l . , 2003). Fcp1 was shown to interact directly with TFIIF (Chambers e t  a l . , 1995; Kamada e t  
a l . , 2003; Nguyen e t  a l . , 2003) and with Pol II via the CTD (Krishnamurthy e t  a l . , 2004). A 
family of Ser2-specific small CTD phosphatases (SCPs) were found in mammals (Yeo e t  a l . , 
2003). 
 
Structure determination of the free CTD using both NMR spectroscopy (Cagas and Corden, 
1995) and x-ray crystallography failed, indicating that the CTD is devoid of a well-defined 
secondary structure. In all crystal structures of Pol II reported so far, the CTD and parts of the 
linker connecting it to Pol II are disordered. Nevertheless, crystal structures of CTD peptides 
bound to the capping enzyme Cgt1, to the peptidyl-proline isomerase Pin1, and to the CTD-
interacting domain of the RNA-processing factor Pcf11, have been solved (Fabrega e t  a l . , 2003; 
Meinhart and Cramer, 2004; Verdecia e t  a l . , 2000). These structures indicate a highly versatile 
nature of CTD folding, depending on its phosphorylation status and binding partner. The CTD 
can be thought of as a nucleation centre for the multitude of factors that regulate mRNA 
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processing events concomitant with elongation. In addition, the CTD could mediate factor 
recruitment in general, using a code comparable to the histone code (Sims e t  a l . , 2004). 
10 THE EUKARYOTIC TRANSCRIPTION CYCLE 
The generation of mature mRNA by RNA polymerase involves multiple processes, some of 
which occur sequentially and others in parallel. The primary phases of transcript generation form 
a so-called transcription cycle and include preinitiation, initiation, elongation, termination and 
reinitiation (Figure 9; Hahn, 2004).  
 
 
Figure 9: The pathway of transcription initiation and re-initiation by Pol II. See Table 4 for a 
description of the general transcription factors. Adapted from (Hahn, 2004). 
 
10.1 Preinitiation and initiation  
The transcription cycle starts with the assembly of a preinitiation complex (PIC) at the promoter. 
The eukaryotic PIC includes the general transcription factors TFIID, TFIIB, TFIIE, TFIIF, and 
TFIIH as well as RNA polymerase II and several additional cofactors (Orphanides e t  a l . , 1996; 
Orphanides and Reinberg, 2002; Table 4). In bacterial RNA polymerase, the σ factor performs 
this function of promoter recognition and may hold the flap in a defined position (Arthur e t  a l . , 
2000; Arthur and Burgess, 1998) during promoter loading. In Pol II, Rpb4/7 restricts the clamp 
to a closed position, potentially preventing duplex DNA from entering the cleft (Armache e t  a l . , 
2003; Bushnell and Kornberg, 2003). Thus, duplex DNA might be suspended over the cleft 
before melting (Armache e t  a l . , 2003). Melting of DNA at the initiation site and formation of a 
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transcription bubble is a prerequisite for initiation. This process is ATP dependent and requires 
the action of TFIIE and TFIIH (Goodrich and Tjian, 1994; Holstege e t  a l . , 1996; Kim e t  a l . , 
2000) in eukaryotes. Initiation factors are believed to dock to other sites on the Pol surface, too, 
in order to align the transcription start site with the active centre (Cramer, 2002b).  
 
Table 4: S. cerevisiae general transcription factors and coactivators 
Factor  Subunits  Function (Hahn, 2004) 
TFIIA  2 stabilises TBP and TFIID-DNA binding; positive and negative gene 
regulation 
TFIIB  1 binds TBP, Pol II and promoter DNA; helps fix transcription start site 
TFIID TBP 1 binds TATA element and bends promoter DNA; platform for 
assembly of TFIIB, TFIIA and TAFs 
 TAFs 14 bind INR and downstream promoter elements; regulatory target 
Mediator 24 target of regulatory factors; stimulates basal and activated transcription 
TFIIF  3 binds Pol II and is involved in Pol II recruitment to the PIC 
TFIIE  2 binds promoter DNA near transcription start; may help open or 
stabilise the transcription bubble 
TFIIH  10 links transcription and DNA repair; kinase and helicase activities; 
essential for open complex formation 
 
10.2 Promoter clearance and early elongation 
Once polymerase has assembled with template DNA to form a so-called “open complex”, 
transcription initiation occurs upon addition of the two initiating nucleoside triphosphates 
dictated by the DNA sequence leading to the formation of a first phosphodiester bond. The 
earliest stages of transcription are marked by instability of the transcription complex and a 
pronounced tendency to release short pieces of RNA (2-5mers) in a phase, which is termed 
“abortive initiation”. Stabilisation of early elongation complexes is observed when the DNA-
RNA hybrid reaches 8 bases in length (Kireeva e t  a l . , 2000a; Kireeva e t  a l . , 2000b). Synthesis of 
about 23 bases renders the elongation complex maximally stable and allows RNA polymerase II 
to clear the promoter (Pal and Luse, 2003). The transition to elongation goes along with partial 
PIC disassembly: A subset of general transcription factors and the Mediator remain at the 
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promoter, serving as a scaffold for the formation of the next transcription initiation complex 
(Yudkovsky e t  a l . , 2000; Zawel e t  a l . , 1995). Therefore, re-initiation of transcription is a much 
faster process compared to the initial round and is responsible for the bulk of transcription in the 
cell (Jiang and Gralla, 1993; Orphanides and Reinberg, 2000; Ranish e t  a l . , 1999). TFIIH plays 
an integral role in facilitating promoter clearance (Dvir e t  a l . , 1996; Goodrich and Tjian, 1994; 
Kumar e t  a l . , 1998). Of all the general general transcription factors, only TFIIF can be found 
bound to Pol II during the elongation phase (Sims e t  a l . , 2004). Most recent structural data of a 
Pol II-TFIIB complex indicate an impediment of the exit-path of newly formed RNA by the 
fingers domain of TFIIB. Only dissociation of this TFIIB domain would allow the synthesis of 
longer transcripts (Bushnell e t  a l . , 2004). 
10.3 Elongation and the nucleotide addition cycle 
A manifold of biochemical data and analogies to T7 RNA polymerase and DNA polymerases led 
to a working model with a catalytic step proceeding via a “unified two metal ion mechanism” 
(Steitz, 1993). According to this mechanism, one divalent metal ion (metal B) enters the active 
site together with an NTP. A permanently bound divalent metal A coordinates the α-phosphate 
group of an NTP and activates it by implying a more positive charge on the P atom. The 3’-OH 
group of the RNA attacks this P atom in an SN2-type reaction, generating an elongated RNA plus 
a pyrophosphate ion, which leaves the active site, presumably together with metal B.  
 
 
Figure 10: Reaction mechanism of RNA chain elongation 
 
There is an ongoing debate to clarify the mechanisms of translocation by single and multi-subunit 
RNA polymerases. The “Brownian ratchet mechanism” assumes that RNA polymerase 
distributes itself by diffusional sliding between all accessible positions on the template with 
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relative occupancy determined by relative free energy. Subsequent NTP binding locks polymerase 
in the post-translocated state (Guajardo and Sousa, 1997). Various “powerstroke” models, in 
which a protein conformational change drives forward translocation have also been suggested 
(Steitz, 2004; Wang and Oster, 2002). In the case of T7 RNA polymerase, the powerstroke can be 
rationalised as rotation of the O-helix, driven by release of pyrophosphate after the catalytic step, 
since coupling between translocation and pyrophosphate release was observed in the recent 
structures of T7 RNA polymerase (Yin and Steitz, 2004). In yeast RNA polymerase II, the 
powerstroke may be accompanied by bending or local unwinding of the bridge helix toward the 
DNA/RNA hybrid, as suggested by several groups (Cramer e t  a l . , 2001; Gnatt e t  a l . , 2001; 
Holmes and Erie, 2003; Vassylyev e t  a l . , 2002). The powerstroke model is further supported by 
recent kinetic data (Zhang and Burton, 2004). However, no alternative bridge-helix 
conformations have been observed in crystal structures of bacterial and yeast Pol so far, which 
would support this model. Landick put forward the idea of the “Brownian ratchet mechanism”, 
in which RNA polymerases oscillate between a pre-translocated and a post-translocated state due 
to Brownian motion (Landick, 2004). Further evidence for a ratchet mechanism of translocation 
comes from investigations of E. co l i  polymerase mutants (Bar-Nahum e t  a l . , 2005). The 
authors suggest two independent “ratchet domains”, namely the incoming NTP and the flexible 
F-/bridge helix, which act in concert to drive forward translocation. Whether a powerstroke 
model or a ratchet mechanism, or a combination of both, best describe translocation of RNA 
polymerase along its template seems to remain a matter of discussion. 
 
10.4 Termination and mRNA processing in eukaryotes 
The choreography of termination and mRNA processing is intimately linked in eukaryotes. 
Before a gene transcript leaves the nucleus as mature mRNA, it has to undergo three major 
processing events: During capping, a GMP molecule is fused to the 5’-terminus of nascent RNA 
via an unusual 5’-5’ triphosphate linkage and methylated at position N7. This cap protects the 
nascent RNA from exonucleolytic 5’→3’ degradation and is recognised during nuclear export of 
mature mRNA. The splicing process removes non-coding sequences (introns), which are present 
in most mammalian genes and some yeast genes. The 3’-terminus of mRNAs is comprised of a 
poly(A) tail of about 200 nucleotides. This poly(A) tail is attached to pre-mRNA after cleavage at 
certain sequences by a nuclease in the polyadenylation machinery or by an intrinsic ribozyme 
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(Teixeira e t  a l . , 2004). All three processes affect each other’s efficiency as well as the efficiency 
of initiation and termination (Proudfoot, 2004; Proudfoot e t  a l . , 2002).  
 
Compared to the extensive information on transcriptional termination in bacteria, control of 
eukaryotic termination is less well understood. Purified Pol III terminates in vitro after the 
synthesis of a series of uracils automatically, without the need for hairpin-structures or auxiliary 
termination factors. Pol I requires a Pol I-specific termination factor which binds to a sequence at 
the end of the rRNA-coding DNA (reviewed in Reeder and Lang, 1994). During termination, 
both the transcript is released from the site of transcription and Pol II is detached from the DNA 
template. While the pre-mRNA is protected from rapid degradation by the 5’-cap and the 
3’-poly(A) tail, the downstream cleavage product is very short-lived. Thus, a so-called “torpedo” 
model suggested that rapid degradation of the downstream product with the RNAse catching up 
with still elongating Pol II is responsible for termination at a site 900-1600 bases downstream of 
the cleavage site (Connelly and Manley, 1988; Kim e t  a l . , 2004; Proudfoot, 1989; Teixeira e t  a l . , 
2004; West e t  a l . , 2004). An alternative “antiterminator” or “allosteric” model (Logan e t  a l . , 
1987) assumes a conformational change in the transcribing Pol II upon passing through the 
poly(A) signal that makes it termination competent. Further research will have to prove the one 
or the other model or reconcile parts of both models (reviewed in Luo and Bentley, 2004).  
10.5 Pol II recycling 
Pol II is recycled through dephosphorylation of serine 2 by the phosphatase activity of Fcp1 
(Cho e t  a l . , 1999) and through dephosphorylation of serine 5 by the Ser5-specific phosphatase 
Ssu72 (Ganem e t  a l . , 2003; Krishnamurthy e t  a l . , 2004; Meinhart e t  a l . , 2003b; see chapter 9). 
A polymerase “reset” this way to its initiation-competent state can engage in another round of 
transcription, maybe as part of a “transcriptional hotspot” (Cook, 1999; Iborra e t  a l . , 1996). 
Recent observations proclaim close spatial proximity of the end and the start of a gene, coupling 
termination and re-initiation (Proudfoot, 2004).  
 
11 ELONGATION FACTORS THAT REGULATE POL II ACTIVITY 
Purified Pol II is capable of elongating RNA chains in vitro at rates of about 100 to 300 
nucleotides per minute (Izban and Luse, 1992a). In contrast, mRNA is synthesised in cells, on 
chromatin templates, at rates approaching 2000 nucleotides per minute (Shermoen and Ofarrell, 
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1991; Thummel e t  a l . , 1990; Ucker and Yamamoto, 1984) These observations prompted the 
search for activities that would enhance the elongation rate of the purified enzyme on both 
chromatin templates and naked DNA. On the other hand, factors were identified that slow down 
the turnover number of elongating Pol II. Table 5 gives an overview of transcription factors 
which modulate the elongation rate of Pol II. Many of these elongation factors act by reducing 
the likelihood for transcriptional pausing (see chapter 12; Takagi e t  a l . , 1995; Sims e t  a l . , 2004). 
 
 
Table 5: Elongation factors which modulate the elongation rate of Pol II  
(Sims e t  a l . , 2004). 
Elongation  
factor 
Homologues  in  
yeast/mammals 
Properties 
TFIIS yes/yes stimulates transcript cleavage to alleviate arrest (see chapter 12) 
TFIIF yes/yes Essential for pre-initiation comlex formation; stimulates Pol II by 
reduced pausing 
Elongins no/yes stimulates Pol II by reduced  pausing 
ELL no/yes stimulates Pol II by reduced  pausing 
DSIF  
 
yes/yes stimulates elongation, suppresses early transcript termination, 
stimulates capping 
NELF yes/yes halts Pol II to allow capping checkpoint control 
P-TEFb yes/yes relieves NELF-mediated pausing, phosphorylates the CTD of Pol II 
and Spt5 
CSB1 yes/yes stimulates elongation, modulates TFIIS, rescues Pol II at DNA 
lesions, involved in transcription-coupled DNA repair 
  
 
TFIIF plays an integral role in recruiting Pol II during PIC formation (Conaway e t  a l . , 1991; 
Flores e t  a l . , 1991; Orphanides e t  a l . , 1996). Aside of this function, TFIIF diminishes the time 
Pol II is paused and thereby stimulates the overall elongation rate (Bengal e t  a l . , 1991; Flores e t  
a l . , 1989; Izban and Luse, 1992a). TFIIF is one of the strongest interacting proteins with Pol II. 
After PIC formation, TFIIF is released from the transcription complex but re-associates with 
stalled elongation complexes (Zawel e t  a l . , 1995).  
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The Elongin complex was initially isolated as a stimulatory factor (Bradsher e t  a l . , 1993a; 
Bradsher e t  a l . , 1993b) which exerts its function in a manner similar to TFIIF. Unlike TFIIF 
however, Elongin is not required for PIC formation or initiation (Bradsher e t  a l . , 1993b). Since 
Elongin is not found in yeast, it may be a higher eukaryotic gene-specific factor.  
 
ELL (eleven-nineteen lysine rich leukemia) is the third member in the group of transcription 
elongation factors, that act by preventing pausing of elongating Pol II (Shilatifard e t  a l . , 1997; 
Shilatifard e t  a l . , 1996). ELL was initially identified by its involvement in acute myeloid leukemia 
(Thirman e t  a l . , 1994). Drosophila ELL (dELL) is an essential factor during development and 
dELL mutants show defects in the transcription of larger genes (Eissenberg e t  a l . , 2002; 
Shilatifard, 2004)  
 
DSIF (DRB sensitivity inducing factor; DRB = 5,6-dichloro-1-D-ribofuranosylbenzimidazole, a 
nucleotide analogue) was reported to antagonise the negative effects of transcriptional pausing 
caused by the chromatin remodelling factor Isw1 (Morillon e t  a l . , 2003). DSIF genetically and 
physically interacts with a set of factors such as TFIIF, TFIIS, FACT and others (Sims e t  a l . , 
2004) and could therefore be an adaptor that connects other modulators to elongating Pol II.  
 
The NELF (negative elongation factor) complex promotes Pol II pausing (Yamaguchi e t  a l . , 
1999) in the presence of  DSIF. DSIF binds directly to Pol II and NELF preferentially binds to 
the assembled DSIF/Pol II complex, but not to DSIF or Pol II alone (Yamaguchi e t  a l . , 2002). 
Elongation is resumed when NELF dissociates from the paused elongation complex when the 
CTD is being phosphorylated by P-TEFb (Ivanov e t  a l . , 2000; Kim and Sharp, 2001).  
 
P-TEFb (positive transcription elongation factor b) is capable to stimulate DRB-sensitive 
transcription of long transcripts in vitro.(Marshall and Price, 1992). P-TEFb has kinase activity 
which targets serine 2 of the CTD repeats of Pol II at actively transcribed genes (Ni e t  a l . , 2004). 
The elongation activity of P-TEFb is dependent on this kinase activity (Sims e t  a l . , 2004). 
 
The elongation factor CSB (cockayne syndrome complementation group B) is a DNA-dependent 
ATPase which directly binds to Pol II and affects the activity of TFIIS (Selby and Sancar, 1997; 
Tantin e t  a l . , 1997). CSB links transcription by Pol II to transcription-coupled nucleotide repair 
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(Gregory and Sweder, 2001; Licht e t  a l . , 2003) and to rescue of stalled Pol II at DNA lesion sites 
(Woudstra e t  a l . , 2002). 
 
12 DISCOVERY AND FUNCTION OF TFIIS 
TFIIS (also referred to as SII) was the first Pol II-associated factor to be purified (Sekimizu e t  
a l . , 1976), based on its ability to promote efficient synthesis of long transcripts in vitro. 
Biochemical studies subsequently revealed that this function relies on the ability of preventing 
Pol II from arrest. Elongating RNA polymerases (bacterial, archaeal and eukaryotic Pol I, II and 
III) appear to oscillate between inactive and active conformations at each step of nucleotide 
addition (Erie e t  a l . , 1993; Gu and Reines, 1995; Rhodes and Chamberlin, 1974). Consequently, 
the overall RNA polymerase elongation rate is not determined solely by the rate of 
phosphodiester bond formation, but also by the fraction of time polymerase dwells in inactive 
conformations. Transcriptional pausing occurs when Pol II halts the addition of NTPs to the 
nascent RNA transcript for a time, before resuming productive elongation on its own. The 
paused state slowly isomerises to an arrested state that can be reversed only by the action of the 
elongation factor TFIIS or its bacterial counterparts GreA and GreB (Gu and Reines, 1995; Wind 
and Reines, 2000). Reasons for transcriptional pausing and arrest include intrinsic DNA 
sequences, which code for unstable A-U rich DNA-RNA hybrids, and proteins or drugs bound 
to DNA, which block the forward movement of transcribing polymerases (Erie, 2002; Fish and 
Kane, 2002; Nudler e t  a l . , 1997; Shilatifard e t  a l . , 2003).  
 
 
elongating Pol paused Pol arrested Pol
TFIIS or GreA/GreB  
Figure 11: During transcription, RNA polymerases undergo frequent pausing, 
which can lead to permanent arrest. The action of TFIIS or GreA/GreB is 
required to reactivate such stalled RNA polymerases 
 
 
Transcriptional pausing and arrest are coupled to a reverse movement (backtracking) of the 
polymerase relative to the DNA template, thereby disengaging the active site and the 3’-OH 
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group of the nascent RNA. Backtracking by a few nucleotides results in pausing, a temporary 
block to elongation, from which Pol II can escape by itself.  More extensive backtracking 
however can lead to transcriptional arrest. The backtracked 3’-terminus is most likely extruded 
through the funnel and pore (Cramer e t  a l . , 2000). Thus, arrest may result from irreversible 
trapping of the 3’-end of the displaced transcript at a binding site in the pore (Cramer e t  a l . , 
2000; Cramer e t  a l . , 2001; Gnatt e t  a l . , 2001; Westover e t  a l . , 2004a). TFIIS or GreA/B then 
promote cleavage of short pieces of the 3’ terminus of the backtracked RNA (preferentially 
dinucleotides and 7-9mers, respectively) (Gu and Reines, 1995), which is a necessary and 
sufficient prerequisite for the reactivation of arrested polymerases (Fish and Kane, 2002; 
Shilatifard e t  a l . , 2003). TFIIS strongly enhances a weak RNA nuclease activity that is intrinsic to 
Pol II (Reines e t  a l . , 1992; Wang and Hawley, 1993).  The nuclease activity represents the second 
enzymatic function of the enzyme beside RNA polymerisation (and its reverse reaction, 
pyrophosphorolysis). (Surratt e t  a l . , 1991). This demonstrates that RNA polymerase-mediated 
transcript cleavage is an evolutionarily conserved process. In addition to stimulating transcription 
by overcoming arrest, TFIIS  was shown to reduce the likelihood of transient pausing of Pol II 
(Bengal e t  a l . , 1991; Rappaport e t  a l . , 1987; Sluder e t  a l . , 1989). The latter stimulatory function 
is different from the function of elongation factors such as TFIIF, Elongin and ELL, which 
increase the rate of nucleotide incorporation (Zhang e t  a l . , 2003).  
 
Studies using an artificial DNA-RNA hybrid demonstrated that Pol II is able to incorporate a 
mismatched nucleotide, and that TFIIS enhances the preferential removal of the misincorporated 
base (Jeon and Agarwal, 1996). This study and additional kinetic studies (Thomas e t  a l . , 1998) 
demonstrated the proofreading activity of Pol II, which is dramatically enhanced by TFIIS in 
vitro. Under normal circumstances, yeast TFIIS null mutants do not show an apparent 
phenotype, thus the relevance of mRNA proofreading is unclear. Under oxidising conditions, 
however, transcriptional fidelity was reported to be ninefold higher in the wild type compared to 
a TFIIS knockout strain (Koyama e t  a l . , 2003). 
 
Chromatin immunoprecipitation studies have shown TFIIS to localise with the coding regions of 
genes (Pokholok e t  a l . , 2002). A knockout of PPR2, the gene encoding for TFIIS in yeast, is not 
lethal but leads to a sensitivity to 6-azauracil (Hubert e t  a l . , 1983; Nakanishi e t  a l . , 1985). The 
substrate analogue 6-azauracil interferes with the pyrimidine biosynthesis pathway and lowers the 
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cellular concentrations of CTP and UTP, thus altering the relative abundance of the four NTPs. 
A sensitivity to 6-azauracil is therefore attributed to defects in transcription elongation.  
 
TFIIS is a modular factor that comprises an N-terminal domain I, a central domain II, and a C-
terminal domain III, which are connected by flexible inter-domain linkers.  The weakly conserved 
domain I forms a four-helix bundle (Booth e t  a l . , 2000)  and is not required for TFIIS activity in 
the context of elongation (see below).  Domain II forms a three-helix bundle (Awrey e t  a l . , 1998; 
Morin e t  a l . , 1996), and domain III adopts a zinc ribbon fold with a thin protruding β-hairpin 
(Olmsted e t  a l . , 1998; Qian e t  a l . , 1993b).  Domain II and the linker between domains II and III 
are required for Pol II binding, whereas domain III is essential for stimulation of RNA cleavage. 
The linker between domains II and III confers species selectivity and was thought to position 
and orient domains II and III (Shimasaki and Kane, 2000). Solution structures of all three 
domains were solved individually (Booth e t  a l . , 2000; Morin e t  a l . , 1996; Qian e t  a l . , 1993b) 
and proved to be useful for driving structure determination in this work. In addition to the major, 
ubiquitously expressed form of TFIIS in higher eukaryotes, there are multiple tissue- or 
developmental stage-specific members of the TFIIS family (Kanai e t  a l . , 1991; Xu e t  a l . , 1994). 
In Pol III, the zinc finger domain of Rpc11 is the functional homologue of TFIIS domain III 
(Huang e t  a l . , 2005), and is essential for 3’-cleavage, tRNA maturation and termination. The 
Pol I subunit A12.2 comprises a zinc ribbon domain which is homologous to the zincribbon of 
TFIIS (Figure 34). 
 
TFIIS genetically interacts with a variety of components of the transcription machinery. Several 
genes were identified that are necessary for either cell survival or robust growth when the gene 
encoding TFIIS has been disrupted. These include amongst others genes for the Swi/Snf 
chromatin remodelling complex. SWI1 and SNF2 disruptions were also synthetically lethal with a 
deletion of the TFIIS-encoding gene PPR2, suggesting that the reduced ability to remodel 
chromatin confers the synthetic phenotype. Detection of these genetic interactions provides 
another functional link between the Swi-Snf complex and the elongation machinery (Davie and 
Kane, 2000). The RNA cleavage activity of TFIIS is required for the ultra-rapid initiation of heat 
shock genes such as Hsp70 (Adelman e t  a l . , 2005), where elongating Pol II is stalled early 
beyond the promoter, poised to be released for transcription by TFIIS upon heat-shock.  
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13 TRANSCRIPTION IN VITRO  
Elongation complexes can be readily assembled in vitro. These complexes are stable for at least a 
week under various conditions and can be resolved by gel electrophoresis and chromatography. 
(Daube and von Hippel, 1994; Gnatt e t  a l . , 1997). Functional elongation complexes to study 
RNA polymerases can be assembled on natural promoters in the presence of general 
transcription factors. Another technique suitable for obtaining large quantities relies on RNA 
polymerases binding to the 3’ end of short RNAs annealed to a single-strand template DNA 
(DNA-RNA hybrid, see chapter 16.1 in Results and Discussion). (Daube and von Hippel, 1992). 
A complementary template strand can be subsequently incorporated into elongation complexes 
assembled this way. Alternatively, Pol II was shown to start de novo RNA synthesis on double-
stranded DNA bearing a poly(dC) tail of > 15 bases at one 3’ end (“tailed template”) (Gnatt e t  
a l . , 1997). Elongation complexes can be separated from free RNA polymerase by 
chromatography on heparin resin, which specifically retains the free enzyme (Komissarova e t  a l . , 
2003). 
14 STRUCTURE DETERMINATION OF MULTI-SUBUNIT COMPLEXES 
Proteins most often interact with partner proteins or other types of (macro)molecules in their 
cellular context (Patrick Aloy, EBI). Current estimates assume an average of about five 
interacting partners per protein in the proteome of the yeast S. cerevisiae. (Grigoriev, 2003). 
Protein interactions and their associated networks are the key to understanding cellular processes 
in the post-genome era. Meanwhile, about 60 % of nearly 30000 entries in the protein data base 
(www.rcsb.org/pdb) consist of more than one biopolymer chain, but most of these structures 
have been deposited over the last few years (Figure 12).  
 
 INTRODUCTION 31 
0
5000
10000
15000
20000
25000
30000
1972 1977 1982 1987 1992 1997 2002
year
PD
B
 e
nt
rie
s
Entries with >1 chains
Total number of entries
 
Figure 12: Entries in the protein data base (www.rcsb.org) by December 31, 
2004. The graph shows the total number of deposited x-ray-derived structures ( ) 
and structures consisting of more than one biopolymer chain 
(protein/DNA/RNA/carbohydrates) ( ). 
 
 
Among all PDB entries, there are 1220 protein-nucleic acid complexes (i.e. 4 %) and only eleven 
(i.e. 0.04 %) ternary complexes of protein, DNA and RNA. Prevalent experimental difficulties 
and the requirement for reliable methods still render structure determination of large complexes a 
formidable challenge.  
 
All methods for structure determination rely on highly purified, homogeneous material. Due to 
the transient nature of many complexes, purification by standard techniques is often impossible. 
Therefore, carefully developed and optimised strategies are necessary to obtain purified 
complexes. One way is affinity chromatography, e.g. with a TAP (tandem affinity purification) tag 
under mild conditions. (Rigaut e t  a l . , 1999). Alternatively, a multi-subunit complex can be 
dissected in subcomplexes, which can be produced recombinantly (“in vivo reconstitution”) (Tan, 
2001). Since isolated components of complexes are often dependent on an interaction partner for 
correct folding to a soluble protein, the art of this strategy lies in finding the correct combination 
of complex components (Tan, 2001). Yet another method is based on in vitro reconstitution of a 
complex from separately purified components. In this approach, complex assemblies, e.g. a fully 
recombinant archaeal RNA polymerase (Ouhammouch e t  a l . , 2004; Werner and Weinzierl, 
2002) or complete Pol II (Armache e t  a l . , 2003) have been obtained. The protein/DNA/RNA 
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complexes of Pol II reported in this thesis have been assembled from endogenous, recombinant 
and synthetic material. In very rare cases, i.e. in the case of a Initiation Factor 1-(IF1)-ribosome 
complex (Carter e t  a l . , 2001) and in this thesis, in vitro assembly was performed in pre-formed 
crystals by soaking these crystals in a solution of an interacting partner protein (see chapter 17). 
 
The next hurdle in structure determination by crystallographic means lies in obtaining diffraction-
quality crystals from the purified material. Buffer conditions have to be found under which the 
complex is monodisperse and stable enough over crystallographic time scales (several days to 
weeks). If initial crystallisation trials do not lead to promising results, the subunit composition or 
the nature of the constructs used offers an over-abundance of parameters to vary for subsequent 
experiments. Moreover, the length and the nature of single-stranded overhangs of co-crystallised 
DNA or RNA can be varied systematically, since in most nucleic-acid complexes, DNA and/or 
RNA is involved in crystal contacts.  
 
The composition of a putative complex crystal can be analysed by gel electrophoresis, which has 
the disadvantage of sacrificing at least one, but typically several large crystals.  Both the presence 
and the size of protein and nucleic acid components can be detected this way. A novel 
fluorescence-based assay, which allows rapid, reliable detection of nucleic acids was developed 
during the course of this thesis.  
 
Structural data of multi-subunit complexes need not only come from crystallography. Lower-
resolution information can also come from techniques such as small angle x-ray scattering 
(SAXS), which can achieve a resolution up to ≈ 10 Å, (Koch e t  a l . , 2003). SAXS proved to be 
particularly useful in cases where no crystals could be obtained or where additional information 
about conformational dynamics in solution was desired. In principle, SAXS can lead to ab initio 
models of biomolecules from several kilodaltons up to several megadaltons. A second technique 
complementary to x-ray crystallography is electron microscopy (EM) in its manifestations of 
electron crystallography, electron tomography and single-particle EM. In fortunate cases, a 
resolution of ≈10 Å can be obtained by multi-particle averaging techniques. 
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15 OPEN QUESTIONS AND SCOPE OF THIS WORK 
Various crystal structures of Pol II and a minimal elongation complex (Cramer e t  a l . , 2000; 
Cramer e t  a l . , 2001; Gnatt e t  a l . , 2001) gave substantial insights into the structural basis of the 
transcription process. However, these structures, as well as extensive biochemical work, left 
several questions unanswered, which were addressed in this work. The mechanism of duplex 
DNA separation and re-annealing  before and after the transcription bubble, and the process of 
DNA/RNA strand separation had not been fully understood. This question was addressed by 
cocrystallising Pol II with a complete, synthetic transcription bubble plus product RNA. 
Moreover, no structural evidence how substrates are bound and selected by Pol II had existed. 
Therefore, structure determination of an NTP analogue bound to an elongation complex was 
another aim of this thesis. Finally, there were no structures of Pol II in complex with 
transcription factors. Such factors can bind transiently to Pol II and enhance or reduce the 
transcription rate by hitherto unknown mechanisms. The structure of TFIIS, the most prominent 
of these factors, bound to Pol II was solved in this work. 
 
X-ray crystallographic studies of large  Pol II complexes (molecular weight > 500 kDa) require 
enhanced techniques for complex assembly, crystallisation, data collection and analysis. The 
standard crystal form of 12-subunit Pol II has a very high solvent content, which impedes 
collection of high-resolution diffraction data. Therefore, one aim of this thesis was to construct a 
variant of the large Pol II subunit, which allows to proteolytically remove the unstructured 
C-terminal domain, leading to an improved crystal form. Two novel fluorescence-based assays 
were developed in order to investigate the complex crystal composition prior to x-ray analysis. 
  
 
 
Results and Discussion 
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16 RNA POLYMERASE II-NUCLEIC ACID COMPLEXES 
16.1 Assembly of complete Pol II-bubble-RNA complexes 
The first prerequisite for any kind of structure determination is isolation of highly pure, 
homogeneous material. During this thesis, an existing purification protocol (Patrick Cramer, 
personal communication; Edwards e t  a l . , 1990) was re-established and slightly modified in order 
to maximise reproducibility and yield (Armache e t  a l . , 2003; see chapter 21.2). In essence, the 
previous DEAE chromatography step was replaced by a Uno-Q anion exchange column.  
Notably, Pol II purified in two days rather than three days, i.e. with the immunoaffinity and the 
UnoQ step performed in one day, does not yield crystallisable Pol II. For unclear reasons, this 
material would merely form showers of small crystals in the usual crystallisation conditions.  
 
Complete yeast Pol II elongation complexes were reconstituted in vitro from endogenous 10-
subunit core Pol II, recombinant Rpb4/7,  and synthetic oligonucleotides. These are comprised 
of a 41-mer DNA duplex with an eleven nucleotide mismatched bubble region, annealed to an 
RNA 20-mer with eight complementary bases (see Table 6 and Materials and Methods). Besides 
this “standard” transcription bubble/RNA construct, a set of different DNA and RNA 
oligonucleotides was designed and used for purposes described in Table 6. Essentially, 
substitutions of uracils by 5-bromouracils as sequence markers at various positions are realised in 
a set of template and non-template DNA oligonucleotides. A set of RNA oligonucleotides with 
various 5’-overhangs was designed, as well as RNAs with and without a 3’-OH group for 
substrate studies (see Table 6).  
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Table 6: Overview of oligonucleotides used for crystallisation 
Hybrid 1 
RNA         5'-                    CCAGGC                   -3' 
TEMPLATE    3'-                  CTGGTCCGGAAA               -5' 
  not detected in core  Pol II crystals. 
 
Hybrid 2 
RNA         5'-                  GACCAGGC*                  -3' 
TEMPLATE    3'-                  CTGGTCCGGAAA               -5' 
  not detected in core  Pol II crystals. 
 
Hybrid 3  
RNA         5'-            CAGCACGACCAGGC*                  -3' 
TEMPLATE    3'-                  CTGGTCCGGAAA               -5' 
  not detected in core  Pol II crystals. 
 
Hybrid 4  
                                         ACGCAGCACG         -3' 
RNA         5'-                  GACCAGGC     
TEMPLATE    3'-                  CTGGTCCGGAAA               -5' 
  not detected in core  Pol II crystals. 
 
Hybrid 5  
RNA         5'-                  GACCAGGC                   -3' 
TEMPLATE    3'-   CCGTCATGATCAAAACTGGTCCGGAAA               -5' 
NONTEMPLATE 5'- CCGGCAGTACTAGT                              -3' 
  not detected in core  Pol II crystals. 
 
Bubble 1-Br 
RNA         5'-                  GACCAGGC                   -3'  
TEMPLATE    3'-   CCGTCATGATCAAAACTGGTCCGGAAACATGAACTCGAACC -5'  
NONTEMPLATE 5'- CCGGCAGTACTAGTAAACTAGTATTGAAAGTACTTGAGCTT   -3'  
  complete transcription bubble.  
 
 
Bubble 2-Br 
            5’-      UAUAUGCAUAAA 
RNA                              GACCAGGC                   -3’  
TEMPLATE    3'-   CCGTCATGATCAAAACTGGTCCGGAAACATGAACTCGAACC -5'  
NONTEMPLATE 5'- CCGGCAGTACTAGTAAACTAGTATTGAAAGTACTTGAGCTT   -3'  
  Complete transcription bubble. Structure solved with this  
  construct 
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Backtracked Bubble 
                                         ACGCAGCACG         -3'  
RNA         5'-                  GACCAGGC 
TEMPLATE    3'-   CCGTCATGATCAAAACTGGTCCGGAAACATGAACTCGAACC -5'  
NONTEMPLATE 5'- CCGGCAGTACTAGTAAACTAGTATTGAAAGTACTTGAGCTT   -3' 
  No density for backtracked RNA. Poor density for hybrid region. 
 
Nontemplate-Br 1 
            5’-      UAUAUGCAUAAA 
RNA                              GACCAGGC                   -3’ 
HK-DNA4:    3'-   CCGTCATGATCAAAACTGGTCCGGAAACATGAACTCGAACC -5' 
HK-BRDNA6A: 5'- CCGGCAGTACTAGTATACTAGTATTGAAAGTACTTGAGCTT   -3' 
  Br labels in non-template strand (1 of 2) 
 
 
Nontemplate-Br 2 
            5'-      UAUAUGCAUAAA 
RNA                              GACCAGGC                   -3'  
HK-DNA4:    3'-   CCGTCATGATCAAAACTGGTCCGGAAACATGAACTCGAACC -5'  
HK-BRDNA6B: 5'- CCGGCAGTACTAGTAATCTATTATTGTAAGTACTTGAGCTT   -3'  
  Br labels in non-template strand (2 of 2) 
 
RNA aptamer for nucleic acid staining assay (Thomas et al. , 1997) 
 5'- GGGCCGCUAAGUCCUCGCUCACGAUACAGCACUGAUUGCGG… 
    …UCGAGGUAGCUUGAUGGGCCACGCGCGACUCGGAUCCAC     -3' 
T = 5-Bromo uracil; bubble region; *: 3'-dideoxy cytidine 
 
 
The complexes could readily be isolated from the excess of Rpb4/7 and nucleic acids by gel 
filtration over a Superose6 10/300HR column (Figure 13). Heparin-derivatised chromatography 
media retain apo-Pol II, whereas Pol II complexed with nucleic acids is not bound (Gnatt e t  a l . , 
1997). Consequently, an additional heparin column following the gel filtration binds less than 5 % 
of the Pol II-bubble/RNA complex after gel filtration  (not shown), indicating satisfactory 
stability of elongation complexes. 
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Figure 13: Purification of complete Pol II-DNA/RNA complexes.  
(A) Size-exclusion chromatogram. The left peak corresponds to the Pol II-DNA/RNA 
complex and is clearly separated from the right peak, which contains the surplus of 
DNA/RNA and Rpb4/7.  
(B) Coomassie-stained SDS-polyacrylamide gel of complete Pol II isolated as described in 
Materials and Methods. The subunits Rpb1-Rpb12 are indicated.   
 
16.2 Characterisation of Pol II-DNA/RNA complexes 
Binding of synthetic transcription bubble constructs to Pol II was assayed by electrophoretic 
mobility shift assay (EMSA). It was known that double-stranded DNA with a single-stranded 5’-
overhang (tailed templates) bind to and can be elongated by purified Pol II in vitro. (Gnatt e t  a l . , 
1997).  However, it was unclear whether a pre-annealed transcription bubble and a synthetic 
RNA product would assemble correctly with Pol II, especially when the Rpb4/7 subcomplex 
forces the clamp to a closed position.  
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Figure 14: Synthetic transcription bubble/RNA constructs bind to 
complete Pol II.  
100 pmol of nucleic acids described in Table 6 were incubated with 20 pmol 
of Pol II and the complex was separated from free nucleic acids by native gel 
electrophoresis as described in Materials and Methods. Nucleic acids were 
stained with SYBR-Gold.  
 
Figure 14 shows an EMSA of several different DNA/RNA constructs, all of which strongly bind 
to Pol II. Remarkably, DNA/RNA hybrids number 1, 2 and 4 (Table 6) bind to Pol II, but are 
not visible in the electron density of core Pol II cocrystals. These hybrids most likely dissociate 
during crystallisation due to their short length. Thus, further studies were carried out with 
complete transcription bubble and product RNA constructs. Notably, nucleic acid binding does 
not depend on the order of addition of Rpb4/7 and nucleic acids to core Pol II within the scope 
of the bandshift assay. Presumably, the clamp conformation imposed by binding of Rpb4/7 has 
enough flexibility to allow entry of a DNA/RNA hybrid.  
 
When NTPs are added to these Pol II elongation complexes, template-directed elongation of the 
RNA is observed (Figure 15). Thus, the elongation complexes are catalytically active.  
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Figure 15: Elongation Assay.  
(A) Complete Pol II was mixed with a synthetic transcription bubble of the given sequence. (T): 
template DNA; (N): non-template DNA. Addition of a subset of NTPs leads to elongation of 
RNA as indicated by arrows. The shaded box denotes the mismatched “transcription bubble” 
region.  
(B) Denaturing gel electrophoresis of RNAs isolated from the transcription assay and stained with 
SYBR-Gold. The RNA length is indicated at the right. With the full set of NTPs (rightmost lane), 
the run-off product and a second, shorter product is observed. 
 
 
16.3 Crystallisation of Pol II-nucleic acid complexes 
The initial strategy of this project was to co-crystallise core Pol II with DNA/RNA hybrids #1 –
 5 (Table 6), representing only the RNA and a template strand. Although such DNA/RNA 
oligonucleotides bound strongly to Pol II (Figure 14), no electron density was visible in crystals 
grown in the original PEG-phosphate conditions (row 1 in Table 7). These initial crystals 
resembled the fully shrunk form of core apo-Pol II (Cramer e t  a l . , 2001) in both morphology 
and unit cell parameters. 
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Open questions (see chapter 15), unanswered by previous crystal structures of Pol II elongation 
complexes (Gnatt e t  a l . , 2001; Kettenberger e t  a l . , 2004; Westover e t  a l . , 2004b) and T7 
RNAP (see Table 2) prompted us to crystallise Pol II together with a whole transcription bubble. 
Core Pol II/bubble/RNA complexes refused to give rise to three-dimensional crystals, and a 
refined crystallographic model of the complete 12-subunit apo-Pol II became available during 
this project (Armache e t  a l . , 2003). Therefore, the focus of this project was re-oriented towards 
achieving a model of a complete transcription bubble and product RNA in the context of 
complete, 12-subunit Pol II.  
 
Well-diffracting crystals of core Pol II were obtained under conditions described earlier (Cramer 
e t  a l . , 2001), and complete Pol II was initially crystallised in a modified version of these 
conditions (Armache e t  a l . , 2003). In contrast to core Pol II crystals, diffraction of complete 
Pol II crystals could not be improved by dehydration described by (Cramer e t  a l . , 2001). For 
Pol II-nucleic acid complexes, these conditions were not ideal due to their high phosphate 
concentration which generally fosters dissociation of complexes. Thus, complete Pol II and its 
nucleic acid complexes were subjected to commercial screens (Crystal screen 1+2, Natrix, 
PEG/Ion screen; Hampton Research). Three-dimensional crystals were obtained in condition 
#38 of the Natrix screen (200 mM ammonium acetate, 150 mM magnesium acetate, 50 mM 
Hepes pH 7.0, 5% PEG4k, 5 mM TCEP) and in condition # 29 of Crystal Screen 1 (800 mM 
potassium-sodium tartrate; 100 mM HEPES pH 7.5). These initial conditions were refined to 
result in the conditions described in Table 7. The modified Natrix condition #29 turned out to 
give rise to reproducible, large crystals with satisfactory occupancy of nucleic acids (see chapter 
16.4). The TFIIS-soak (chapter 17.1) is possible in both the Natrix condition and in the 
ammonium-sodium-tartrate condition (Table 7).  TFIIS is however insoluble in the original 
phosphate/PEG conditions (Table 7).  
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Table 7: Overview of Pol II crystallisation conditions 
Conditions 10 su 
Pol II 
12 su 
Pol II 
12su + 
bubble 
cryoprotocol comments max. 
resolution 
original PEG/PO4 
390 mM NH4NaPO4, 
pH 6.0 
15-18 % PEG 6k 
50 mM dioxane 
5 mM DTT 
 
+ - - 
shrinkage 
protocol 
(Cramer e t  a l . , 
2001): 
16% PEG6K, 
100 mM MES 
pH 6.3, 50 mM 
dioxane, 350 
mM NaCl, 17% 
PEG400 in 7 
steps ; 4°C over 
24 h 
conditions for 
high-
resolution 10 
subunit Pol II 
2.8 Å 
PEG20K/PO4 
320 – 360 mM 
NH4NaHPO4, pH 6.0 
8-12 % PEG20k  
25 mM NaCl 
5 mM DTT 
- + n.d. 
mother solution 
+ 0-(16-22)% 
glycerol in 5 
steps; 8 °C over 
night 
original 12 
subunit  
Pol II 
conditions 
(Armache e t  
a l . , 2003) 
 
4.2 Å 
Natrix #38 
200 mM ammonium 
acetate 
150 mM magnesium 
acetate 
50 mM Hepes pH 7.0 
5 % PEG4k or 6k 
5 mM DTT or TCEP 
n.d. + + 
mother solution 
+ 0-20% 
glycerol in 5 
steps; 8 °C over 
night 
 
3.8 Å 
Citrate/PEG 
12 % PEG-6000  
80-100 mM Na3-
citrate 
100 mM Hepes pH 7.5 
100 mM ammonium 
sulphate 
5 mM DTT or TCEP 
n.d. n.d. + 
mother solution 
+ 0-16% 
glycerol in 5 
steps; 8 °C over 
night 
2D and 3D 
crystals mixed. 
max. 120  by 
80 by 30 µm n.d. 
Tartrate/Hepes 
750 – 950 mM 
NH4NaTartrate 
100 mM Hepes-Na  
pH 7.5 
5 mM DTT or TCEP 
- + + 
mother solution 
+ 0-22% 
glycerol in 5 
steps; 8 °C over 
night 
modified 
Hampton 
screen 1 #29 3.8 Å 
 RESULTS AND DISCUSSION 42 
Conditions 10 su 
Pol II 
12 su 
Pol II 
12su + 
bubble 
cryoprotocol comments max. 
resolution 
Tartrate/PEG/ 
KSCN 
12-13 % PEG-6000  
300 mM ammonium-
sodium tartrate 
100 mM Hepes pH 7.5 
100 mM KSCN 
5 mM DTT or TCEP 
n.d. + + 
mother solution 
+ 0-16% 
glycerol in 5 
steps; 8 °C over 
night 
good and 
reproducible 
for bubble 
complexes  3.8 Å 
Tartrate/PEG 
additive 
12-13 % PEG-6000  
300 mM ammonium-
sodium tartrate 
100 mM Hepes pH 7.5 
10 mM spermidine  
    or 50 mM ethylene   
    diamine  
    or 50 mM LiCl 
5 mM DTT or TCEP 
n.d. n.d. + 
mother solution 
+ 0-16% 
glycerol in 5 
steps; 8 °C over 
night 
additives give 
bigger 
crystals, esp. if 
bubble is 
present in 
excess. n.d. 
+: 3D crystals obtained; –: no 3D crystals obtained; n.d.: not determined 
 
A small number of larger crystals is typically achieved with a protein : reservoir ratio of 2 : 1, 
whereas use of sitting drop plates or microdialysis crystal set-ups did not lead to improved crystal 
size. At a later stage of this work, crystal size could be improved by covering the reservoir 
solution with 200 – 400 µL of Al’s oil (paraffin oil : silicon oil 1 : 1; Hampton Research). Crystals 
grew to an ideal size of about 0.4 x 0.3 x 0.2 mm within 1-2 weeks at 20 °C. Larger crystals often 
showed damage due to cracking during cryo treatment.  
 
Early electron density maps showed poor electron density for nucleic acid regions (see chapter 
16.7). A drastic improvement was achieved by adding a slight excess (1-2 µM) of nucleic acids to 
the crystal setup in order to achieve full occupancy of nucleic acid sites (see Materials and 
Methods). Figure 16 shows typical representatives of crystals obtained under conditions 
described in Table 7.  
 
 
 RESULTS AND DISCUSSION 43 
Natrix # 38 
 
Sodium citrate/PEG 
NH4-Na Tartrate/PEG/KSCN 
 
NH4-Na Tartrate/PEG/additive 
NH4-Na Tartrate/Hepes 
 
PEG20K/phosphate 
Figure 16: Typical representatives of crystals of the complete Pol II/nucleic acid 
complex, obtained under various conditions described in Table 7. 
 
 
16.4 Characterisation of complete Pol II-DNA/RNA cocrystals 
Crystals of the 12-subunit Pol II are characterised by their unusually high solvent content of 
80 % (Matthews coefficient of 6.2). This is the highest solvent content of all Pol II crystal forms 
described so far (Table 8). Consequently, only a slow, stepwise procedure allowed adding the 
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necessary amounts of glycerol as cryoprotectant to the mother solution surrounding the crystals. 
Other cryoprotectants such as PEG400, sucrose, 2-methyl-propanediol (MPD), ethylene glycol, 
propylene glycol, and glucose destroyed diffraction. Crystals are extremely sensitive to any kind 
of osmotic stress. Diffraction quality must be further enhanced from about 6 Å up to 3.8 Å by 
slowly cooling crystals to 4 – 8 °C in the last cryo-solution. Cryo-cooling in liquid nitrogen was 
performed after storage over night in the last cryo-solution. Further lowering the temperature to 
–20 °C before cryocooling did not improve diffraction, possibly because of the high amounts of 
glycerol (30 %) necessary to avoid ice formation at –20 °C. Likewise, diffraction was hampered 
by cryocooling in mother solution without additives using supercooled liquid propane. 
 
Table 8: Crystal forms of core and complete Pol II and Pol II complexes 
Crystal Form Unit Cell (Å) Space 
group 
Solvent 
content 
Reference 
Free core Pol II,  
form 1 
131, 225, 369 I222 58 % (Cramer e t  a l . , 2000) 
Free core Pol II, 
shrunk form 
123, 223, 376 I222 56 % (Cramer e t  a l . , 2001) 
Minimal elongation 
complex1 
157, 221, 191 
β=97.5° 
C2 65 % (Gnatt e t  a l . , 2001; 
Westover e t  a l . , 
2004b) 
Complete Pol II 220, 391, 282 C2221 80 % (Armache e t  a l . , 2003) 
and this study 
1 All complexes of core Pol II and nucleic acids exhibit a very similar crystall lattice (Westover e t  a l . , 
2004a; Westover e t  a l . , 2004b). 
 
All DNA/RNA oligonucleotides cocrystallised with complete Pol II resulted in the same crystal 
form, regardless the length and nature of dsDNA ends and overhangs of all constructs tested.  
16.5 Data collection 
Having harvested a total of about 700 crystals of the 12-subunit Pol II crystal form, of which 
about 300 crystals were screened at the synchrotron, a great deal of experience in judging the 
quality and in optimising data collection could be gained. Mosaicities < 0.5 greatly facilitate data  
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Figure 17: Diffraction pattern of a complete Pol II-transcription bubble-
RNA cocrystal.  
(A) The diffraction pattern was recorded with a Mar MosaicCCD 225 detector at 
beamline X06SA of the SLS, at a wavelength of 0.98 Å and a crystal-detector 
distance of 400 mm. White circles indicate the resolution and a dashed line marks 
the path of the linescan in panel (B).  
(B) Linescan between points a and b in panel (A). The vertical axis represents the 
diffraction intensity (arbitrary units). 
 
processing and improve statistics. Radiation damage is the factor, which limits the resolution and 
quality of diffraction data of the 12-subunit crystal form. Thus, particular care was taken to 
reduce both the dose and the background due to diffuse scattering. Both aims were achieved by 
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routinely taking diffraction images of small 0.25° oscillation increments at the longest reasonable 
crystal-detector distance and an x-ray beam focused on the detector. “Light” mother solutions, 
i.e. those, which do not contain phosphorous or other heavier elements, were preferred to reduce 
diffuse scattering from the solvent.  
 
A considerable improvement was observed when the detector at the SLS beamline X06SA was 
changed from a MarCCD165 with 165 mm diameter to a Mar225 MOSAIC CCD detector with 225 
mm diameter. This larger detector allows longer crystal-detector distance at a given resolution 
cut-off. Since background due to diffuse scattering falls off with 1/d ² (d being the crystal-
detector distance), any increase in the distance reduces the background on diffraction images and 
thus increases the signal-to-background ratio.  
 
Recently, the use of radical scavengers such as ascorbic acid was shown to reduce radiation 
sensitivity in some cases (Garman, 2003; Garman and Nave, 2002; Murray and Garman, 2002). 
First experiments with Pol II crystals indicate that 100 mM of ascorbate or 5 mM of TEMPO 
(2,2,6,6-tetramethylpiperidinyl-N-oxid) might slightly prevent radiation damage. However, the 
availability of sufficiently large crystals and a reliable data collection strategy largely bypassed the 
need for additional stabilisation by radical scavengers. A dose necessary to obtain I/σ(I) values 
greater than about 4 in the highest resolution shell was best judged by visual inspection of 
diffraction images during data collection. Typical exposure times at the SLS beamline X06SA 
ranged between 1.0 and 1.5 seconds of unattenuated beam per 0.25° at a wavelength of 0.91 Å 
and a ring current of 350 mA. Whenever possible, an oscillation range ≥100° was collected per 
dataset and the crystal was translated when the mosaicity increased or the intensities of high-
resolution spots decreased noticeably. Radiation damage did not lead to a reproducible increase 
of unit cell volume as described (Murray and Garman, 2002). However, a sometimes dramatic 
increase of mosaicity during data collection could be observed (Figure 18). 
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Figure 18: Typical mosaicity increase during data collection.   
In most Pol II datasets collected during this work, mosaicity increased during data 
collection, presumably due to radiation damage. The arrow indicates a translocation 
of the crystal in the x-ray beam, so that a “fresh” portion of the crystal is irradiated. 
Together with increasing mosaicity, decreasing I/σ(I) and disappearing high-
resolution reflections are observed.  
 
 
16.6 Phasing and refinement 
The phase problem was solved by molecular replacement with the core Pol II elongation 
complex (PDB-ID 1I50; Gnatt e t  a l . , 2001; Rfree= 36.8 %), with the model of core Pol II and the 
archaeal homologues of Rpb4/7 (PDB-ID 1NT9; Armache e t  a l . , 2003; Rfree= 36.0 %) or, from 
the time it was available, with the refined model of 12-subunit Pol II (PDB-ID 1WCM; Armache 
e t  a l . , 2004; Rfree= 27.6-29.7 %). The resulting electron density strikingly depends on the nature 
of the phasing model (Figure 20). Only the atomic model of the complete Pol II results in maps 
that show excellent electron density for the nucleic acid regions. Density modification (CNS), 
however, annihilated much of the additional electron density and was not used further on.  
 
Backbone phosphate groups and individual nucleotides were resolved, but the identity of the 
nucleotides was not revealed at the given resolution of 3.8-4.5 Å. Therefore, 5-bromouracil was 
introduced in various positions of the DNA template and non-template strand. A bromine atom 
in the nucleotide at position -4 of the template strand was evident in an anomalous difference 
Fourier map, defining the register of nucleic acids (Figure 20B). However, no anomalous signals 
above noise were detected for the other bromine labels at positions +7, +12, -7, -14 and –20 in 
 RESULTS AND DISCUSSION 48 
the template strand, and at positions +6, -1, -2, -4, -5, -7, -9, -10, and -12 in the non-template 
strand, indicating high mobility of DNA before and after the hybrid.  
 
Nucleic acids were built into unbiased electron density. Starting with the refined 12-subunit Pol II 
model, positional and B-factor refinement (20 cycles each, target: maximum likelyhood function) 
converged readily at a free R-factor of 27.6 % (Table 9).  
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Table 9: X-ray diffraction data and refinement statistics 
Dataset number 1 2 3 
Crystal composition Pol II-bubble-RNAa Pol II-bubble-RNA  
(with Br-dU)a,b 
Pol II-bubble-RNA 
+ GMPCPPa,c 
Unit cell axes (Å)e 221.4, 392.5, 283.2 220.6, 393.1, 282.0 222.5, 393.1, 283.7 
Wavelength (Å) 0.9200 0.9195 (Br peak) 0.97960 
Resolution range (Å)f 50-4.0 (4.14-4.0) 50-4.2 (4.35-4.20) 50-4.5 (4.66-4.50) 
Unique reflectionsf 102020 (10148) 69541 (6559) 58178 (5134) 
Completeness (%)f 99.3 (99.5) 77.5 (73.8) 78.4 (69.8) 
Redundancy f 4.0 (4.0) 4.9 (4.3) 2.8 (2.5) 
Mosaicity (°) 0.35-1.23d 0.51 0.20-0.54d 
Rsym (%)f 9.0 (27.9) 7.6 (18.6) 8.1 (23.1) 
I/σ(I)f 13.7 (4.8) 16.6 (7.2) 7.2 (3.0) 
Peaks in anomalous Fourier - 8 Zn in Pol II  
(15.1-8.1 σ) 
1 Br in DNA (5.4 σ) 
- 
Rfree after rigid body 
refinement (%)  
 28.6 29.7 
Refinement    
Number of residues 3926 amino acid 
residues, 36 
nucleotides 
  
RMSD bonds (Å) 0.010   
RMSD angles (°) 1.55   
Rcryst  (%) 25.3   
Rfree  (%) 27.6   
PDB-ID 1Y1W  1Y77 
a Diffraction data were collected at beamline X06SA at the Swiss Light Source. 
b The complex contained a DNA template strand in which thymine at position –4 was replaced by the isosteric 
bromouracil, and the G at position +1 was exchanged to C. 
c The complex was cocrystallized with the nonreactive NTP analogue GMPCPP. 
d Due to radiation damage, mosaicity increased during data collection, and was refined in segments of five frames. 
eCrystals belong to the space group C2221. 
f Values in parentheses correspond to the highest resolution shell. 
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16.7 Overview of nucleic acid structure 
The final model comprises all 12 Pol II subunits, and 19, 7 and 10 residues of template DNA, 
non-template DNA, and RNA, respectively (Figure 19).  
 
Figure 19: Structure of the complete Pol II elongation complex.  
(A)-(C): Three views of a ribbon model of the protein subunits and nucleic acids. The polymerase 
subunits Rpb1-Rpb12 are colored according to the key between the views. Template DNA, 
nontemplate DNA and product RNA are shown in blue, cyan and red, respectively. Phosphorous 
atoms are indicated as spheres and extrapolated B-form downstream DNA is coloured in light pink. 
Eight zinc ions and the active site magnesium ion are depicted as cyan spheres and a magenta sphere, 
respectively. This color code is used throughout. Secondary structure assignments for Pol II are 
according to (Cramer e t  a l . , 2001) and (Armache e t  a l . , 2004). 
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Strong continuous electron density is observed for seven base-pairs of downstream DNA before 
the active site, for the DNA-RNA hybrid, for the template strand connecting between the 
downstream duplex and the hybrid, and for three unpaired nucleotides of both DNA and RNA 
upstream of the hybrid (Figure 20). The complex adopts the post-translocation state, with no 
density in the presumed NTP-binding site (position +1; Figure 20A, D). The nucleic acids are not 
involved in crystal packing, and their location is thus determined by interactions with the 
polymerase, providing an unbiased view of the elongation complex.  
 
Although all nucleic acids of a natural elongation complex are present in the crystals, only 
selected regions are bound by the polymerase and thus visible in the electron density. DNA 
entering the cleft is highly mobile, but is bound for strand separation closer to the active site 
(Figure 20D). Downstream DNA runs along the Rpb1-face of the cleft (Figure 19). Upstream of 
the point of downstream DNA strand separation, the DNA template strand projects the coding 
base in the active site. The DNA-RNA hybrid forms numerous polymerase contacts (Figure 20A, 
C) which are generally in accordance with earlier observations (Gnatt e t  a l . , 2001), and confer 
stability and thus processivity to the elongation complex (Kireeva e t  a l . , 2000b). Upstream of the 
hybrid, the polymerase continues to contact the RNA and the DNA template strand, and these 
contacts may be mainly responsible for strand separation and proper RNA exit. The upstream 
DNA duplex and the non-template strand in the bubble are not observed, and they do not 
contribute significantly to elongation complex stability (Kireeva e t  a l . , 2000b).  
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Figure 20: Nucleic acids in the elongation complex.  
(A) Nucleic acid constructs and Pol II interactions. Filled and open circles denote nucleotides that are 
ordered and disordered, respectively, in the electron density of the cocrystals. Pol II residues that are 
within 4 Å distance of nucleic acids are depicted. Residues that are invariant, conserved, and differing 
among the three yeast nuclear RNA polymerases are in dark green, light green, and black, respectively. 
Italics are used to distinguish Rpb2 from Rpb1 residues. The yellow circle marks the thymine substituted  
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Figure 20 (continued) 
by 5-bromo uracil and localised by anomalous diffraction. Nucleotide positions are numbered with respect 
to the nucleotide addition site (position +1). Upstream and downstream nucleotides/positions have 
negative and positive numbers, respectively. 
(B) Bromine anomalous difference Fourier map. The map was calculated from data set 2 (Table 9), taken 
at the bromine absorption maximum, and phases from the complete Pol II structure without nucleic acids. 
It is contoured at 4.0 σ. The observed peak has a height of 5.4 σ and coincides with the location of the 
bromine atom in a 5-bromouracil residue incorporated at position –4 of the DNA template strand, 
thereby defining the register of nucleic acids. The view is related to that in Fig. 2A by a 180° rotation 
about a vertical axis.  
(C) Long-range Pol II–nucleic acid interactions. Bars indicate Pol II domains and elements within a 
distance of 8 Å from the nucleic acids (Cramer e t  a l . , 2001). The extent and color of the bars define the 
DNA or RNA nucleotides contacted by Pol II. Rpb2 elements are in italics. The encircled nucleotide 
positions have previously been observed in Pol II–nucleic acid complex structures [solid black line (Gnatt 
e t  a l . , 2001); dashed black line, (Westover e t  a l . , 2004b)].  
(D) Electron density map. A 2Fo-Fc map was calculated from data set 1 (Table 9), using phases from the 
final model with nucleic acids omitted. The map is contoured at 1.0σ. The final model for the nucleic 
acids is superimposed. The region within the dashed box is magnified in 1B. Note the absence of electron 
density in the substrate-binding (+1) site.  
(E) Initial electron density map. The 2Fo-Fc map has been calculated with the same experimental data as in 
(D), but was phased with the incomplete 10-subunit core Pol II structure (PDB-ID 1I6H). The map is 
contoured at 1.0σ. 
 
16.8 DNA unwinding 
In contrast to previous structures of Pol II-nucleic acid complexes (Gnatt e t  a l . , 2001; Westover 
e t  a l . , 2004b), seven base pairs of downstream DNA are observed, at positions +3 to +9 (Figure 
19, Figure 20). The downstream double-stranded DNA forms direct contacts with Pol II, and is 
surrounded by several polymerase elements (see Figure 20C and Figure 21 for details). The 
ordered part of the downstream DNA occupies a DNA-binding site identified previously in 
bacterial polymerase (Nudler, 1999; Nudler e t  a l . , 1996; Nudler e t  a l . , 1998), and its sequence 
can influence polymerase pausing (Palangat e t  a l . , 2004; Palangat e t  a l . , 1998). The overall 
position of downstream DNA agrees with those inferred from electron microscopy (Poglitsch e t  
a l . , 1999) and from scattered electron density features in a crystallographic map (Gnatt e t  a l . , 
2001). The observed conformation of downstream DNA suggests how the template strand is 
removed from the non-template strand before reaching the active site. DNA at register +5 to +9 
is essentially in canonical B-form, but the template strand deviates from this conformation at 
position +2 to +4 (Figure 21A). Apparently, this deviation is achieved by three positively charged 
residues in switch 2 (R326, K330, R337 of Rpb1), which cause the template strand to deviate 
from the duplex axis. Three negatively charged residues in switch 1 (E1403, E1404, E1407 of 
Rpb1) repel the DNA strand  Figure 21A). Thus, an enzyme-induced distortion and 
destabilisation of the incoming DNA duplex may drive strand unwinding. In addition, the 
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polymerase fork loop 2 sterically blocks duplex binding, interferes with the non-template strand 
upstream of position +3, and prevents re-association of separated strands (Figure 21). 
 
 
Figure 21: Nucleic acid strand separation.  
(A) DNA unwinding and DNA-RNA strand separation. Nucleic acid backbones are colored as in Figure 
20. Spheres represent the location of phosphorous atoms. Downstream DNA that has been extrapolated 
as a canonical B-form duplex is in light magenta. The DNA/RNA hybrid at positions –1 to –5 has been 
used to extrapolate the hybrid structure upstream and is also shown in light magenta. The active site metal 
ion A is shown as a pink sphere. Pol II residues that are apparently involved in nucleic acid strand 
separation are colored according to their conservation in Pol I, II and III as in Fig. 2A. The bridge helix, 
fork loop 2, and the lid are depicted. Basic amino acids in switch 2 that may pull the template strand 
upwards are encircled with a dashed line. 
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Figure 21 (continued) 
(B) Sequence alignments of loops that partition the cleft. Amino acid alignments of the two fork loops in 
Rpb2 and the rudder and lid in Rpb1 are colored according to conservation between eukaryotic, archaeal, 
and bacterial RNA polymerases. Invariant, conserved, and weakly conserved residues are colored in dark 
green, light green, and yellow, respectively. Red and blue squares above the alignments indicate residues 
within 4 Å and 8 Å distance from nucleic acids, respectively. Sequences in subunits of Pol II of S. 
cerevisiae (S.c.), human (H.s.) and Thermus thermophilus (T.th.) are aligned with their homologues in S.c. 
Pol I and III, and E. coli (E.c.) and Methanococcus janaschii (M.j.) RNA polymerase. 
 
16.9 RNA displacement and exit 
The hybrid comprises seven base pairs in the post-translocation state, and would be eight base 
pairs long upon nucleotide incorporation. At register –8, the Watson-Crick edges of the bases are 
≈4 Å apart, indicating that the RNA begins to separate from the DNA template strand. At 
position –9 and –10, the RNA deviates from an extrapolated course beyond the point of strand 
separation (Figure 21A), suggesting that Pol II induces a distortion of the stable heteroduplex 
structure. The separating strands form backbone contacts with Pol II residues that are generally 
conserved among nuclear RNA polymerases (Figure 20A, Figure 21A, and K. Armache 
[unpublished data]), suggesting that these enzymes make use of a common mechanism. Contacts 
of Pol II to RNA positions –8 to –10 may constitute a previously characterized RNA-binding site 
that contributes to elongation complex stability (Nudler, 1999). The contacts to the separating 
strands were not observed in the tailed-template structure (Gnatt e t  a l . , 2001), apparently due to 
formation of an overextended hybrid. Lack of these contacts explains the negative effect of an 
overextended hybrid on elongation complex stability (Kireeva e t  a l . , 2000a). 
 
In principle, it is possible that the design of the nucleic acids used in this project, and in particular 
the A-A mismatch at position –9, result in an artificial situation, and that the hybrid in a natural 
elongation complex may be one base pair longer. Indeed it cannot be excluded that a different 
nucleic acid sequence at the point of DNA-RNA strand separation would allow for Watson-Crick 
base-pair formation at position –8, since only a 1 Å decrease in the distance between the bases 
would be required. Overall, however, the location of the separating upstream strands detected 
here is very similar to that seen in the Pol II core complex with a synthetic hybrid (Westover e t  
a l . , 2004b), although the sequence of nucleic acids differs, strongly arguing for the sequence-
independent nature of the nucleic acid locations and the polymerase-nucleic acid interactions 
observed here.  
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Maintenance of the upstream end of the hybrid also involves the lid, a prominent loop that 
protrudes from the edge of the clamp (Figure 21, Figure 22). Modelling shows that an 
extrapolated template strand clashes with the lid (Figure 21A).  
 
 
Figure 22: Conservation and compartmentalization of the polymerase cleft.  
(A) Overall structure of the Pol II-bubble-RNA complex. The complete Pol II is shown as a molecular 
surface, and nucleic acid backbones are drawn as ribbons. The view corresponds to the front view 
(Cramer e t  a l . , 2000; Cramer e t  a l . , 2001). A dashed line indicates the slice plane used to create the 
views in (C).  
(B) Top view of the model in (A). Pol II loops are outlined that partition the enzyme cleft. During 
transcription elongation, DNA enters from the right. Previously proposed RNA exit grooves are labeled 
 and . 
(C) Conservation of nucleic-acid interaction surfaces. The model in (A) was intersected along the plane 
indicated in (A), and the resulting halves were rotated by 90° around a vertical axis in opposite directions. 
The molecular surface of residues within 8 Å distance from nucleic acids is colored in beige. Residues 
that are invariant and conserved between Pol I, II and III are highlighted in dark and light green, 
respectively. Pol II elements that contact nucleic acids and partition the enzyme cleft are outlined. 
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Except phenylalanine 252, the lid residues do not contact separating nucleic acids, and are weakly 
conserved between the three nuclear RNA polymerases (Figure 21B). Hence, the lid apparently 
plays a steric role in DNA-RNA strand separation. The lid and the saddle between the wall and 
the clamp (Cramer e t  a l . , 2001) form a narrow RNA exit tunnel that only allows passage of a 
single strand (Figure 22C). A similar ordering of the loops occurs in the Pol II core bound to a 
DNA-RNA hybrid (Westover e t  a l . , 2004b). The RNA 5’-end is located at the entrance to this 
tunnel, and its extension through the tunnel leads to two potential RNA-binding grooves that 
flank the Pol II dock domain (Cramer e t  a l . , 2000; Cramer e t  a l . , 2001; Figure 22B). There is no 
electron density in the grooves although the RNA in the complex crystals is long enough to reach 
them, indicating that RNA does not interact stably with the grooves in the absence of other 
factors. 
16.10 Initiation-elongation transition 
After transcription initiation, growing RNA roving along the identified path may trigger structural 
transitions that lead to a stable elongation complex. Growing RNA would displace the initiation 
factor TFIIB, which binds to the dock domain (Chen and Hahn, 2003), and extends over the 
saddle into the hybrid site (Bushnell e t  a l . , 2004). The transition from the closed pre-initiation 
complex to an open complex includes movement of downstream DNA, which lies inside the 
cleft during elongation, but is apparently suspended above the cleft in the initiation complex 
(Armache e t  a l . , 2003; Bushnell and Kornberg, 2003; Craighead e t  a l . , 2002). Upstream DNA is 
mobile during elongation, but during initiation it is bound by several factors, and may lie above 
the cleft (Chen and Hahn, 2004), as in a bacterial RNA polymerase–DNA complex (Murakami e t  
a l . , 2002a).  
 
The transition also goes along with an almost complete embedding of the DNA-RNA hybrid, the 
hallmark of the elongation complex (Figure 22). Two loops that extend from opposite sides of 
the cleft, the rudder and fork loop 1, are mobile in free Pol II (Cramer e t  a l . , 2001), but are 
ordered and contact each other in the elongation complex, creating two compartments in the 
cleft for holding downstream DNA and the hybrid (Figure 22; Westover e t  a l . , 2004b). Given 
the apparent importance of the lid, fork loops, and rudder for separation of the nucleic acids, it is 
surprising that these loops are not well conserved in Pol I and Pol III, and even deviate in length 
(K. Armache [unpublished results], Figure 22B). Apparently, these loops are only responsible for 
a passive topological partitioning of the cleft. 
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The initiation-elongation transition was structurally characterized for the single subunit RNA 
polymerase of phage T7, which does not require initiation factors. A large portion of this 
polymerase refolds during the transition, to create a hybrid-binding site and an RNA exit tunnel 
(see Figure 4; Steitz, 2004; Tahirov e t  a l . , 2002; Yin and Steitz, 2002). In Pol II, the hybrid site 
and exit tunnel pre-exist in the initiation-competent form of the enzyme, but are partially filled 
during initiation with TFIIB (Bushnell e t  a l . , 2004), and possibly also with the general 
transcription factors TFIIE (Forget e t  a l . , 2004; Kim e t  a l . , 2000; Meinhart e t  a l . , 2003a) and 
TFIIF (Chung e t  a l . , 2003). These factors may all contribute to the stabilisation of an early 
transcribing complex, but must liberate the hybrid site and RNA exit tunnel during formation of 
a stable elongation complex. Whereas the initiation complexes of the single-subunit polymerase 
from T7 bacteriophage and Pol II are very different, the arrangement of nucleic acids in the 
elongation complexes is similar (Figure 25).  
 
 
16.11 NTP binding, selection, and incorporation 
The electron density shows an empty space at the 3’-end of the RNA, which corresponds to the 
presumed binding site for substrate NTP (Figure 20D). The DNA template cytidine at position 
+1 points towards this site, ready for binding a complementary GTP. This provided an incentive 
to co-crystallise the complex with the non-reactive GTP analog GMPCPP (see chapter 28.1). The 
resulting small co-crystals diffracted weakly and were very radiation sensitive, but complete 
diffraction data to 4.5 Å resolution were obtained by merging datasets from five crystals  
(Table 9).  
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Figure 23: NTP-binding site.  
(A) Fourier difference electron density for a GTP substrate analog. The Fo-Fc map was calculated 
from data of the Pol II–bubble-RNA complex after cocrystallization with GMPCPP (Table 9), was 
phased with the final elongation complex structure, and is contoured at 2.8σ. Two prominent lobes 
of electron density are seen in the presumed NTP-binding site that is empty in the Pol II-bubble-
RNA structure. One lobe can represent the nucleotide base near the template DNA base at 
position +1 (the “coding” base). The other lobe may be attributed to the triphosphate moiety of 
the NTP. Invariant Pol II residues in the vicinity of the density peak are shown. Between the two 
lobes, the ribose moiety would be located, at a position where its 2’-OH group could form a 
hydrogen bond with Rpb1 residue N479, consistent with a role of this residue in NTP over dNTP 
selection.  
(B) Sequence alignment of residues surrounding the NTP site. Sequences in subunits of Pol II of S. 
cerevisiae (S.c.), human (H.s.) and Thermus thermophilus (T.th.) are aligned with their homologues in 
S.c. Pol I and III, and E. coli (E.c.) and Methanococcus janaschii (M.j.) RNA polymerase.  
 
A difference Fourier map revealed electron density in the Pol II pore near the presumed NTP 
site between the RNA 3’-end and the bridge helix (Figure 23A). Two density lobes can be 
ascribed to the nucleotide base and triphosphate moiety (Figure 23A). The nucleotide base is 
slightly further away from the DNA template base at position +1, as required for Watson-Crick 
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base pairing. The NTP ribose would be close to the side chain of Rpb1 residue N479, which 
could bind the ribose 2’-OH group, selecting for ribonucleotides (Gnatt e t  a l . , 2001). Indeed 
NTP versus desoxy-NTP discrimination in bacterial RNA polymerase involves the residue 
corresponding to N479 (Svetlov e t  a l . , 2004). Polymerase residues lining the NTP site and the 
active site are highly conserved among species and among nuclear RNA polymerases (Figure 
23B), suggesting that the mechanism of NTP binding, selection and incorporation is the same in 
all these enzymes. The NTP triphosphate moiety could be bound by four conserved basic 
residues (Figure 23), but is not in a position that allows nucleotide incorporation into RNA. The 
triphosphate is too far away from the catalytic metal ion A, and from Rpb2 residue D837, which 
may bind a second catalytic metal ion (Cramer e t  a l . , 2001; Sosunov e t  a l . , 2003), and is required 
for full activity of an archaeal RNA polymerase (Werner and Weinzierl, 2002). Together, these 
results indicate that the observed NTP site is apparently not identical to the insertion site 
occupied during catalysis, but may correspond to a pre-insertion site.  
 
Indeed, in November 2004, Kornberg and coworkers presented crystallographic models of an 
elongation complex with both a matched and a mismatched NTP in the +1-site (Westover e t  a l . , 
2004a).  In this model, the “matched”, i.e. templated NTP is about 1 Å closer to the Watson-
Crick edge of the template base. The alpha-phosphate group is in a position poised for a metal A-
assisted catalysis and incorporation to the RNA 3’-end.  These apparent differences might be 
explained by slightly different experimental conditions: While in this study the non-hydrolysable 
GMPCPP and an intact RNA 3’-end was present, Kornberg e t  a l .  made use of a 3’-deoxy-RNA 
and an unmodified substrate base. The resolution is similar in both studies.  
 
 RESULTS AND DISCUSSION 61 
 
Figure 24: NTP sites in the Pol II active center.  
Parts of the DNA and RNA strands and the bridge helix of the complete EC structure are depicted 
(Kettenberger e t  a l . , 2004), together with the two catalytic metal ions A and B (Westover e t  a l . , 2004a). 
The bridge helix and the aspartate loop (residues 478-489 of the largest subunit) were used for 
superposition of the complete EC and core EC structures. Note that only the nucleic acid strands in the 
complete EC are depicted.  
(A) Two binding sites for templated (“matched”) NTPs. NTPs in the insertion/A-site (Westover e t  a l . , 
2004a; PDB 1R9S), and in the putative preinsertion site (Kettenberger e t  a l . , 2004; PDB 1Y77) are 
shown.  
(B) Two inverted NTP sites (Westover e t  a l . , 2004a). A mismatched nucleotide bound to core EC is 
shown in light blue (PDB 1R9T). A UTP bound to core Pol II in the absence of DNA and RNA is shown 
in orange (PDB 1TWF). 
 
 
When a “mismatched” NTP is bound to an elongation complex, Kornberg and coworkers 
observed an unexpected rotation of the NTP around metal B (Westover e t  a l . , 2004a). The NTP 
orientation is similar to an NTP bound to Pol II in the absence of nucleic acids (Figure 24). 
Considering these structures in the light of biochemical data, a possible pathway of NTP 
incorporation emerges. NTPs may enter through the funnel and pore, and may bind to the entry 
site (Figure 24B). This interaction may help overcome restricted NTP diffusion in the pore as 
inferred by simulation (Batada e t  a l . , 2004). The NTP may then rotate into the preinsertion site 
(Figure 24B) for sampling of correct pairing with the template base, and for discrimination 
against dNTPs (Figure 23A). Only correctly paired NTPs may dwell long enough in the insertion 
site, allowing catalytic phosphodiester bond formation. In an alternative model, NTPs pair with 
downstream template bases and enter from the Pol II cleft (Epshtein e t  a l . , 2002; Nedialkov e t  
a l . , 2003). Indeed, the template base at position +2 is unpaired in the complete EC structure, and 
could bind an incoming NTP, but this requires conformational changes in fork loop 2. Posotion 
+2 corresponds to the point of strand separation. Hence, further line-up of template-paired 
 RESULTS AND DISCUSSION 62 
NTPs before the active site, including positions +3 and +4, disagrees with the structural 
observations. 
 
The active site in the free Pol II core structure revealed a metal ion A, bound by aspartates D481, 
D483 and D485 of the largest Pol II subunit, and a metal ion B, located 5-6 Å from metal A, near 
residues D836 and E837 of the second largest subunit (Cramer e t  a l . , 2001). Metal B was mobile 
and thought to enter with the NTP substrate (Cramer e t  a l . , 2001). The new core EC study 
supports and extends this view. Two metal ions are bound by the NTP in the insertion site 
(Westover e t  a l . , 2004a). Whereas metal A remains at the previously detected location, metal B 
binds closer to metal A, interacting with D481 and D483 of the largest subunit, with D836 of the 
second largest subunit, and with two NTP phosphates. Details of the mechanisms of catalysis or 
NTP incorporation are however not revealed, since the core EC and complete EC structures 
with matched NTPs have been determined at 4.2 Å and 4.5 Å resolution, respectively (Westover 
e t  a l . , 2004a) and (Figure 24). At higher resolution, structures of the free Pol II core with bound 
NTP and of a bacterial RNA polymerase bound to  ppGpp (guanosine 3’-diphosphate 5’-
diphosphate) revealed two metal ions at the same location, supporting the two metal ion 
mechanism (Artsimovitch e t  a l . , 2004). 
 
The overall location of the NTP with respect to the active site, DNA and RNA, is similar to 
recent substrate complexes of T7 RNA polymerase (Landick, 2004; Temiakov e t  a l . , 2004; Yin 
and Steitz, 2004). Cocrystallisation of a T7 RNA polymerase elongation complex with the NTP 
analog AMPCPP can result in NTP binding to a pre-insertion site, and in an open conformation 
at the active site (Temiakov e t  a l . , 2004), as observed here for a Pol II elongation complex co-
crystallized with GMPCPP. Analysis of the pre-insertion site in T7 RNA polymerase suggested 
that the NTP triphosphate moiety is bound by three basic residues in bacterial RNA polymerase 
(Temiakov e t  a l . , 2004), which correspond exactly to the basic residues found near the difference 
density in the Pol II complex.  
 
16.12 Comparison with a single-subunit RNA polymerase 
Comparison of the new Pol II EC structures with EC structures of the unrelated single-subunit 
RNA polymerase from phage T7 (Temiakov e t  a l . , 2004; Yin and Steitz, 2004) shows that two 
catalytic metal ions bind in the same relative orientation, supporting a general two-metal ion 
mechanism for all nucleic acid polymerases (Steitz, 1998). The comparison with T7 elongation 
 RESULTS AND DISCUSSION 63 
complex structures further reveals a similar overall arrangement of DNA, RNA and NTP 
substrate, but also clear differences. The length of the DNA-RNA hybrid is the same in both 
elongation complexes. There is also a similar 90° bend between axes of the incoming DNA and 
the exiting DNA-RNA hybrid (Cramer, 2002a), but the two duplex axes intersect in the Pol II 
EC, whereas they are offset in the T7 EC (Figure 25). Further, there is a similar 90° twist between 
template bases at positions +2 and +1. The distance between the insertion and the pre-insertion 
sites is small in the Pol II, but much larger in the T7 elongation complexes. The entry site in 
Pol II (Figure 24B) does apparently not exist in the T7 enzyme. The Pol II elongation complex 
structures did not reveal conformation changes upon NTP binding, but the T7 structures showed 
structural changes in the active centre that accompany NTP incorporation and nucleic acid 
translocation (Landick, 2004; Steitz, 2004). 
 
Figure 25: Nucleic acid conformation in elongation complexes of Pol II and T7 RNA 
polymerase.  
(A) Complete yeast Pol II elongation complex (PDB 1Y1W, this study). The two views are 
related by a 90° turn about a vertical axis.  
(B) Bacteriophage T7 RNA polymerase elongation complex (Yin and Steitz, 2004; 
PDB 1S0V). 
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17 THE RNA POLYMERASE II-TFIIS COMPLEX 
17.1 Purification of TFIIS 
The TFIIS variant comprising domains II and III (residues 131-309, Figure 29A), as well as the 
double mutant D290A/E291A could be readily overexpressed in E. coli and purified via an 
N-terminal hexahistidine tag, essentially as described (Awrey e t  a l . , 1997). Yields ranged around 
20 mg of purified TFIIS variant per litre of culture. Purification by a nickel-NTA affinity column 
followed by a cation exchange column (Mono-S) resulted in two peaks which were both 
identified as the same species by SDS gel electrophoresis, mass spectroscopy and circular 
dichroism (Figure 26 and chapter 26).  
 
Overexpression in selenomethionine-containing minimal medium and an analogous purification 
strategy resulted in a protein which was indistinguishable from the underivatised protein, except a 
molecular weight difference of 47 Da (ESI-MS). This difference is consistent with the 
incorporation of a single selenomethionine residue. Unexpectedly, despite its modular nature, the 
TFIIS variant turns out to be stable towards degradation for weeks at 4 °C.  
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Figure 26: TFIIS purification. (A) Chromatogram of the Mono-S column. TFIIS elutes in 
two peaks (peaks A and B) in the salt gradient. (B) The Coomassie-stained SDS-
polyacrylamide gel shows peak fractions of the two-step purification protocol described in 
chapter 26. 
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17.2 Structural analysis 
The 12-subunit yeast Pol II was prepared as described in chapter 28. Harvested crystals were 
incubated with recombinant TFIIS (see chapter 17.1).  The very large solvent channels of the 
crystals allowed TFIIS entry and binding to its specific site on Pol II, which is not obstructed by 
crystal contacts (Figure 39).   
 
Table 10: X-ray structural analysis of the RNA polymerase II–TFIIS complex 
Crystal Pol II+TFIIS Pol II+TFIIS SeMet Pol II+DNA+RNA+TFIIS5
 Data collection1   
Unit cell dimensions (Å)2 218.9 x 395.3 x 281.0 219.7 x 394.9 x 282.3 220.2, 395.7, 282.1 
Wavelength (Å) 0.9790 0.9795 0.9919 
Resolution range (Å)3 50-3.8 (3.94-3.8) 50-6.5 (6.73-6.5) 50-4.0 (4.14-4.0) 
Unique reflections3 115 508 (9618) 24 571 (2407) 103460 (10312) 
Completeness (%)3 96.2 (81.0) 100 (100) 98.7 (99.2) 
Redundancy3 2.9 (1.2) 6.1 (6.1) 4.3 (4.3) 
Mosaicity (°) 0.21-0.534 0.40 0.29-0.37 g 
Rsym (%)3 8.9 (35.5) 7.1 (32.6) 7.0 (27.9) 
I/σ(I)3 9.3 (1.9) 11.6 (4.6) 20.3 (5.4) 
Peaks in anomalous 
Fourier map 
8 Zn in Pol II  
(10.9-5.1 σ) 
1 Zn in TFIIS (9.1σ) 
8 Zn in Pol II  
(11.6-7.4 σ) 
1 Zn in TFIIS (4.5σ) 
1 Se in TFIIS (7.3σ) 
— 
Refinement    
Number of residues 4001   
RMSD bonds (Å) 0.011   
RMSD angles (°) 1.62   
Rcryst (%) 28.2   
Rfree (%) 29.4  28.1 (after rigid body 
refinement) 
PDB-ID 1Y1V  1Y1Y 
1Diffraction data were collected at beamline X06SA at the Swiss Light Source. 
2Crystals belong to the space group C2221. 
3Values in parentheses correspond to the highest resolution shell. 
4Due to radiation damage, the mosaicity increased during data collection, and was refined in segments of 10°. 
5The complex crystals were soaked with the inactive TFIIS variant D290A/E291A 
6 Due to radiation damage, mosaicity increased during data collection, and was refined in segments of five frames. 
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It is intriguing that the crystal lattice can accommodate extensive structural changes induced by 
TFIIS (Figure 32).  The resulting 13-polypeptide asymmetric complex has a molecular weight of 
536 kDa. Diffraction data to 3.8 Å resolution could be obtained at the synchrotron SLS and data 
set statistics are shown in Table 10. 
 
Initial electron density maps were phased with the core Pol II structure and were improved by 
solvent flipping (see chapter 30).  These maps showed positive difference density on the Pol II 
surface, which could to a large extent be accounted for with the rigid cores of the NMR 
structures of TFIIS domains II and III (Morin e t  a l . , 1996; Qian e t  a l . , 1993a), (Figure 28A, 
Figure 29A).  The positioning of the TFIIS domains was confirmed by locating a 
selenomethionine residue in domain II and the zinc ion in domain III by means of anomalous 
signals (Figure 28B, Table 9). The first electron density map also revealed a long linker between 
the two TFIIS domains, and extensive structural changes in Pol II.   
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17.3 Induced folding of TFIIS 
Structure analysis and model building was assisted by the availability of NMR structures of 
domains II and III (Morin e t  a l . , 1996; Qian e t  a l . , 1993a; Figure 27). A striking feature of these 
structures is the apparent flexibility, particularly of the inter-domain linker, which flanks a rigid 
core of domain II. However, in the context of Pol II, most of the flexible parts of TFIIS undergo 
induced folding and adopt a well-defined conformation (Figure 28). Induced folding upon Pol II 
interaction could indeed be a recurring motif in many transcription factors (Chen and Hahn, 
2003; Chung e t  a l . , 2003; Hahn, 2004). This would explain the prevalent difficulties in 
crystallising isolated factors such as TFIIF or TFIIB. 
 
 
Figure 27: NMR ensembles of isolated TFIIS domains.  
(A) Ribbon model of domain III according to PDB-ID 1ENW (Qian e t  a l . , 1993b).  The acidic hairpin 
residues D290 and E291 are coloured in green. Magenta spheres represent zinc ions.  
(B) Domain II (green) and part of the domain II-III inter-domain linker (yellow) according to PDB-ID 
1TFI (Morin e t  a l . , 1996). 
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Figure 28: Structural analysis of the Pol II–TFIIS complex.  
(A) Electron density omit map.  The map is contoured at 1.0 σ and was calculated after solvent flipping 
using phases from the positioned atomic model of the 10-subunit Pol II.  Omitted from map calculation 
were the TFIIS model, the Rpb4/7 complex, the bridge helix, and newly ordered elements of Pol II such 
as the trigger loop.  TFIIS is depicted as a ribbon model.  TFIIS domain II, the inter-domain linker and 
domain III are coloured in green, yellow, and orange, respectively, and this colour code is used 
throughout.  The light green ribbon fragment in domain III corresponds to the acidic hairpin residues 
D290 and E291.   
(B) Anomalous difference Fourier maps were calculated from anomalous differences in native (cyan mesh) 
and TFIIS-SeMet (orange mesh) data, and were contoured at 2.5 σ and 3.0 σ, respectively.  Anomalous 
peaks in the anomalous coincide with the position of a zinc ion in domain III (cyan sphere) and a 
selenium atom in SeMet 182 of domain II (orange sphere).  
(C) Electron density omit map described in (A).  Depicted are the Pol II bridge helix and trigger loop, 
which were omitted from map calculation.  Figures were prepared with RIBBONS (Carson, 1997). 
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Figure 29: Architecture of the Pol II–TFIIS complex.  
(A) Domain organisation and secondary structure of TFIIS.  The diagram shows TFIIS domain borders.  
Secondary structure elements (cylinders, α-helices; arrows, β-strands) are indicated above an alignment of 
TFIIS sequences from the yeast Saccharomyces cerevisiae (Sc) and human (Hs).  Identical and conserved 
residues are printed in red and light orange, respectively.  The colour code for TFIIS domains is the same 
as described in the legend of Figure 28.  Black double-headed arrows span regions for which available 
NMR structures (PDB accession codes in parentheses) were placed in the experimental electron density 
map.  Residue M182 in domain II, which was observed in the anomalous Fourier map shown in Figure 
28B, is indicated with an asterisk.  The four cysteine residues that co-ordinate the zinc ion in domain III 
are highlighted in cyan, and the acidic hairpin residues D290 and E291 in light green.  Regions in TFIIS 
that are involved in Pol II interactions are underlined with blue bars.  TFIIS-interacting structural 
elements in Pol II subunits Rpb1 and Rpb2 are indicated below the blue bars.   
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Figure 29 (continued) 
(B) Ribbon diagram of the Pol II–TFIIS complex backbone model.  The 12 subunits of Pol II are 
coloured in grey.  A pink sphere marks the location of the active site metal ion A (Cramer e t  a l . , 2000; 
Cramer e t  a l . , 2001).  Eight structural zinc ions in Pol II and one zinc ion in TFIIS are depicted as cyan 
spheres.  The two views are related by a 90° rotation around a vertical axis.   
(C) Binding of TFIIS to the crevice, funnel and pore.  TFIIS is shown as a ribbon model on the molecular 
surface of Pol II.  The view is from the bottom face, as indicated in panel (B). 
(D) Conservation of TFIIS viewed from the side as in panel (B).  Residues that are identical or conserved 
between yeast and human TFIIS are in red and orange, respectively. 
(E-F) Details of polymerase–TFIIS interaction.  Shown are two stereo views of the part of the model 
shown in (C), with the Pol II surface removed.  Regions of Pol II that interact with TFIIS are labelled 
with plain and italic lettering for subunits Rpb1 and Rpb2, respectively. 
 
 
Pol II regions that had shifted were omitted from electron density calculation and were manually 
docked to the resulting map.  After rigid body refinement, the quality of the map was very high, 
and large protein side chains were generally visible.  Newly ordered Pol II regions, and TFIIS 
regions that were not accounted for by the NMR structures, were modelled as Cα-backbones. 
Revision of molecular replacement with an improved model of complete Pol II (Armache e t  a l . , 
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2003), followed by positional and B-factor refinement further improved the electron density 
maps.  Into these maps, side-chains of TFIIS residues 240-309 could be built and refined.  
Refinement of all Pol II residues and residues 240-309 of TFIIS converged at a final free R-factor 
of 29.4 %. 
17.4 TFIIS extends from a polymerase jaw to the active site 
The structure shows that TFIIS extends along the Pol II surface, spanning a distance of 100 Å 
(Figure 28B, Figure 29).  Based on visual inspection of the structure, the domain borders of 
TFIIS were re-defined (Figure 29A).  To describe interactions of TFIIS with Pol II, the 
nomenclature of Pol II domains and secondary structure elements introduced previously (Cramer 
e t  a l . , 2001) is used throughout.  TFIIS domain II docks to the exposed Rpb1 jaw domain of 
Pol II.  The TFIIS inter-domain linker extends from domain II along the Pol II surface into the 
“funnel” (Figure 29B, C).  Domain III inserts into the Pol II “pore”, and approaches the 
polymerase active site from the bottom face of the enzyme as predicted (Cramer e t  a l . , 2000).  
The binding sites for domain III and α-amanitin overlap, explaining why this toxin interferes 
with TFIIS activity, but not with the intrinsic nuclease activity of Pol II (Izban and Luse, 1992b; 
Rudd and Luse, 1996; Weilbaecher e t  a l . , 2003).  
 
TFIIS domain II comprises a bundle of three helices (α1-α3, Figure 29A, D), which had been 
observed for the isolated domain by NMR (Morin e t  a l . , 1996), and three short helices, which 
form upon Pol II interaction (α4-α6).  TFIIS helices α1 and α3 pack against helix α40 in the 
Rpb1 jaw, to bury leucines L1172 and L1176 in helix α40 (Figure 29E).  An acidic loop following 
Rpb1 helix α40 interacts with a basic patch on TFIIS helix α3, which includes residues required 
for TFIIS–Pol II interaction (Awrey e t  a l . , 1998).  In addition, TFIIS helix α6 contacts Rpb1 
loop β30-β31 (Figure 29E).  Consistently, mutation of residue E1230 in this loop weakens Pol II 
binding to TFIIS (Wu e t  a l . , 1996).  The location of TFIIS domain II at the Rpb1/9 jaw, next to 
the point of DNA entry to the cleft, may be relevant for interaction of TFIIS with the chromatin 
remodelling complex Swi/Snf, revealed in a genetic screen (Davie and Kane, 2000).  The N-
terminal domain I of TFIIS stays on the outer surface of Pol II, where it is potentially available 
for interaction with other components of the transcription machinery. Domain I was shown to 
engage in specific interactions with Spt8, a part of the SAGA co-activator, and with Med13, a 
subunit of the Mediator kinase module (Shimasaki and Kane, 2000). 
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17.5 TFIIS opens a crevice in the funnel 
The TFIIS inter-domain linker is unstructured in free TFIIS (Olmsted e t  a l . , 1998).  Upon Pol II 
binding, the linker forms an α-helix (α7), which runs along the Pol II bottom face, near loop 
β29-α41 and helix α38 in Rpb1 (Figure 29E).  At the end of helix α7, the linker passes through a 
narrow crevice into the funnel (Figure 29C).  The crevice is lined by loop α20-α21 in the Rpb1 
funnel domain on one side, and by strand β32 in the Rpb1 cleft domain on the other side (Figure 
29E, F).  The crevice is closed in previous Pol II structures, with its two sides contacting each 
other, and opening of the crevice is partly responsible for major structural changes in Pol II (see 
chapter 17.12).  The induced folding and polymerase interactions of the TFIIS linker are 
important for its function:  Linker residues contribute to TFIIS activity (Awrey e t  a l . , 1998), and 
confer species-specificity to the Pol II–TFIIS interaction (Shimasaki and Kane, 2000) and 
isolated domains II and III are not functional (Awrey e t  a l . , 1998). Since the attachment of 
TFIIS on Pol II is accomplished by domain II, an important function of the linker is the correct 
positioning of domain III in the funnel and pore.  Accordingly, mutations that change the linker 
length abolish TFIIS activity (Awrey e t  a l . , 1998).  
 
17.6 TFIIS domain III inserts into the pore 
TFIIS domain III is bound with its zinc-binding base at the entrance to the pore on the bottom 
face of Pol II (Figure 29B, C, F).  The thin β-hairpin of domain III extends along one side of the 
pore, and approaches the active site.  Although dispensable for Pol II binding, domain III is 
ordered in the electron density due to many contacts with Pol II (Figure 29A, F).  The base of 
domain III makes a hydrophobic contact to Rpb1 residues 755-756 (Figure 29F).  Several salt 
bridges can be formed between charged residues at the base of domain III and helix α21 and 
loop β20-β21 of Rpb1 (Figure 29F).  The β-hairpin of domain III is highly flexible in free TFIIS 
(Qian e t  a l . , 1993b), but is fixed here by contacts with polymerase regions that line the pore, 
including Rpb1 residues 823-830 in the bridge helix and residues 1078-1080 in the trigger loop, as 
well as several Rpb2 residues (Figure 29A, F).  The high conservation of the pore-lining regions 
concurs with the high conservation of TFIIS domain III and the Pol II-interacting residues of 
domain II.  
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Figure 30: Inter-species conservation of the TFIIS interaction surface. The view is similar to the 
view in Figure 29C. TFIIS is shown as orange ribbons on a molecular surface of Pol II. Pol II residues 
which are conserved between S. cerevisiae, S. pombe, C. elegans, D. melanogaster and H. sapiens are 
coloured in dark green, light green and yellow, corresponding to 100, 80, and 60 % conservation, 
respectively. Major binding sites (Awrey e t  a l . , 1998) on Rpb1 are indicated with arrows. 
 
17.7 The TFIIS acidic hairpin complements the polymerase active site 
TFIIS domain III reaches the Pol II active site with the highly conserved loop of the protruding 
β-hairpin (Figure 31).  Two invariant acidic residues in this loop, D290 and E291, are in close 
proximity of the Pol II catalytic metal ion A.  The two acidic hairpin residues are essential for 
TFIIS activity, and even conservative mutations of these residues render TFIIS inactive (Jeon e t  
a l . , 1994).  The domain III hairpin therefore complements the polymerase active site with acidic 
groups that are essential for TFIIS function. 
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Figure 31: Model of a Pol II–TFIIS–nucleic acid complex.  
(A) Side view of the Pol II–TFIIS–nucleic acid complex model.  The DNA template strand (blue) and the 
RNA transcript (red) were placed onto the ribbon model of Fig. 2B according to their location in the 
elongation complex structure (Gnatt e t  a l . , 2001).  The Rpb2 protrusion, fork, and external domains were 
omitted for clarity.  The presumed location of backtracked RNA is indicated as a dashed red ribbon.  The 
arrows indicate movement of Pol II relative to the nucleic acids.  
(B) Cut-away view of the model in (A) from the front.  TFIIS and nucleic acids are shown as ribbon 
models on the molecular surface of Pol II, which is cut along the vertical slice plane indicated in (A).  The 
presumed path of backtracked RNA through the restricted pore is drawn as a dashed ribbon.  This 
portion of RNA would be cut during TFIIS-induced RNA cleavage. 
(C) Proximity of the TFIIS acidic hairpin to the potential scissile RNA phosphodiester bond.  The view is 
as in (A).  RNA was placed according to the location in the Pol II elongation complex structure (Gnatt e t  
a l . , 2001), and is shown as a stick model with phosphorous atoms highlighted as blue spheres.  The black 
arrow indicates the direction of a possible SN2-type nucleophilic in-line attack of the scissile bond (blue). 
(D) Reaction mechanism of cleavage and polymerisation. During TFIIS-mediated RNA cleavage, a 
coordinated nucleophilic water molecule attacks the P atom of the phosphodiester bond, leading to a 
break of the scissile bond (blue). During RNA polymerisation, the 3’-OH group of the RNA terminus acts 
as the nucleophile to attack the Pα atom of a substrate NTP. By breaking the scissile bond (blue), 
pyrophosphate is liberated. A and B indicates the two catalytic metal ions; encircled letters “P” symbolise  
phosphate groups.  
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Thus, Pol II apparently contains a single tuneable active site for both RNA polymerisation and 
cleavage, instead of two catalytic sites with distinct locations.  It had been suggested previously 
that the active sites for RNA polymerisation and cleavage are close together or even identical 
(Powell e t  a l . , 1996; Rudd e t  a l . , 1994; Wang and Hawley, 1993).  
 
17.8 RNA cleavage 
The approximate location of the TFIIS hairpin loop with respect to substrate RNA is revealed by 
superposition of the presented model with the previous Pol II elongation complex structure 
(Figure 31).  The superposition shows that TFIIS domain III comes in close proximity of the 
RNA, explaining why the RNA 3’-end can be crosslinked to TFIIS (Powell e t  a l . , 1996).  The 
two acidic residues in the TFIIS hairpin approach the RNA from the side of the sugar-phosphate 
backbone, as required for catalytic RNA cleavage.  The RNA phosphodiester bond that is 
potentially cleaved is observed in the elongation complex structure, since this complex is 
apparently trapped after nucleotide incorporation, but before translocation, adopting the pre-
translocation state (Gnatt e t  a l . , 2001).  The potential scissile phosphodiester bond (Figure 31C, 
D) connects the 3’-oxygen in the ribose of the penultimate nucleotide with the α-phosphorous of 
the terminal RNA nucleotide, since RNA cleavage leaves a 3’-OH group on the RNA, while 
liberating 5’-phosphonucleotides (Izban and Luse, 1993b). 
 
The exact location of chemical groups in the active site cannot be determined at the given 
resolution.  However, the location of the TFIIS hairpin and metal ion A with respect to the 
potential scissile RNA bond in the model suggests that the mechanism of RNA cleavage could 
resemble that of DNA cleavage by the Klenow DNA polymerase.  In the Klenow exonuclease 
active site, two catalytic metal ions are co-ordinated by acidic residues (Beese and Steitz, 1991; 
Joyce and Steitz, 1994).  A first metal ion binds the 3’ oxygen of the leaving ribose.  A second 
metal ion and one of the acidic residues position a water molecule for an SN2-type nucleophilic 
attack of the phosphorous atom from the side opposite the 3’ oxygen, in-line with the scissile 
phosphodiester bond.  In Pol II, metal A coordinates the RNA 3’-oxygen.  One of the TFIIS 
acidic hairpin residues could place a metal ion B nearby, and could help position a water molecule 
for hydrolytic RNA cleavage.  Such a mechanism would be consistent with the requirement for 
divalent metal ions in RNA cleavage by the Pol II–TFIIS complex (Izban and Luse, 1992b; 
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Weilbaecher e t  a l . , 2003). It is also consistent with evidence for a nucleophilic water molecule, 
based on dramatic increase in cleavage activity at high pH (Weilbaecher e t  a l . , 2003). 
 
17.9 Switching between polymerisation and cleavage 
A two-metal-ion mechanism could thus underlie both RNA cleavage (see chapter 17.8) and RNA 
polymerisation by Pol II (Cramer e t  a l . , 2001).  Both polymerisation and cleavage require metal 
A, that is persistently bound by the Rpb1 aspartate loop. Switching from polymerisation to 
cleavage may however involve differential positioning of a mobile metal ion B.  For 
polymerisation, metal B could be recruited by the substrate nucleoside triphosphate (Cramer e t  
a l . , 2001).  For cleavage in the presence of TFIIS, the TFIIS acidic hairpin could contribute to 
metal B coordination.  Cleavage in the absence of TFIIS, however, would likely require additional 
coordination partners for metal B.  Based on analysis of the nuclease activity in bacterial RNA 
polymerase, Goldberg and co-workers suggested that during cleavage, metal B could be 
coordinated by the phosphates of an unpaired nucleotide bound to a site in the pore (Sosunov e t  
a l . , 2003).  They further suggest a unified two-metal-ion mechanism for RNA synthesis and 
cleavage that is consistent with implications of the present Pol II–TFIIS model.  The unique 
feature of Pol II is its capability to switch between two distinct catalytic activities at a single active 
site. This is in contrast to a mere activation of an enzyme by complementation of an active site by 
an external factor, which was observed e.g. in the Ras-RasGAP complex (Scheffzek e t  a l . , 1997). 
 
17.10 Proofreading 
The available Pol II structures and many biochemical observations are consistent with the 
following model for mRNA proofreading:  Incorporation of the correct nucleotide drives rapid 
forward translocation (Nedialkov e t  a l . , 2003).  However, upon incorporation of an incorrect 
nucleotide, forward translocation is disfavoured, opening a time window for hydrolytic RNA 
cleavage and removal of the misincorporated nucleotide.  Alternatively, misincorporation can 
trigger backtracking by one nucleotide and subsequent cleavage of a dinucleotide.  Cleavage of 
mononucleotides (from the pretranslocation state) and of dinucleotides (from a backtracked 
state) both result in a new RNA 3’-end at metal A, from which polymerisation can continue.  
Proofreading may involve mainly cleavage of mono- and dinucleotides, so that extensive 
backtracking and RNA extrusion into the pore would not be required.  Proofreading reactions 
can be stimulated by TFIIS in vitro (Jeon and Agarwal, 1996; Thomas e t  a l . , 1998), but a 
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contribution of TFIIS to proofreading in vivo does not necessarily have to be significant (Shaw e t  
a l . , 2002).   
 
17.11 Pore restriction and RNA backtracking 
The present model shows that TFIIS domain III does not completely block the pore, but 
restricts it (Figure 31B).  The restricted pore leaves enough space for NTP entry, as required for 
RNA polymerisation in the presence of TFIIS (Horikoshi e t  a l . , 1984).    Modelling shows that 
RNA backtracking by more than two nucleotides (relative to the post-translocated state) would 
result in a clash with the TFIIS hairpin, unless RNA base stacking is given up, and the RNA is 
redirected and threaded into the restricted pore.  Restriction of the pore may thus explain why 
TFIIS preferably releases dinucleotides (Izban and Luse, 1992b; Izban and Luse, 1993a; Izban 
and Luse, 1993b).  
 
While transient pausing of Pol II is associated with minimal backtracking (0-2 nucleotides, see 
Introduction), arrest occurs after more extensive backtracking by about 7-9 nucleotides (Fish and 
Kane, 2002; Wind and Reines, 2000). The restricted pore is wide enough to accommodate an 
RNA single strand, and likely corresponds to an RNA-binding site defined previously in Pol II–
RNA binary complexes that undergo TFIIS-induced cleavage (Johnson and Chamberlin, 1994).  
Extensively backtracked RNA and TFIIS can thus bind simultaneously to the Pol II pore, as 
required for rescue of arrested Pol II complexes.  Consistently, the backtracked RNA 3’-end in an 
arrested bacterial RNA polymerase complex was crosslinked to a protein fragment that lines the 
restricted pore (Markovtsov e t  a l . , 1996). 
 
17.12 TFIIS remodels the polymerase active centre 
In addition to a complementation of the Pol II active site, TFIIS induces structural changes in 
the active centre (Figure 32A).  These changes are revealed by a comparison of the Pol II–TFIIS 
complex with the free 12-subunit Pol II (Armache e t  a l . , 2004).  Since both models were 
obtained from the same crystal form, and since TFIIS binding does not induce significant 
changes in crystal packing or unit cell dimensions, the detected structural changes can be 
attributed to TFIIS binding. 
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Figure 32: TFIIS-induced structural changes in Pol II 
(A) Local remodelling of the Pol II active centre.  Structural elements of the active centre in the Pol II–
TFIIS complex are shown as ribbons in different colours.  The corresponding elements in the free 12-
subunit Pol II structure are shown superimposed in beige.  In the Pol II–TFIIS complex, the trigger loop 
(blue) and fork loop 2 (pink) are folded, parts of the bridge helix (cyan) are shifted upwards, and switches 
1 and 2 (red and purple, respectively) moved outwards.  The DNA template strand (blue) and product 
RNA have been placed according to the Pol II elongation complex structure (Gnatt e t  a l . , 2001).  A pink 
sphere marks the location of metal ion A. 
(B) Opening of the Pol II crevice by insertion of the TFIIS linker.  Detailed view of the TFIIS linker 
(yellow) passing through the crevice (magenta).  The location of the two crevice-forming elements in free 
Pol II is shown in beige.  The view is from the bottom, as in Figure 29C, E and F. 
(C-E) Global repositioning of the Pol II mobile mass.  In (C), regions of the model in Figure 29B that are 
repositioned upon TFIIS binding (mobile mass) are highlighted in magenta.  In (D), changes in the mobile 
mass between free Pol II (beige) and the Pol II-TFIIS complex (magenta) are shown.  The models were 
superimposed based on the unchanged regions in the Pol II core module (Cramer e t  a l . , 2001).  Arrows 
indicate the direction and magnitude of movements at outer positions.  The location of the incoming 
DNA duplex during transcription elongation is indicated as a dashed blue circle.  In (E), the contents of 
the mobile mass are shown.  Subunits that contribute to the mobile mass are coloured according to the 
colour code used previously (Armache e t  a l . , 2003; Cramer e t  a l . , 2000; Cramer e t  a l . , 2001).  Pol II 
subunits and domains that contribute to the mobile mass are labelled. 
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Binding of TFIIS domain III induces folding of Rpb1 residues 1082-1091 (Figure 28C, Figure 
29F, Figure 32A), which correspond to the trigger loop in bacterial RNA polymerase (Vassylyev 
e t  a l . , 2002).  TFIIS makes potential contacts to residues 1078-1080 preceding the trigger loop.  
The folded trigger loop closes a previously observed second perforation in the polymerase cleft 
(pore 2, (Cramer e t  a l . , 2000).  Structural changes in the trigger loop, and in the preceding 
helix α36, are propagated to the bridge helix (Figure 32A).  TFIIS can form several potential 
contacts to Rpb1 residues 820-830, resulting in a movement of the C-terminal half of the bridge 
helix towards the top face of Pol II by 2–3 Å (Figure 28C, Figure 32A).  Changes in the bridge 
helix are further propagated to switch regions 1 and 2, which move slightly outwards, resulting in 
a widening of the DNA-RNA hybrid binding site (Figure 32A), which may influence the strength 
of hybrid-polymerase interaction.  Since both switches and the C-terminal half of the bridge helix 
all interact with the DNA template strand in the elongation complex (Gnatt e t  a l . , 2001), 
changes in their position might be responsible for repositioning nucleic acids in the active centre, 
maybe to facilitate RNA cleavage (see chapter 17.13). Structural changes further include ordering 
of fork loop 2 (Rpb2 residues 503-508, Figure 32A), which restricts the cleft to a diameter of 
15 Å, consistent with the proposal that this loop removes the DNA non-template strand from 
the template strand before the active site (Cramer e t  a l . , 2001; Gnatt e t  a l . , 2001). 
 
17.13 TFIIS realigns RNA 
In chapter 17.12, remodelling of about one third of Pol II in the context of TFIIS was discussed. 
This conformational change also affects the active site region and the DNA/RNA binding site. 
DNA and RNA discussed in Figure 31, Figure 32 and chapter 17.8 represent merely a model, 
based on previously determined elongation complex structure. Only a genuine Pol II-
transcription bubble-RNA complex could disclose the effects of TFIIS on bound DNA and 
RNA. To this end, crystals (see chapter 16.3) were soaked with a TFIIS variant that is inactive in 
RNA cleavage stimulation, due to a D290A E291A double mutation in the acidic hairpin (see 
chapter 26). A dataset was collected to a resolution of 4.0 Å, and for molecular replacement, the 
refined model of the Pol II-TFIIS complex described in chapter 17.2, was used. The resulting 
difference electron density in the Pol II-bubble-RNA-TFIIS complex was noisy but allowed 
modelling of four base pairs of the DNA-RNA hybrid (positions –1 to –4, Figure 33). 
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Figure 33: TFIIS-induced RNA realignment 
Selected elements in the Pol II active center that move upon TFIIS binding are shown. 
The bridge helix, DNA, and RNA in the Pol II-bubble-RNA-TFIIS complex are in 
green, blue and red, respectively. The TFIIS hairpin is in orange with the two acidic 
functionally essential and invariant residues in green. Nucleic acids in the Pol II-bubble-
RNA complex structure after superposition of residues in the active site aspartate loop 
or in switch 2 are shown in beige and grey, respectively. Switch 2 moves slightly upon 
TFIIS binding (Kettenberger e t  a l . , 2003), explaining the difference in the two 
superpositions. 
 
 
TFIIS induces an unexpected shift of the RNA strand, with phosphate groups moving up to 4 Å 
(Figure 33). This realignment of the RNA in the active site may advantage an optimised in-line 
attack by a nucleophilic water molecule during RNA cleavage (compare chapter 17.8 and Figure 
32). TFIIS does not simply reposition the DNA-RNA hybrid as a rigid body, but its exact 
conformation is not revealed at the limited resolution of the data. These new structural data 
suggest alternative explanations for how TFIIS facilitates readthrough. First, the TFIIS-induced 
repositioning of RNA may result in a different elongation complex conformation that is less 
prone to pausing. Recent kinetic data are consistent with an alternative TFIIS-induced state of 
the elongation complex (Zhang and Burton, 2004). Second, the acidic residues in the TFIIS 
hairpin could assist in NTP binding. The TFIIS hairpin overlaps the NTP site described above, 
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but small changes in the hairpin conformation may promote metal-mediated stabilising 
interactions with the NTP triphosphate. 
17.14 Functional conformations of Pol II 
In addition to a local remodelling of the active centre, TFIIS induces a co-ordinated repositioning 
of about one third of the polymerase mass (Figure 32C, D).  The repositioned mass includes the 
jaws, the clamp, and the Rpb1 cleft and foot domains, and corresponds essentially to three 
previously identified mobile polymerase modules (Cramer e t  a l . , 2001).  The mobile mass is 
tilted towards the top face of Pol II, by up to 6 Å at the jaws.  The repositioning seems to be 
caused by insertion of TFIIS into the Pol II funnel and pore.  In particular, the TFIIS linker 
opens the crevice, and TFIIS domain III forms a wedge between helix α21 and loop α46-α47 in 
the Rpb1 funnel and cleft domains, respectively (Figure 29C, E, F).  The mobile polymerase mass 
is connected to the remainder of the enzyme by the bridge helix, the switches, and the linker 
between the two Rpb9 domains, which all undergo structural changes to accommodate the 
repositioning.  
 
A major conformational change in the polymerase upon TFIIS binding was suggested by 
functional studies of TFIIS and Pol II mutants (Cipres-Palacin and Kane, 1994; Hemming e t  a l . , 
2000).  There is also evidence for a conformational isomerisation of Pol II upon the transition 
from initiation to elongation, and for distinct conformational states of elongating Pol II (Erie, 
2002; Palangat and Landick, 2001).  Since the mobile Pol II mass surrounds nucleic acids (Figure 
32D), its repositioning could influence Pol II elongation properties, and the observed Pol II 
conformation may correspond to one of the functional states of the enzyme.  Consistently, 
deletion of a region in bacterial RNA polymerase that corresponds to the Rpb1/9 jaw (Figure 
32E) affects transcriptional pausing (Ederth e t  a l . , 2002). 
 
17.15 Conservation of transcript cleavage factors 
Eukaryotic Pol III is capable of RNA cleavage, and its C11 subunit and magnesium ions are 
required for this activity (Chedin e t  a l . , 1998).  C11 consists of two zinc ribbon domains.  The C-
terminal zinc ribbon shows high sequence similarity to domain III of TFIIS, and comprises the 
two acidic hairpin residues (Figure 34).  Since mutation of these two residues is lethal to yeast 
(Chedin e t  a l . , 1998), the C-terminal domain of C11 may function like domain III of TFIIS, with 
a corresponding acidic hairpin playing an essential role.  The N-terminal domain of C11 is related 
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in sequence to the N-terminal domain of Rpb9, and may occupy the same position, since only 
few amino acid residues would be required to connect it to its C-terminal domain that would be 
located in the pore. This model may also apply to the archaeal transcript cleavage factor TFS, 
which shows sequence similarity to C11, and contains the acidic hairpin residues (Hausner e t  a l . , 
2000). The role of the zinc finger of A12.2 in transcript cleavage remains unclear since it is 
completely dispensible in yeast (Van Mullem e t  a l . , 2002) and transcript cleavage in Pol I is 
mediated by a TFIIS-like factor (Tschochner, 1996).  
 
   Zinc finger                 ** 
   TFIIS 274 : CKEKKVSYYQLQTRSADEPLTTFCTCEAC 
   A12.2  89 : CGNEEMNYHTLQLRSADEGATVFYTCTSC 
   C11    75 : CGGESAYFFQLQIRSADEPMTTFYKCVNC 
 
Figure 34: Alignment of the zinc finger domains of TFIIS and its 
homologues in RNA Pol I (A12.2) and Pol III (C11).  
Invariant and conserved residues are shaded in dark grey and light grey, 
respectively. The asterisks mark the acidic hairpin residues D290 and 
E291 in TFIIS. 
 
Bacteria do not contain a TFIIS homolog, but several lines of evidence have suggested that the 
bacterial transcript cleavage factors GreA and GreB function essentially like TFIIS.  First, the 
binding site for GreB on bacterial polymerase corresponds to the rim of the Pol II funnel where 
TFIIS binds (Korzheva e t  a l . , 2000; Koulich e t  a l . , 1997).  Second, the structure of GreA, 
although different from that of TFIIS, shows a coiled-coil protrusion with acidic residues at the 
tip (Stebbins e t  a l . , 1995), which could reach the polymerase active site just like the TFIIS acidic 
hairpin does.  Third, like TFIIS, Gre factors can be crosslinked to the RNA 3’ end (Stebbins e t  
a l . , 1995).  
 
Darst and coworkers published a manuscript back-to-back with the present results, that describes 
docking of structures of GreB and bacterial RNA polymerase to a 15 Å molecular envelope of 
the polymerase-GreB complex derived from electron microsopy (Opalka e t  a l . , 2003).  
Strikingly, Opalka e t  a l .  find that the coiled coil of GreB binds in the secondary channel of 
bacterial polymerase, which corresponds to the Pol II pore, and reaches the active site with its 
acidic tip.  The authors further show that the acidic tip residues are critical for Gre factor 
function.  These findings are fully consistent with the findings discussed above and demonstrate 
in a powerful way the conserved strategies employed for RNA cleavage stimulation by the 
structurally unrelated bacterial and eukaryotic RNA polymerase cleavage factors.  
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Figure 35: Common features of TFIIS-Pol II complex (left, this study) and the bacterial 
GreB-Pol complex (right), (Opalka et  al . , 2003). Shown are major features of the 
complexes, including the RNA polymerase II pore and bacterial RNA polymerase channel, 
TFIIS, and GreB (orange), and the catalytic magnesium ion (metal A, pink). The positions of the 
conserved acidic residues in TFIIS and GreB are indicated by the green circles. The nascent 
transcript is shown in red, and the DNA template is blue. The presumed locations of 
backtracked RNAs are indicated by the dashed arrows. Adapted from (Conaway e t  a l . , 2003). 
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18 ASSAYS FOR THE COMPOSITION OF COMPLEX CRYSTALS 
18.1 Fluorescence-based detection of nucleic acids in the crystals 
During the efforts to co-crystallise Pol II with synthetic nucleic acids, an assay was developed for 
the detection of nucleic acids in presumed complex crystals. The assay involves incubation of 
putative co-crystals with the nucleic acid-specific fluorescent dye SYBR-Gold, and their 
observation under a fluorescence microscope with standard FITC filters (see Mat&Meth). 
Crystals are incubated in mother solution containing trace amounts of SYBR-Gold, an 
asymmetric cyanine dye that binds to any class of nucleic acids, irrespective if single or double-
stranded, DNA or RNA (Cosa e t  a l . , 2001; Tuma e t  a l . , 1999). Binding to nucleic acids 
enhances the fluorescence yield of SYBR-Gold dramatically (> 1000-fold), whereas proteins have 
essentially no effect (Tuma e t  a l . , 1999). Nucleic acid-containing Pol II crystals show intense 
green fluorescence after 1-2 hours of incubation with SYBR-Gold, whereas crystals of the free 
polymerase remained essentially non-fluorescent under the same conditions (Figure 36).  
 
To demonstrate the broad applicability of the assay for the detection of nucleic acids in crystals, it 
was applied to three different protein-nucleic acid complexes. One complex was the restriction 
enzyme NgoMIV with and without an 11 bp DNA duplex (a gift from Saulius Grazulis, 
Vilnius/Lithuania), for which the structure is known (Deibert e t  a l . , 2000). Crystals of the 
restriction enzyme-DNA complex were compared side-by-side with free enzyme crystals under 
identical conditions. The NgoMIV-DNA complex crystals exhibited strong fluorescence, whereas 
crystals of the free enzyme remained essentially dark (Figure 36A). Crystals shown in Figure 36B 
were assembled from core Pol II and an 80mer synthetic RNA oligonucleotide (Table 6). RNA 
binding could meanwhile be confirmed by a crystallographic electron density map (not shown). 
The third crystal form investigated (Figure 36C) was comprised of complete Pol II with and 
without a transcription bubble and product RNA (Bubble 1 in Table 6) 
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Figure 36: Selective fluorescence staining of nucleic acid-containing crystals.  
Three comparisons of protein crystals (P) and protein-nucleic acid complex crystals (C) are 
shown.  Transmission light microscopic images (left) reveal all crystals and fluorescence 
images (right) show selective staining of nucleic acid complex crystals after incubation with 
SYBR-Gold.   
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Figure 36 (continued) 
(A) Crystals of the restriction enzyme NgoMIV, in free form and in complex with an 11 
base pair DNA duplex (Deibert e t  a l . , 2000).   
(B) Crystals of Pol II, in free form and in complex with an 80-mer inhibitory RNA (Thomas 
e t  a l . , 1997). The yellow line marks the path of the intensity-profile shown in Figure 37.  
(C) Crystals of Pol II, in free form and in complex with a partially mismatched 41-mer DNA 
duplex and an 11-mer RNA.   
The white scale bar corresponds to 0.1 mm. 
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Figure 37: Intensity profile of the fluorescence micrograph shown in Figure 36B. 
Regions along the yellow line in Figure 36B, which correspond to the Pol II-RNA complex 
crystal and to the protein crystal, are indicated.  
 
 
For all three nucleic acid complex crystals, fluorescence was directly visible under the 
fluorescence microscope, without the need for digital image processing. Quantified fluorescence 
intensities for complex crystals were at least tenfold, and up to 50-fold, higher than intensities 
observed for free protein crystals of similar size, demonstrating the specificity of the assay.  
 
Since crystals of the free proteins remained essentially non-fluorescent, even after prolonged 
incubation with the dye overnight, it can be inferred that this method can reliably detect nucleic 
acid complex crystals, bypassing the need for control crystals of the free protein if these are 
unavailable. The sensitivity of the assay is remarkable, considering the low relative amounts of the 
nucleic acids in the crystallised complexes. The DNA in the NgoMIV-DNA complex contributes 
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19 % to the mass of the complex, whereas the nucleic acids in the Pol II-DNA-RNA complex 
and the Pol II-RNA complex account for only 7 % and 5 % of the complex mass, respectively.   
 
In order to investigate the kinetics of crystal staining, a time course (Figure 38) was recorded.  
For observing a defined layer in the crystal during dye diffusion and accumulation, the 
experiment was done under a confocal microscope.  
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Figure 38: Time course of staining with SYBR-Gold. The time 
course was started with the immersion of a crystal (size approx. 100 by 
80 by 80 µm) in mother solution containing SYBR-Gold. The increasing 
fluorescence intensity in a thin slice (3.9 µm), integrated in a polygon 
encircling the crystal, was followed under a confocal microscope.  
 
Under the experimental conditions used, saturation of the crystal with the dye was reached after 
about one hour. Since SYBR-Gold binds to nucleic acids within seconds (Tuma e t  a l . , 1999), the 
slow staining apparently reflects dye diffusion through the solvent channels of the crystals. This 
implies that small molecules can take hours to penetrate a crystal, and to occupy all binding sites. 
Soaking times of several hours may therefore be beneficial for derivatisation of crystals with small 
ligands or for cryoprotection. By means of this assay, those conditions could be identified, which 
lead to maximum fluorescence, i.e. where the occupancy of nucleic acids was as complete as 
possible. Optimising occupancy was particularly critical because both apo-Pol II and the nucleic 
acid complexes crystallise under the same conditions and give rise to the same crystal form (Table 
8). Thus, both the complex and free Pol II could be present in the same crystal. However, a slight 
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excess of free nucleic acids shifts the equilibrium to the side of the complex and low-salt 
crystallisation conditions were found to diminish the dissociation of elongation complexes (see 
chapter 16.4).  
 
18.2 Monitoring protein soaking into crystals 
The initial inspiration to soak additional proteins into preformed crystals of the complete 12-
subunit RNA polymerase II resulted from the crystallographic analysis. It revealed a solvent 
content of 80 % (see chapter 16.4) and wide solvent channels of up to 140 Å in diameter (Figure 
39).   
 
 
Figure 39: Crystal packing in complete Pol II crystals soaked with 
TFIIS. The view is along the crystallographic c-axis. 12-subunit Pol II is 
shown in yellow and TFIIS bound to Pol II is shown in green.  
 
Although a 20 kDa polypeptide like TFIIS should easily fit through the solvent channels, it 
cannot be predicted whether a specific target site on the polymerase surface is accessible in the 
crystal packing. There is only one example in the literature where a multi-component complex 
was assembled by soaking a protein into pre-formed crystals (Carter e t  a l . , 2001). In that case, 
the translation initiation factor IF1, a 8.1 kDa protein, was diffused into crystals of the 30S 
ribosomal subunit and the structure was determined at 3.1 Å resolution. 
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To determine whether TFIIS can indeed diffuse into polymerase crystals, and whether it can bind 
to its specific site on the polymerase surface, accumulation of TFIIS in the crystals was 
monitored by fluorescence microcropy. A Cy3 label was covalently attached to TFIIS. Crystals 
were incubated in a solution of the labelled TFIIS, and were observed under a fluorescence 
microscope. The fluorescence intensity within the crystals increased up to around 2-fold over 
background after 4 hours (Figure 40).  
 
 
Figure 40: Fluorescence micrograph of complete Pol II crystals 
soaked for 4 hours in Cy3-labelled TFIIS. TFIIS accumulates 
within the crystals, since mere diffusion into crystals would not lead 
to an increase of fluorescence over background.  
 
 
This indicated that TFIIS indeed bound to the polymerase and accumulated in the crystals, since 
mere diffusion of TFIIS through the crystals would not have resulted in an increase of 
fluorescence intensity over background levels. This assay allowed testing protein soaking in 
various buffers, and with crystals grown under different conditions. Specifically, the original 
phosphate-PEG20K crystallisation conditions (Table 7) caused most of TFIIS to precipitate 
before it could penetrate the crystals and TFIIS. The result was a protocol that led to maximum 
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fluorescence intensity, and thus to maximum TFIIS occupancy (see Materials and Methods). It 
was found that the crystals withstand a high concentration of TFIIS, up to 2 mg/mL, which 
corresponds to a concentration of 0.1 mM or ≈1000⋅KD (Awrey e t  a l . , 1998; Sijbrandi e t  a l . , 
2002; Wu e t  a l . , 1996), suggesting that the protocol is applicable to weak and transient protein 
interactions that have dissociation constants in the micromolar range. 
Attempts to derivatise crystals of the 10-subunit RNA polymerase II core (Cramer e t  a l . , 2000; 
Cramer e t  a l . , 2001; Fu e t  a l . , 1999) with TFIIS under similar conditions failed and the 
fluorescence assay showed labelled TFIIS not to accumulate in the crystals. Compared to the 
complete polymerase crystals, this crystal form (see Table 8) has a much lower solvent content of 
around 56 %, and a much larger area of the polymerase surface, including the TFIIS binding site, 
is involved in crystal contacts (not shown). Thus, the fluorescence assay could correctly predict 
the outcome of a later crystallographic analysis of protein-soaked polymerase crystals, and 
allowed to optimise the soaking procedure to achieve maximum occupancy of the additional 
protein on the polymerase surface, dramatically accelerating the crystallographic analysis. 
Nevertheless, such diffusion and binding of a protein into a crystal is limited to exceptional cases, 
since many prerequisites have to be fulfilled: The preformed crystals need to have large solvent 
channels that allow the diffusion of the additional protein into the crystal lattice. Moreover, the 
specific binding site of the soaked protein on the molecular surface of the target must be 
accessible and not involved in crystal contacts, and possible conformational changes 
accompanying binding must be tolerated by the crystal lattice. Soaking of Pol II crystals with 
labelled subunits of TFIIF, with TFIIE, Spt4/5 and the Mediator subcomplex MED7/MED21 
did not lead to any detectable accumulation within the crystals.  
19 ISOLATION AND CRYSTALLISATION OF POL II WITHOUT CTD 
In all crystal structures of Pol II solved so far, the C-terminal repeat domain (CTD) is apparently 
disordered. Nevertheless, these disordered 281 amino acids comprise a mass of about 30 kD. 
Crystals of 12-subunit Pol II are characterised by an unusually high solvent content (see chapter 
17.2), i.e. by a loose packing of Pol II molecules in the crystal lattice. Thus, proteolytic removal of 
the (essential) CTD prior to crystallisation was thought to facilitate the formation of a more 
closely packed crystal form, eventually leading to higher resolution. It has been shown that the 
initiation and chain elongation properties of a CTD-less Pol II are unchanged compared to the 
full-length enzyme (Li and Kornberg, 1994). Different from a previously described factor Xa 
 RESULTS AND DISCUSSION 92 
protease site immediately preceeding the first heptapeptide repeat (Li and Kornberg, 1994), the 
present strategy aimed to remove all of the CTD including the disordered part of the linker.  
 
Mutagenesis in the yeast strain CB010∆Rpb4 as described in chapter 25 of Materials and 
Methods resulted inthe strain (CB010)∆rpb4 RPB1-TEV, which carried a TEV protease cleavage 
site in the linker region of Rpb1. Hence, the C-terminal domain could be cleaved off during 
Pol II purification (see Materials and Methods chapter 25.3).  
 
 
Figure 41: Attempted insertions and mutations of the TEV protease site into 
Rpb1. Diamonds indicate the three sites in the disordered linker region of Rpb1 at which 
the heptapeptide TEV protease consensus sequence was inserted. An asterisk shows the 
position of the (successful) mutation of RPB1 into a TEV protease cleavage site, leaving 
the linker length unchanged. Amino acid numbers of the respective sites are given below 
the bar.  
 
Interestingly, only a mutation but not an insertion of the heptapeptide TEV protease consensus 
sequence gave rise to a viable strain in the context of the rpb4 knockout strain. This indicates 
that, at least in the context of this strain, alterations in the linker length are detrimental for yeast 
viablility. The resulting strain is characterised by slow growth (doubling time in the fermenter at 
25 °C is about 3.5 hours) and a clustering phenotype (Figure 42). A mutation of five residues plus 
an insertion of another residue in the linker-CTD junction was however not reported to show an 
apparent growth defect in an otherwise wildtype strain (Li and Kornberg, 1994).  
 
Treating this purified Pol II variant with TEV protease lead to quantitative cleavage of the CTD 
(Figure 43), so that an additional step in the purification protocol, namely dialysis and TEV 
treatment after the immunoaffinity step (see Materials and Methods chapter 21.2), resulted in 
crystallisable amounts of Pol II-∆CTD. However, compared to the wild-type variant, overall 
yields are about 50 % lower.  
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Figure 42: Micrograph of yeast strain (CB010)∆rpb4 RPB1-TEV 
(80-fold magnification). Cells were grown in the small fermenter at 
25 °C to late logarithmic phase. 
 
 
Figure 43: TEV protease treatment of Pol II.  
The silver-stained SDS-polyacrylamide gel shows Rpb1 and Rpb2 of Pol II after the 
immunoaffinity step (see chapter 21.2). Samples were treated with 0.2 µg/µL TEV 
protease in buffer UnoQ-A (see Materials and Methods) and incubated at 25 °C for the 
time indicated. (A) Timecourse to show rapid cleavage of Rpb1 by TEV protease. 
(B) Wild-type Pol II does not undergo proteolysis when treated with TEV protease. 
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Nucleic acid complexes of CTD-less core Pol II have been subjected to a set of commercial 
crystal screens (Crystal Screen 1 and 2, PEG-Ion Screen, Natrix [Hampton Research]), but no 
immediate hits could be obtained (Florian Brückner, personal communication). Nevertheless, 12-
subunit Pol II lacking the CTD gives rise to large, three-dimensional crystals. These form more 
readily and more reproducibly as crystals of the full-length Pol II. Crystallographically, these 
crystals are indistinguishable from full-length Pol II in terms of unit cell dimensions and space 
group (data not shown). Generally, larger size enhances diffraction intensity and reduces the 
susceptibility to radiation damage. Indeed, the first complete dataset to 3.6 Å resolution was 
obtained with a CTD-less Pol II crystal (Florian Brückner, personal communication).
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20 CONCLUSION AND OUTLOOK 
 
Details of the mechanisms of RNA elongation, substrate selection, maintenance of the 
transcription bubble and RNA exit were revealed by the results presented in this thesis. The 
structural analysis of the Pol II-TFIIS complex gave experimental evidence for a tuneable active 
site of Pol II, which can perform both RNA elongation and cleavage. The model system of 
complete, 12-subunit Pol II, together with a complete transcription bubble, product RNA, and 
the extrinsic transcription factor TFIIS approximates the in vivo situation of a regulated 
elongation complex as closely as possible at the moment.  
 
Further research will have to clarify the relevance of proposed conformational changes during the 
nucleotide addition cycle and during pausing and arrest. Higher resolution data are necessary to 
reveal chemical details responsible for the selection of correct nucleotides and the consequences 
of transcription through DNA lesion sites. Structures of other Pol II-transcription factor 
complexes will shed light onto the way in which these factors dynamically regulate Pol II.  An 
initiated structural investigation of an RNA inhibitor bound to Pol II is the first step into an 
investigation of the way Pol II transcription is being regulated by RNAs. 
 
 
Results and Discussion 
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21 ISOLATION OF RNA POL II FROM YEAST 
21.1 Yeast fermentation 
Core RNA polymerase II was isolated from the Saccharomyces cerevisiae strain CB010∆Rpb4 
(MATa  pep4::HIS3/prb1::LEU2, prc1::HISG, can1, ade2, trp1) (Edwards e t  a l . , 1990; Fu e t  a l . , 
1999). This strain carries knockouts of several cellular proteases and of RPB4. In the absence of 
Rpb4, Rpb7 dissociates from core Pol II during purification, giving rise to homogeneous 10-
subunit core Pol II. Two types of fermenters were available for producing up to 1.5 kg of yeast 
pellet per batch. The small fermenter (ISF200, Infors) has a nominal volume of 20 L and is 
ideally run with up to 15 L of media. The large fermenter (ABEC, Infors) has a nominal volume 
of 200 L and can be filled with up to 160 L of media. Table 11 shows the media composition and 
the culture parameters of both fermenters:  
 
Table 11: Conditions for the fermentation of yeast 
 small fermenter (20 L) large fermenter (200 L) 
YPD media  300 g peptone 
300 g glucose 
222 g yeast extract 
15 L desalted water 
3200 g peptone 
3200 g glucose 
2370 g yeast extract 
160 L desalted water 
Antibiotics1 0.75 g ampicillin 
0.15 g tetracycline⋅HCl 
8.0 g ampicillin 
1.6 g tetracycline⋅HCl 
typical inoculate volume 0.3 L @ OD600 ≈ 2 4-5 L @ OD600 ≈ 2 
air flow 8 L/min 20 L/min 
stirrer speed 800 rpm 200 rpm 
typical growth time 12 – 15 hours 12 – 15 hours 
 1added after sterilisation, prior to inoculation 
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21.2 Purification of RNA Pol II 
21.2.1 Buffers 
3x freezing buffer 
150 mM Tris-Cl, pH 7.9 @ 4 °C 
3 mM EDTA 
30 % glycerol 
30 µM ZnCl2 
3 % DMSO 
30 mM DTT 
3 x protease inhibitor mix 
 
100 x protease inhibitor mix (p.i.) 
1.42 mg Leupeptin 
6.85 mg Pepstatin A 
850 mg PMSF 
1650 mg benzamidine 
dry ethanol to 50 mL 
 
stored at –20 °C; added immediately before use 
1 x HSB150 
50 mM Tris-Cl, pH 7.9 @ 4 °C 
150 mM KCl 
1 mM EDTA 
10 % glycerol 
10 µM ZnCl2 
10 mM DTT 
1 x protease inhibitor mix 
 
1 x HSB600 
50 mM Tris-Cl, pH 7.9 @ 4 °C 
600 mM KCl 
1 mM EDTA 
10 % glycerol 
10 µM Zn Cl2 
10 mM DTT 
1 x protease inhibitor mix 
1x TEZ 
50 mM Tris-Cl, pH 7.5 @ 20 °C 
1 mM EDTA 
10 µM ZnCl2 
5 mM DTT 
1 x protease inhibitor mix 
 
UnoQ buffer 
50 mM Tris-Cl, pH 7.5 @ 20 °C 
1 mM EDTA 
10 µM ZnCl2 
10 % (v/v) glycerol 
10 mM DTT 
no protease inhibitors 
 
1 x Pol II buffer 
5 mM Hepes pH 7.25 @ 20 °C 
40 mM ammonium sulphate 
10 µM ZnCl2 
10 mM DTT 
 
Acetate buffer 
100 mM sodium acetate pH 4.0 
500 mM sodium chloride 
 
PBS 
4.3 mM Na2HPO4 
1.4 mM KH2PO4 
137 mM sodium chloride  
2.7 mM potassium chloride 
pH 7.4 
Coupling buffer 
100 mM sodium bicarbonate pH 8.3 
500 mM sodium chloride 
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21.2.2 Harvesting and storage of yeast 
Yeast was harvested at late logarithmic/early stationary phase, monitored by OD600 
measurement. Cells were pelleted by centrifugation for 20 min. at 5000 rpm in a SLC6000 rotor 
(small fermenter) or by a continuous flow centrifuge (Padberg Z4IG, 20000 rpm) in case of the 
large fermenter. The cell pellet was resuspended in 330 mL of 3x freezing buffer per kg cells and 
stirred at 4 °C for 30 min., before shock-freezing in liquid nitrogen and stored at – 80 °C. 
 
21.2.3 Purification - day 1 (lysis and heparin column) 
For three bead-beaters (BioSpec), up to 600 mL of cell suspension were thawed in warm water. 
Each bead-beater was filled with 200 mL of borosilicate glass beads (0.45-0.50 mm diameter), 1 
mL of protease inhibitor mix and 200 mL of the cell suspension. HSB150 was added to fill the 
bead-beater completely, taking care to avoid any remaining air bubbles. Lysis was achieved within 
one hour of bead-beating (30 s on/90 s off) while the beater chambers were submersed in a 
salt/ice mixture. 
 
Glass beads were removed by filtration through a mesh funnel. The beads were washed with 
HSB150 until the flowthrough was clear. The lysate was cleared by two rounds of centrifugation 
(30 min. at 12000 rpm in a GS3 rotor). Lipids were then removed by filtration of the supernatant 
through two layers of paper filter discs underneath a dressing cloth.  
 
The cleared lysate was applied onto a column packed with 250 mL of Heparin Sepharose 6 FF 
(Amersham), pre-equilibrated with 750 mL of HSB150. Elution was accomplished with 500 mL 
of HSB600. Proteins in the eluate were precipitated by adding 291 g of fine-ground ammonium 
sulphate per litre of eluate (= 50 % saturation), followed by 20 min. of stirring at 4 °C and 
centrifugation (45 min. at 12000 rpm in a GS3 rotor). The pellet was stored over night at 4 °C. 
The heparin column was restored by washing with 1 L of 6 M urea, followed by water, and stored 
in 5 mM potassium acetate and 20 % (v/v) ethanol. Every five runs, the heparin column was 
regenerated by a brief wash with 500 mL of 0.1 M NaOH, followed by water and 5 mM 
potassium acetate in 20 % (v/v) ethanol.  
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21.2.4 Purification - day 2 (immunoaffinity column) 
The ammonium sulphate pellet of day 1 was dissolved in 50 mL of buffer TEZ. More TEZ was 
added to adjust the conductivity below the conductivity of TEZ containing additionally 400 mM 
ammonium sulphate (TEZ400). This sample was loaded by gravity flow onto the immunoaffinity 
column (see chapter 21.2.6). The column was pre-equilibrated with 20 mL of TEZ containing 
250 mM ammonium sulphate (TEZ250). The flowthrough was re-loaded to yield 10-20 % more 
Pol II. The column was brought to room temperature, washed with 25 mL of TEZ250 at room 
temperature and Pol II was eluted in 1 mL fractions with TEZ500 containing additionally 50 % 
(v/v) glycerol (ca. 15 mL). Directly afterwards, the column was washed with 5 mL of TEZ500 
containing 70 % (v/v) ethylene glycol but no DTT, and re-equilibrated with 25 mL of TEZ250 
containing 0.02 % sodium azide.  The column can be used > 10 times before recovery decreases.  
 
21.2.5 Purification - day 3 (anion exchange column) 
Peak fractions from day 2 were diluted six-fold and loaded onto a UnoQ column (BioRad, 
column volume 1.35 mL), pre-equilibrated with buffer UnoQ containing 60 mM ammonium 
sulphate (UnoQ-A). The column was washed with 3 column volumes of this buffer, and Pol II 
was eluted with a linear gradient over 10 column volumes from 0 – 50 % buffer UnoQ 
containing 1 M ammonium sulphate (UnoQ-B). Pol II elutes at about 25 % buffer UnoQ-B. The 
column was restored by washing with 5 column volumes of UnoQ-B. 
 
Peak fractions were pooled and split into aliquots of 500 µg Pol II. The aliquots were mixed 1 : 1 
with ammonium sulphate solution saturated at room-temperature, incubated for > 1 hour at 4 °C 
and centrifuged for 45 min. at 4 °C in a table-top centrifuge at 15000 rpm. Most of the 
supernatant was decanted so that the pellet was still covered with supernatant, before it was 
shock-frozen in liquid nitrogen and stored at –80 °C. Pol II stored this way is stable for about 3 
months. From 600 g yeast pellet, a yield of 5-8 mg of highly purified Pol II can be expected. 
 
21.2.6 Preparation of Pol II immunoaffinity resin 
The monoclonal antibody 8WG16 (NeoClone, Madison/USA), described in (Thompson and 
Burgess, 1996) is specific for the unphosphorylated CTD of Pol II and optimised to release Pol 
II upon treatment with glycerol or ethylene glycol at room temperature (“polyol responsive 
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antibody“). The antibodies were purified from mouse ascites and immobilised on activated 
chromatography media according to the following procedure:  
 
Lyophilised ascites was dissolved in PBS to its original volume and filtered through 0.2 µm 
membrane filters. The solution was passed > 3 times through a protein-A sepharose column 
(5 mL column volume, Sigma), pre-equilibrated in PBS. The column was washed with 50 mL 
PBS and antibodies were eluted with 20 mL of 0.75 M acetic acid. Fractions of 1 mL were 
collected into tubes containing 200 µL of 2 M Hepes (pH 7.9) to neutralise the acid. Peak 
fractions were pooled and the protein-A sepharose column was regenerated by washing for 5 
min. with 1 M acetic acid, followed by PBS with 0.02 % sodium azide. 
 
The matrix for immuno-affinity columns was cyanogen bromide (CNBr)-activated sepharose 4 B 
(Sigma), which reacts with free amines, e.g. accessible -NH2 groups on proteins. Care was taken 
to avoid other sources of free amines (e.g. Tris) and to use a sealed bottle of activated sepharose. 
For each immunoaffinity column, 5 mL of gel was prepared by suspending 1.43 g of CNBr-
sepharose in several mL of 1 mM HCl in a disposable gravity-flow column. The suspended 
CNBr-sepharose was washed with 20 mL of coupling buffer. Coupling was performed with 10 
mg of purified antibodies per column for 2 hours at 20 °C or over night at 4 °C. When the 
coupling reaction was completed, no protein was detectable in the supernatant. The column was 
then washed with 25 mL of 1 M Tris, pH 8 and incubated for 2 hours at room temperature. 
Finally, the column was washed with 20 mL of coupling buffer, followed by acetate buffer and 
coupling buffer. Columns were stored at 4 °C in TEZ60 with 0.02 % sodium azide and could be 
used > 10 times, if DTT exposure was reduced to a minimum.  
 
22 PURIFICATION OF THE SUBCOMPLEX RPB4/7 
Buffer 1 
150 mM NaCl 
5 % (v/v) glycerol 
50 mM Tris pH 7.5 
10 mM β-mercaptoethanol 
protease inhibitors  
(see chapter 26.2) 
Buffer 2 
50 mM Tris pH 7.5 
5 mM DTT 
1 mM EDTA 
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Recombinant yeast Rpb4/7 was cloned and overexpressed in E. coli using a bicistronic vector, as 
described (Sakurai e t  a l . , 1999). Cells from 2 L of culture were resuspended in buffer 1 and lysed 
by means of a French Press. The lysate was cleared by centrifugation (30 min. at 15000 rpm in a 
SS34 rotor) and applied onto a NiNTA column (Quiagen; 1 mL column volume). The column 
was washed with 5 mL of buffer 1 containing additionally 20 mM imidazole. Elution was 
performed with 6 mL of buffer 1 containing additionally 200 mM imidazole. Peak fractions were 
pooled, diluted 1:3 with buffer 2 and applied on a ResourceQ column (Amersham, 6 mL column 
volume), pre-equilibrated in buffer 2. Rpb4/7 was eluted with a linear gradient from 0-1000 mM 
NaCl in buffer 2. Peak fractions were concentrated and applied on a Superose12 HR10/30 
gelfiltration column (Amersham), pre-equilibrated in Pol II buffer (see chapter 21.2). The purified 
Rpb4/7 heterodimer was concentrated to 10 mg/mL and aliquots were stored at –80 °C.  
 
23 ELECTROPHORETIC MOBILITY SHIFT ASSAY 
TGEM-buffer  
25 mM Tris pH 7.5  
190 mM glycine 
1 mM EDTA 
8 mM magnesium acetate 
10 % (v/v) glycerol 
20 g/L PEG6000. 
Sample buffer 
TGEM buffer containing 
additionally 40 % (v/v) 
glycerol 
 
Nucleic acids were analysed for their capability to bind Pol II by electrophoretic mobility shift 
assays, essentially as described (Daube and von Hippel, 1992). In 10 µL of Pol II buffer (see 
chapter 21.2.1), 100 pmol of nucleic acids were incubated with 20 pmol of Pol II for 20 minutes 
at 20 °C. 4 µL of sample buffer was added before the samples were loaded on a 5 % acrylamide 
gel in TGEM buffer. Electrophoresis was carried out at 4 °C at a voltage of 70-90 V for 90-120 
minutes. Nucleic acids were stained for 30 minutes with 0.01 % SYBR gold in TBE buffer and 
visualized with 310 nm UV light. Thereafter, protein bands were stained with Coomassie Brilliant 
Blue.  
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24 TRANSCRIPTION ASSAY 
This assay was utilised as a quality control for the purified Pol II complex, showing that it is 
transcriptionally active on the template used for crystallisation.  
 
Transcription buffer 
20 mM Hepes pH 7.5 
10 % glycerol 
8 mM magnesium chloride 
40 mM ammonium sulphate 
Stop solution 
24 µL of 10 % (w/v) SDS 
26 µL proteinase K (20 mg/mL)  
750 µL RNAse-free water (Sigma) 
 
To 560 pmol of purified Pol II in 120 µL of transcription buffer, 1.4 equivalents of an artificial 
transcription bubble (Table 6) and 1 mM each of CTP, UTP, ATP and GTP was added. The 
mixture was incubated at 28 °C for 20 minutes. The reaction was quenched by adding 800 µL of 
stop solution. This mixture was incubated for 1 hour at 40 °C before 600 µL Phenol/Chloroform 
(1:1) (Rotiphenol, Roth) were added and RNA was extracted. To precipitate RNA, 6 µL glycogen 
(20 mg/mL), 60 µL 5 M NaCl and 2.4 mL cold ethanol were added and precipitation was allowed 
to proceed over night at –20 °C. RNA was isolated by centrifugation at maximum speed at 0 °C. 
RNAs were separated on a denaturing 3 % acrylamide-urea gel (Sambrook, 2001), stained for 30 
minutes with 0.01 % SYBR gold in TBE buffer, followed by 30 minutes of destaining with water. 
RNA bands were visualised with 310 nm UV light.  
 
25 INTRODUCTION OF A TEV PROTEOLYSIS SITE INTO RPB1 
25.1 Construct design and mutagenesis 
The consensus sequence of the cleavage site of tobacco etch virus (TEV) NIa protease 
(Carrington and Dougherty, 1988; Parks e t  a l . , 1992) was introduced into the linker region of 
Rpb1 by mutating the residues DELMFSP (residues 1488-1497) to ENLYFQG. This site was 
chosen because it required a minimal number of unconservative mutations. Previous experiments 
to insert the consensus sequence into three different positions in the linker, rather than keeping 
the linker length constant, failed (see chapter 19). To create a construct for homologous 
recombination in yeast, the sequence encoding the C-terminus of Rpb1 (residues 1271-1734) and 
440 bases of the 3’-UTR was amplified from wild-type yeast genomic DNA by the primer pair 
A_forw and A_rev. 
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Table 12: Primers for introduction of a TEV cleavage site in Rpb1 
name sequence (5’ → 3’) 
A_forw TCCCCCCGGGGGGACATTACGTGGTGTAGAGAACATCGAG 
A_rev GCGTATTTCCGTGATCTGGTAATGCGCGGATCCGCG 
mut_forward GAAAATTTGTACTTTCAAGGTGATCTTGACGTTAAAGATGAGC 
mut_reverse ACCTTGAAAGTACAAATTTTCGTTACTGTATGGTGTGACGCC 
458_fo GATTGTCGTGGTGTTTCG 
1400_rev CCCAGGCTTTACACTTTATG 
trp_rev CGTCTGCAAGCCGCAAACTTTC 
shading marks the sequence coding for the TEV-site 
  
Mutagenesis was performed with the overlapping pair of primers mut_forward and mut_reverse 
(Table 12). This fragment was cloned into the vector pBS II KS(+) (Stratagene) using the 
restriction sites XmaI and BamHI. A TRP1 auxotrophy marker cassette was inserted at position 
5408 of the 3’-UTR. For this purpose, the plasmid described above was cut with SwaI (NEB). 
The TRP1 cassette was excised from the plasmid YDp-W (Berben e t  a l . , 1991) using BamHI. 
Blunt ends of the excised fragment were created with Pfu DNA polymerase (New England 
Biolabs), before it was ligated into the linearised vector using T4 ligase (Fermentas). The correct 
incorporation of the TRP1 gene was confirmed by PCR using primer pair 458_fo and trp_rev, 
that anneal in the TRP1 insert (Table 12, Figure 44) and in the 3’-UTR before the insertion. The 
correct sequence of the whole construct was confirmed by DNA sequencing. 
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Figure 44: Cloning strategy for the inclusion of a TEV protease site in the Rpb1 “linker” region.  
(A) Schematic representation of the C-terminus and the 3’ UTR of RPB1. Sites of attempted but 
unsuccessful TEV site insertions are indicated with grey lines. An asterisk and a black line marks the site 
of mutation yielding viable clones. Numbers refer to the base or the amino acid followed by the mutation. 
The position of the C-terminal repeat domain (CTD) and TRP1 cassette in the transformed fragment are 
indicated. Primers used for cloning and test-PCRs are indicated with arrows. 
(B) A 942 bp DNA sequence surrounding the desired site of mutation was amplified with the primer pair 
indicated with arrows. RsaI cut sites are depicted as black lines. An additional RsaI site, marked with an 
asterisk, is present in the sequence coding for the TEV site. 
(C) Agarose gel (1 %) of six clones tested for the presence of the TEV-site by RsaI digest. The restriction 
profile shown in (B) leads to a 450 bp and a 241 bp fragment (and to shorter fragments not shown on this 
gel). The 241 bp fragment is absent in the positive case. 1-7: clone numbers; +: positive control; WT: 
wild-type. All clones except #6 carry the desired mutation. 
 
25.2 Yeast transformation 
For the transformation, the construct described above was cut from the plasmid using XmaI and 
BamHI. Yeast transformation was performed according to the lithium acetate-PEG procedure 
(Ito e t  a l . , 1983): 
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Buffers: 10 x TE 
100 mM Tris pH 7.4 
10 mM EDTA 
(sterile filtered) 
 
10 x LiAc 
1 M lithium acetate 
pH 7.5 
(sterile filtered) 
 solution 1 
0.5 mL 10 x TE 
0.5 mL 10 x LiAc 
4 mL water 
(sterile filtered) 
 
solution 2 
0.5 mL 10 x TE 
0.5 mL 10 x LiAc 
4 mL 50 % (w/v) PEG4000 
Media: YPD medium 
20 g peptone 
20 g glucose 
14.8 g yeast extract 
H2O ad 1 L 
SDC-Trp medium 
6.75 g Yeast nitrogen base 
(Formedia) 
20 g glucose 
50 mg arginine HCl 
80 mg aspartate 
50 mg isoleucine 
50 mg lysine HCl 
20 mg methionine 
50 mg phenylalanine 
100 mg threonine 
50 mg tyrosine 
140 mg valine 
20 mg adenine 
20 mg histidine 
100 mg leucine 
20 mg uracil 
H2O ad 1 L 
pH 5.5 
 
For five transformations, 50 mL of yeast culture were grown to an OD600 of 0.5-0.8 and pelleted 
by centrifugation for 5 min. at 3600 rpm. As a host strain, the BJ926 strain described in chapter 
21.1 was used which proved to be suitable for producing crystallisable core Pol II. The pellet was 
washed with 10 mL of sterile water, centrifuged again and resuspended in 500 µL of solution 1. 
Cells were washed once with solution 1 and resuspended in 250 µL of solution 1. For each 
transformation, 50 µL of the cell suspension was mixed with 1-4 µg of the linearised DNA in < 4 
µL TE buffer and mixed with 300 µL of solution 2 and 5 µL of carrier DNA. The mixture was 
incubated at room temperature for 30 min. and heat-shocked for 10 min. at 42 °C, followed by a 
3 min. incubation on ice. Cells were then washed twice with water, resuspended in 100 µL of 
water and spread on SDC-Trp selective media plates. 
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Colonies that grew within 3 days at 25 °C on SDC-Trp plates were re-plated and grown for 
another 3 days at 25 °C. From 19 colonies and a wild type control, genomic DNA was isolated 
and the region of interest (1824 bp, Figure 44) was amplified by PCR using the primer pair 
A_forw and A_rev (Table 12). The presence of one correctly oriented copy of TRP1 in the 3’-
UTR of RPB1 was confirmed by PCR using the primer pair 458_fo and trp_rev. These primers 
were designed to yield fragments of 1298 bp in case one correctly oriented copy of TRP1 is 
present in the template.  
 
In order to assay for the presence of the TEV cleavage site, 942 bp of DNA including the site of 
mutagenesis was amplified by PCR using the primers 458_fo and 1400_rev. The presence of the 
mutation encoding for the TEV cleavage site introduces an additional RsaI restriction site. 
Therefore, clones, carrying the desired mutation can be identified by a distinct restriction pattern 
(Figure 44). From the 19 clones tested, 17 clones had the TRP1 gene in the correct position. 
From these 17 clones, the fastest growing six clones were further analyzed. Eventually, five out 
of six clones carried the desired TEV site mutation. No other mutation was present in the gene 
coding for Rpb1p as confirmed by DNA sequencing.  
 
It is noteworthy that an alternative strategy to insert rather than to mutate the TEV consensus 
sequence in three positions in the linker (after residues 1480, 1489 and 1501, respectively, Figure 
44) following an analogous procedure did not lead to any viable clones carrying the mutation, 
although about 60 clones per site were analysed.  
 
The resulting yeast strain carrying the TEV site mutation in RPB1 is characterized by a clumpy 
phenotype and a prolonged doubling time of about 4 hours, compared to about 2.5 hours for the 
original BJ926 strain. This phenotype makes cell density determination by measuring the optical 
density imprecise. Therefore, cells were counted directly using a Neubauer counting chamber.  
 
25.3 Isolation of Pol II ∆CTD 
The first steps of RNA Pol II preparation, namely chromatography via a heparin column and an 
immunoaffinity column were performed as described above (chapter 21.2.4). No protease 
inhibitors were present in the wash and elution buffer of the immunoaffinity column. The eluate 
was mixed with 400 µg of recombinant TEV protease and dialysed against UnoQ buffer A in a 
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dialysis membrane (5 kDa cutoff) over night at 4 °C. The dialysed sample was centrifuged and 
applied onto a UnoQ column, precipitated and shock-frozen as described above (chapter 21.2.5). 
Quantitative TEV cleavage of Rpb1 was confirmed by SDS-PAGE (Figure 43). 
 
26 CLONING, MUTAGENESIS AND PURIFICATION OF TFIIS 
26.1 Cloning and mutagenesis 
The TFIIS variants were expressed in E. coli as a fusion protein containing an amino-terminal 
hexahistidine tag, essentially as described (Awrey e t  a l . , 1997). The DNA encoding for yeast 
TFIIS domains II and III (residues 131-309) was amplified by PCR from S. cerevisiae genomic 
DNA using primers IIS_fo and IIS_rev (Table 13), and subcloned into vector pET28a(+) 
(Novagen) via the restriction sites BamHI and NdeI. A double mutant D290A E291A was 
constructed by site-directed mutagenesis using two-step PCR with the primers DE_fo and 
DE_rev. 
 
Table 13: Primers for cloning and mutagenesis of TFIIS 
name sequence (5’ → 3’) 
IIS_fo GGGAATTCCATATGCCAAGAAATAGTAAGAACGATGG 
IIS_rev CGCGGATCCCTAAGAGAATTTCCATCTGTTACC 
DE_fo GCAAACAAGATCTGCGGCTGCACCATTGACC 
DE_rev GGACAATGGTGCAGCCGCAGATCTTGTTTGC 
 DE AA mutation  
 
 
26.2 Expression and purification 
buffer A  
50 mM Hepes pH 7.5 
300 mM NaCl 
5% glycerol 
10 µM ZnCl2 
1 x protease inhibitors 
10 mM β-mercaptoethanol
10 x protease inhibitors 
3 mg/L leupeptin 
14 mg/L pepstatin A 
1.7 g/L PMSF 
3.3 g/L benzamidine 
dissolved in ethanol 
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For the expression of TFIIS variants, transformed BL21(DE3) RIL (Stratagene) cells were grown 
in LB medium, supplemented with chloramphenicol (30 mg/L) and kanamycin (30 mg/L), to an 
OD600 of 0.7 and cooled down to 20 °C before expression was induced with 1 mM IPTG, and 
continued over night. For selenomethionine incorporation, the TFIIS variant was introduced to 
the methionine auxotroph E. c o l i  strain B834(DE3) (Budisa e t  a l . , 1995).  Cells were grown in 
one litre of LB medium, supplemented with kanamycin (30 mg/L) to an OD600 of 0.6, harvested 
by centrifugation (10 min, 5000 rpm, GS-3 rotor), and were resuspended in one litre of 
selenomethionine-containing minimal medium (Budisa e t  a l . , 1995).  The cell suspension was 
agitated until growth resumed (2-3 hours) at 20°C, before expression was induced with 1 mM 
IPTG, and continued over night.  
 
Cells from 1 L of culture were lysed by sonication in 50 mL of buffer A.  The lysate was cleared 
by centrifugation (30 min, 16000 rpm, SS34 rotor) and was applied to a Ni-NTA agarose column 
(1.5 mL; Quiagen).  The column was washed with buffer A containing 500 mM NaCl, and the 
protein was eluted with a gradient of 0 mM to 500 mM imidazole in buffer A containing 500 mM 
NaCl.  Peak fractions were diluted 5-fold in buffer A and loaded onto a Mono-S 5/50HR anion 
exchange column (Amersham), pre-equilibrated with buffer A containing 100 mM NaCl.  The 
TFIIS variant was eluted over a total of 15 column volumes with a gradient of 100-500 mM NaCl 
in buffer A.  This yielded two peaks, which both contained the TFIIS variant, as confirmed by 
mass spectroscopy.  TFIIS in the two fractions shows the same apparent molecular weight in gel 
electrophoresis and gives rise to the same CD spectra.  Fractions of both peaks were pooled, 
concentrated to 8 mg/mL, shock-frozen in liquid nitrogen and stored at –80°C.  
 
27 PREPARATION OF POL II-NUCLEIC ACID COMPLEXES 
Assembly buffer 
50 mM Hepes pH 7.5 
40 mM ammonium sulphate 
5 µM ZnCl2  
5% glycerol 
10 mM DTT 
Pol II buffer 
5 mM Hepes pH 7.25 
40 mM ammonium sulphate 
10 µM ZnCl2 
10 mM DTT 
 
Endogenous yeast ten-subunit Pol II core and recombinant Rpb4/7 heterodimer were purified as 
described in chapters 21 and 22. DNA bubble-RNA complexes were annealed by mixing 
equimolar amounts of synthetic template DNA, non-template DNA (biomers.net) and RNA 
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oligonucleotides (biomers.net) (Table 6) in RNAse-free TE buffer (Fluka) at a final concentration 
of 100 µM.  The mixture was heated to 90 °C in a preheated thermo block, and slowly cooling to 
20 °C over night.  
 
The Pol II-bubble-RNA complex was assembled by incubating core Pol II for 5 minutes at 20 °C 
with a 1.5-fold molar excess of the bubble-RNA construct in assembly buffer. To this complex, a 
5-fold molar excess of recombinant Rpb4/7 was added, followed by incubation for another 10 
minutes at 20 °C. The complex was purified by gel filtration (Superose 6 HR, Amersham, 
flowrate 0.3 mL/min) in Pol II buffer. The complex was concentrated to 3.5-4.5 mg/mL using a 
MembraSpin centrifugal concentrator (100 kDa cutoff). Prior to crystallisation, an additional 
amount of bubble-RNA complex was added to a final concentration of 2 µM in order to ensure 
full occupancy. The light-sensitive bromine-derivatised template DNA contained 5-bromo-uracil 
at positions –4, –7 and –10 and was treated with minimal light exposure.  
28 CRYSTAL GROWTH AND TREATMENT 
Generally, crystals were grown at 20 °C with the hanging drop vapour diffusion method by 
mixing 2-4 µL of sample solution with 1-2 µL of reservoir solution. Crystals typically reached 
their maximum size after about 10 days. For cryoprotection, the mother solution was exchanged 
in five steps to mother solution containing 20, 40, 60, 80 and 100 % of the final glycerol 
concentration (Table 7). Incubation time between these steps was 1 hour. Subsequently, crystals in 
the final cryo-protecting solution were slowly cooled down to 4-8 °C in a styrofoam box, 
incubated for another 14-24 h, mounted into nylon loops (Hampton Research) and plunged into 
liquid nitrogen.  
 
28.1 Preparation of substrate-containing Pol II cocrystals 
Crystals containing additionally the substrate analogue GMPCPP (Guanosine-5'-
[(α,β)-methyleno]-triphosphate) were grown under modified Natrix condition #38 (Table 7) in 
the presence of 3 mM GMPCPP (Jena Biosciences). To ensure maximum occupancy, GMPCPP 
was also present in the last cryo solution at a concentration of 3 mM. 
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28.2 Preparation Pol II-TFIIS complex crystals 
Crystals of the Pol II-TFIIS complex (Kettenberger e t  a l . , 2003) were prepared by soaking 
preformed cryo-protected crystals of 12-subunit Pol II for 24 hours at 4 °C in the last cryo 
solution of the ammonium-sodium tartrate condition (Table 7), containing additionally 1 mg/mL 
of TFIIS. Crystals of the Pol II-bubble-RNA-TFIIS complex were obtained analogously by 
soaking crystals grown in the modified Natrix condition #38 (Table 7) for less than 12 hours in 
the last cryo solution, containing 1 mg/mL TFIIS double mutant D290A/E291A. Additionally, 
the RNA-derivative present in this complex is less prone to hydrolysis because it contains only 
thiophospho-diester groups in order to reduce cleavage by TFIIS.  
 
29 FLUORESCENCE-BASED ASSAYS FOR COMPLEX CRYSTALS 
29.1 Detection of nucleic acids in crystals  
 
Mother solutions: NgoMIV and its DNA complex 
4.0 M sodium formate 
 
 Core Pol II and its complexes 
390 mM (NH4)2HPO4/NaH2PO4 pH 6.0 
16 % PEG-6000 
50 mM dioxane  
5 mM DTT 
 
 Complete 12-subunit Pol II 
150 mM magnesium acetate 
200 mM ammonium acetate 
50 mM HEPES pH 7.0  
5% PEG4000 
 
Crystals were harvested in their respective mother solutions. To assure complete removal of non-
specifically associated nucleic acids, crystals were back-soaked in harvest solution at 20° C 
overnight. To allow for direct comparison under identical conditions, crystals of free protein and 
the protein-nucleic acid complex were placed side by side on a glass spot plate in 50 µL of the 
harvest solution. To this drop, 50 µL of SYBR-Gold (Molecular Probes, Eugene/USA), diluted 
1:5000 with harvest solution were added. The excitation and emission maxima of SYBR-Gold, 
497 nm and 520 nm, respectively (Molecular Probes, www.probes.com), are close to the values 
for fluorescein (498 nm and 520 nm, respectively; Molecular Probes, www.probes.com). 
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Therefore, filters that are routinely used for fluorescein could be employed. Maximal fluorescence 
was typically reached within one hour, although prolonged incubation for up to 12 hours did not 
significantly change the results, nor did it lead to increased staining of crystals containing only 
protein. Fluorescence microscopic images were collected with a Zeiss Axioskop microscope at 
50-fold magnification. Digital images were recorded with a VisiCam (Visitron Systems) black-
and-white CCD camera and processed with ScionImage (Scion Corporation) 
 
A time-course for quantitative kinetics was recorded on a confocal microscope (Leica DM IRE2) 
at 64-fold magnification. The time course was started by placing a back-soaked crystal (size ≈100 
by 80 by 80 µm) in 20 µL of harvest solution containing 0.01% of SYBR gold. Images of a 
3.9 µm thick slice were recorded every 168 seconds. Integration times were chosen to stay within 
the dynamic range of the cameras and image processing was carried out with ScionImage. 
 
29.2 Monitoring TFIIS soaking into RNA polymerase II crystals.  
Carbonate buffer 
100 mM NaHCO3 
100 mM NaCl 
5 mM DTT pH 9.0 
Storage buffer 
5 mM HEPES 
40 mM ammonium sulphate 
5 mM DTT, pH 7.25 
 
Cy3-labelled TFIIS was prepared following the manufacturer’s protocol. To this end, 1.0 mg of 
purified TFIIS in 1 mL of carbonate buffer was incubated with one aliquot of Cy3 antibody 
labelling kit (Amersham) at 20 °C for 1 hour. The reaction was quenched by adding 100 µL of 1 
M TRIS pH 8, followed by incubation for another hour. Labelled protein was separated from 
unreacted dye by chromatography over a PD10 desalting column (Amersham), pre-equilibrated 
with storage buffer.  Labelled protein was concentrated to 10 mg/mL. During concentration, no 
free dye was detectable in the flowthrough by absorption spectroscopy. Labelling resulted in a 
molar dye-to-protein ratio of 0.6. Cryo-protected crystals were then incubated for 18-24 hours in 
the final cryo solution containing additionally 2 mg/mL TFIIS. Only for the fluorescence assay, 
labelled TFIIS was used and fluorescence micrographs were recorded with the equipment 
described in chapter 29.1. The excitation and emission maxima of Cy3 are at 550 and 570 nm, 
respectively (Amersham Biosciences), thus a standard Cy3  filter pair was used here. 
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30 X-RAY ANALYSIS 
30.1 Data collection 
All data were collected at the protein crystallography beamline X06SA at the Swiss Light Source 
(SLS) in Villigen/Aargau. Because the crystals were radiation sensitive and diffraction power was 
rather weak, the best I/σ(I) values possible had to be obtained with the lowest possible x-ray 
dose. To this end, fine-slicing (0.25 °/frame) was applied routinely, together with a beam focused 
on the detector rather than on the sample. Since the background level due to diffuse scattering 
decreases with 1/d² (d = crystal to detector distance), the maximum reasonable crystal to 
detector distance was chosen for data collection. This strategy notably benefited from a larger 
Mar225 detector (Mar Research) with an active surface of 225 by 225 mm², which became 
available at the SLS from November 2004.  
 
The total oscillation range of 90°, which yields maximum completeness was determined prior to 
data collection with MOSFLM (Powell, 1999). In case of premature decay, crystals were 
translated up to four times in order to irradiate an undamaged zone of the crystal. When only 
small crystals were available, partial datasets of up to five crystals could be merged at the step of 
scaling (Table 9, dataset 3). This was possible by selecting the combination of five out of eight 
crystals that were most isomorphous and gave rise to the best statistics of the merged dataset.  
 
30.2 Data Reduction 
Raw data were indexed and integrated with DENZO (vers. 1.97.2) (Otwinowski and Minor, 
1997) and (from the time it was available, September 2003) with HKL2000. Three-dimensional 
profile fitting, implemented in HKL2000, slightly enhanced data quality, because it better 
accounts for mosaicities greater than the oscillation width. Due to radiation damage, mosaicity 
increased, typically from 0.3° to about 1.2°. Therefore it was refined in segments of 5 frames 
(HKL2000) or in segments of 20° (DENZO). Choosing a small spot size (0.18-0.22 mm 
diameter) is beneficial for stable refinement. Scalepack Vers. 1.97.2 or its derivatives 
Scalepack8m, Scalepackbig or Scalepack_ribo (Otwinowski and Minor, 1997) were used when 
necessary to allow for a high amount of measured reflections. A total of 10 cycles of global 
refinement was carried out and the maximum resolution was set to the shell in which Rmerge was 
< 32 % or I/σ(I) was < 3.  
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30.3 Molecular replacement and phasing 
Intensity data were converted to structure factor amplitudes using scalepack2mtz (CCP4 4-5.0.2) 
(Collaborative Computational Project, 1994). Further conversion to CNS format was performed 
by mtz2various (Collaborative Computational Project, 1994). To obtain model phases, the 12-
subunit apo-Pol II model (Armache e t  a l . , 2004) was subjected to molecular replacement, using 
the program Phaser (Storoni e t  a l . , 2004), and the orientation was further improved by rigid-
body refinement  with CNS (Brunger e t  a l . , 1998). The clamp (residues 2-346 and 1395-1436 of 
Rpb1 and residues 1151-1224 of Rpb2) and the rest of the enzyme were defined as 2 independent 
rigid bodies in the case of the transcription bubble structure. Further subdivision into 6 rigid 
bodies was necessary for the TFIIS complex. Initial examination of the electron density of the 
Pol II-TFIIS complex showed that about one third of the Pol II mass underwent a 
conformational rearrangement. Therefore, following rigid bodies were defined: foot (Rpb1 877-
1081), Rpb5-jaw (2-137), Rpb2 N-terminus (1-852), Rpb1-jaw (1092-1330), Rpb9-jaw (2-51), 
clamp (Rpb1 2-346 and 1395-1436, and Rpb2 1151-1224) 
 
Rigid-body refinement was carried out in 2 cycles of 30 steps against e²e² as a refinement target. 
Electron density for the TFIIS complex could be further improved by solvent flipping (CNS), 
assuming a solvent content of 70 %. Solvent flipping could albeit not improve the quality of the 
electron density for the nucleic acid complexes, because initially observed density in the nucleic 
acid region was flattened out by solvent flipping. 
 
30.4 Anomalous Maps 
Anomalous Fourier maps were calculated by CNS using measured anomalous structure factor 
amplitude differences plus model phases derived as described above.  
 
30.5 Model Building 
30.5.1 Pol II-TFIIS complex 
After rigid body refinement and solvent flipping, clear electron density (3.8 Å resolution) was 
visible in a 2fo-fc map for the Pol II regions which moved upon TFIIS binding and for parts of 
TFIIS. Hence, these regions were fitted manually and by a second round of rigid-body 
refinement to match the electron density. Model maps calculated from this updated model gave 
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rise to consecutive difference electron density for most parts of the cocrystallised TFIIS variant. 
Since NMR models for domain II and III were available (Figure 27), these models were docked 
into the electron density maps as rigid bodies. Slight deviations from these NMR models were 
accounted for by manual rebuilding. A selenomethionine label in M182 of domain II served as a 
sequence marker. A newly ordered loop (trigger loop, residues 1078-1080 in Rpb1) was built 
manually into this electron density map, as well as parts of the TFIIS inter-domain linker, which 
is unstructured in solution (Figure 27). 
30.5.2 Pol II-nucleic acid complexes 
Modelling of nucleic acids started from the high-resolution coordinates of the minimal elongation 
complex (Gnatt e t  a l . , 2001) and from coordinates of a canonical B-DNA. At the given 
resolution, the phosphate backbone and most bases showed clear density, thus adjustments to 
the initial base positions were made, followed by positional and B-factor refinement. During this 
refinement, base-planarity and Watson-Crick base-pairing of paired bases was restrained.  
30.5.3 Refinement 
Positional refinement was carried out starting with a set of coordinates and B-factors derived as 
described (Armache e t  a l . , 2004). Starting B-factors for nucleic acids and for the refined part of 
TFIIS (residues 240-309) were set to 60 Å2. The set of reflections not included in the refinement 
was the same than the set used to refine the apo-Pol II structure (Armache e t  a l . , 2004).  The 
maximum likelihood function was used as a target for 20 steps each of positional and B-factor 
refinement.  
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